DENVER, Oct. 27, 2026 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (the “Company” or “NBHC”) reported:

                                           
    For the quarter(1)   For the nine months ended September 30(1)   2026 Adjusted (1)(2)
    3Q26   2Q26   3Q25   2026   2025   QTD   YTD
Net (loss) income ($000’s)   $ (8,761 )   $ 26,490     $ 35,285     $ 38,522     $ 93,538     $ 2,941     $ 70,860  
(Loss) earnings per share – diluted   $ (0.20 )   $ 0.58     $ 0.92     $ 0.84     $ 2.43     $ 0.06     $ 1.56  
Return on average assets     (0.28 )%     0.86 %     1.43 %     0.42 %     1.27 %     0.09 %     0.77 %
Return on average tangible assets(2)     (0.23 )%     0.96 %     1.54 %     0.50 %     1.38 %     0.16 %     0.87 %
Return on average equity     (2.07 )%     6.34 %     10.25 %     3.07 %     9.30 %     0.69 %     5.65 %
Return on average tangible common equity(2)     (2.32 )%     9.70 %     14.21 %     5.01 %     13.05 %     1.62 %     8.67 %

____________                            

(1 )   Ratios are annualized.
(2 )   Represents a non-GAAP financial measure. See “Non-GAAP Financial Measures and Reconciliations” tables for reconciliations to the most directly comparable financial measures calculated and presented in accordance with GAAP.

In announcing these results, Chief Executive Officer Tim Laney shared, “This was a deeply disappointing quarter. We reported a net loss of $8.8 million, driven primarily by $40.6 million of provision expense tied to a handful of specifically identified commercial credits, mainly in the franchise and healthcare industries.  We take these credit events seriously and have made a series of both personnel and process improvements in these specific coverage areas of our business. To that end, none of these actions were driven by our regulators, and we will be relentless in our focus to meet the highest standards of credit risk management.”

Mr. Laney added, “Our margin expansion and deposit growth are positive, and all integration activity has been a success. Our responsibility is to protect the bank while driving to our target of a dollar plus of earnings per share in the fourth quarter. While the third quarter represented a painful setback, I believe our team is more than capable of delivering for our clients, communities and shareholders.”

Third Quarter 2026 Results
(All comparisons refer to the second quarter of 2026, except as noted)

As previously announced, third quarter results were impacted by elevated provision expense related to specifically identified credits addressed during the quarter. During the third quarter of 2026, net loss totaled $8.8 million, or ($0.20) per diluted share, compared to net income of $26.5 million, or $0.58 per diluted share. The quarter’s results were impacted by $40.6 million of provision expense, $15.2 million of pre-tax acquisition and restructuring expense, and a $4.0 million impairment on a third-party FinTech partnership investment classified within other securities. Fully taxable equivalent pre-provision net revenue totaled $30.9 million, compared to $36.3 million. The return on average tangible assets totaled (0.23)%, compared to 0.96%, and the return on average tangible common equity totaled (2.32)%, compared to 9.70%. Adjusting for the $15.2 million of pre-tax acquisition and restructuring related expenses in the third quarter, adjusted net income totaled $2.9 million, or $0.06 per diluted share, and adjusted fully taxable equivalent pre-provision net revenue totaled $46.1 million. The adjusted return on average tangible assets totaled 0.16%, and the adjusted return on average tangible common equity totaled 1.62%.

Net Interest Income
Fully taxable equivalent net interest income increased $3.6 million to $115.2 million, primarily due to average interest earning assets growth of $69.9 million and one additional day during the third quarter. The fully taxable equivalent net interest margin expanded six basis points to 4.00%, driven by a nine basis point increase in earning asset yields. The cost of deposits increased one basis point to 1.94%.

Loans
Loans increased $119.4 million, or 4.9% annualized, to $9.9 billion at September 30, 2026. We generated quarterly loan fundings of $819.3 million, led by commercial loan fundings of $351.2 million.

Asset Quality and Provision for Credit Losses
The Company recorded provision expense of $40.6 million during the quarter, compared to $1.5 million. The increase was primarily driven by write downs on specifically identified commercial loans, principally within the franchise and healthcare industries, related to credit events impacting the third quarter. Annualized net charge-offs for the nine months ended September 30, 2026 totaled 0.85% of average total loans. Non-performing loans totaled 0.44% of total loans at September 30, 2026, compared to 0.31%, and non-performing assets totaled 0.50% of total loans and OREO at September 30, 2026, compared to 0.35%. The allowance for credit losses as a percentage of loans was 1.11% at September 30, 2026, compared to 1.13%.

Deposits
The Company maintains a low cost, diversified deposit franchise. Average total deposits increased $96.0 million to $10.3 billion, and average transaction deposits (defined as total deposits less time deposits) increased $102.9 million to $9.0 billion. The loan to deposit ratio totaled 93.8% at September 30, 2026, compared to 94.1%. The mix of transaction deposits to total deposits increased 20 basis points to 88.0% at September 30, 2026.

Non-Interest Income
Non-interest income totaled $13.5 million, compared to $19.8 million, during the second quarter. Other non-interest income decreased $5.9 million and included $4.0 million of impairment on a third-party FinTech partnership investment classified within other securities. Mortgage banking income decreased $0.6 million driven by the current rate environment. These decreases were partially offset by a $0.3 million increase in bank card fee income.

Non-Interest Expense
Non-interest expense totaled $97.8 million, compared to $95.0 million. Included in the third and second quarters were acquisition and restructuring related expenses of $15.2 million and $11.2 million, respectively. Excluding these items, third quarter adjusted non-interest expense decreased $1.1 million, to $82.6 million, compared to $83.7 million. The linked-quarter decrease reflects management’s continued execution on operational synergies following the successful third-quarter integration of Vista’s core systems. Third quarter’s expenses include one additional payroll day compared to the second quarter and $1.4 million of OREO and problem loan expenses. The fully taxable equivalent efficiency ratio totaled 76.0%, compared to 72.3%. The adjusted fully taxable equivalent efficiency ratio totaled 62.3%, compared to 61.8%.

Income tax benefit totaled $3.2 million, compared to income tax expense of $6.1 million in the previous quarter. The effective tax rate for the nine months ended September 30, 2026 was 17.3%, compared to 18.3% for the same period prior year.

Capital
Common book value per share totaled $36.71 at September 30, 2026, compared to $37.48 at June 30, 2026. Tangible book value per share totaled $25.37, compared to $26.23, primarily reflecting the quarterly dividend payment, share repurchases and an increase in accumulated other comprehensive loss due to changes in the interest rate environment.

NBHC executed $11.9 million of share buybacks in the third quarter as part of its ongoing capital strategy. Capital ratios continue to be well in excess of federal bank regulatory agency “well capitalized” thresholds. The tier 1 leverage ratio totaled 10.00%, and the common equity tier 1 capital ratio totaled 11.69% at September 30, 2026. Shareholders’ equity totaled $1.6 billion at September 30, 2026, compared to $1.7 billion.

Recent Events
On October 24, 2026, NBH Bank (the “Bank”) entered into a definitive agreement to sell its Palm Beach, Florida banking center location, including the banking center’s loans and deposits. The sale is expected to result in a reduction of the Bank’s total assets of approximately $0.2 billion, including total loans of approximately $0.2 billion, and a reduction of total deposits of approximately $0.2 billion. The agreement provides for a deposit premium of 5.00%, subject to a minimum deposit premium of $8.8 million. The Bank expects to close the transaction in mid-2027.

Year-Over-Year Review
(All comparisons refer to the first nine months of 2025, except as noted)

Net income totaled $38.5 million, or $0.84 per diluted share, compared to $93.5 million or $2.43 per diluted share. Current year results were impacted by $46.1 million of provision expense, primarily due to third quarter credit events within the franchise and healthcare industries, $42.0 million of pre-tax acquisition and restructuring expense, and a $4.0 million impairment on a third-party FinTech partnership investment classified within other securities. Fully taxable equivalent pre-provision net revenue totaled $99.4 million, compared to $129.0 million. The return on average tangible assets totaled 0.50%, compared to 1.38%, and the return on average tangible common equity totaled 5.01%, compared to 13.05%. Adjusting for $42.0 million and $1.7 million of pre-tax acquisition and restructuring related charges for the nine months 2026 and 2025, respectively, adjusted net income totaled $70.9 million, or $1.56 per diluted share, compared to adjusted net income of $94.9 million, or $2.47 per diluted share. Adjusted, the fully taxable equivalent pre-provision net revenue increased $10.6 million, or 8.1%, to $141.4 million. The adjusted return on average tangible assets totaled 0.87%, and the adjusted return on average tangible common equity totaled 8.67%.

Fully taxable equivalent net interest income increased $69.6 million, or 26.0%, to $337.7 million. Average earning assets increased $2.2 billion, or 24.4%, driven by $500.9 million of average originated loan growth and loans acquired through the Vista acquisition. The Vista acquisition added $1.9 billion in total loans on January 7, 2026. The fully taxable equivalent net interest margin expanded five basis points to 4.00%, primarily driven by an eight basis point improvement in the cost of funds.

Loans outstanding increased $2.5 billion, or 33.2%, to $9.9 billion. New loan fundings over the trailing twelve months totaled a record $3.1 billion, led by commercial fundings of $1.7 billion.

The Company recorded $46.1 million of provision expense for credit losses, compared to $8.7 million. The increase was primarily driven by write downs on specifically identified commercial loans, primarily within the franchise and healthcare industries, related to credit events impacting the third quarter. Annualized net charge-offs totaled 0.85%, compared to 0.27%. Non-performing loans totaled 0.44% of total loans at September 30, 2026, compared to 0.36%, and non-performing assets totaled 0.50% of total loans and OREO at September 30, 2026, compared to 0.37%. The allowance for credit losses as a percentage of loans totaled 1.11% at September 30, 2026, compared to 1.19% at September 30, 2025.

Average deposits increased $2.0 billion to $10.2 billion, and average transaction deposits increased $1.8 billion to $8.9 billion compared to the same period prior year. The mix of transaction deposits to total deposits increased 167 basis points to 88.0% at September 30, 2026. The Vista acquisition added $2.2 billion of total deposits, including $2.0 billion of transaction deposits and $0.2 billion of time deposits on January 7, 2026.

Non-interest income totaled $51.3 million, compared to $53.1 million, decreasing due to $4.0 million of impairment on a third-party FinTech partnership investment within other securities and a $1.8 million decrease in mortgage banking income driven by the current rate environment. These decreases were mostly offset by increases in our diversified sources of fee income including service charges, bank card fees, trust income and swap fee income.

Non-interest expense totaled $289.6 million, compared to $192.2 million. Included in the periods were $42.0 million and $1.7 million of acquisition and restructuring expenses during the nine months ended September 30, 2026 and 2025, respectively. Excluding these items, the current period adjusted non-interest expense totaled $247.8 million, an increase from the same period prior year primarily due to our recent acquisition. Occupancy and equipment expense during the nine months ended September 30, 2026, included a full period of 2UniFiSM capitalized asset depreciation in connection with the launch of 2UniFi in the third quarter of 2025. The fully taxable equivalent efficiency ratio totaled 74.5%, compared to 59.8% in the same period prior year. The adjusted fully taxable equivalent efficiency ratio totaled 61.8% for the nine months ended September 30, 2026, compared to 57.5%.

Income tax expense decreased $13.0 million to $8.0 million driven by lower pre-tax income in the current period. The effective tax rate was 17.3%, compared to 18.3% in the prior year.

Conference Call
Management will host a conference call to review the results at 11:00 a.m. Eastern Time on Wednesday, October 28, 2026. The call may also include discussion of company developments, forward-looking statements and other material information about business and financial matters. Interested parties may listen to this call by dialing (800) 330-6710 using the participant passcode of 3883449 and asking for the NBHC Q3 2026 Earnings Call. The earnings release and a link to the replay of the call will be available on the Company’s website at www.nationalbankholdings.com by visiting the investor relations area.

About National Bank Holdings Corporation
National Bank Holdings Corporation is a bank holding company created to build a leading community bank franchise, delivering high quality client service and committed to stakeholder results. Through its bank subsidiaries, NBH Bank and 2UniFi Bank, National Bank Holdings Corporation operates a network of over 90 banking centers, serving individual consumers, small, medium and large businesses, and government and non-profit entities. Its banking centers are located in its core footprint of Colorado, the greater Kansas City region, Texas, Utah, Wyoming, New Mexico, Idaho, and Palm Beach, Florida. Its comprehensive residential mortgage banking group primarily serves the bank’s core footprint. Its trust and wealth management business is operated through its trust and wealth department under Bank of Jackson Hole Trust & Wealth, a division of NBH Bank. NBH Bank operates its core banking business under a single state charter through the following brand names as divisions of NBH Bank: in Colorado, Community Banks of Colorado and Community Banks Mortgage; in Kansas and Missouri, Bank Midwest and Bank Midwest Mortgage; in Texas, Utah, New Mexico, Idaho, in Palm Beach, Florida, Vista Bank; and in Wyoming, Bank of Jackson Hole, Bank of Jackson Hole Mortgage and Bank of Jackson Hole Trust & Wealth. Additional information about National Bank Holdings Corporation can be found at www.nationalbankholdings.com.

For more information visit: cobnks.com, bankmw.com, bankofjacksonhole.com, vistabank.com, or nbhbank.com, or connect with any of our brands on LinkedIn.

About Non-GAAP Financial Measures
Certain financial measures and ratios we present are supplemental measures that are not required by, or are not presented in accordance with, U.S. generally accepted accounting principles (GAAP). We refer to these financial measures and ratios as “non-GAAP financial measures.” We consider the use of select non-GAAP financial measures and ratios to be useful for financial and operational decision making and useful in evaluating period-to-period comparisons. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain expenditures or assets that we believe are not indicative of our primary business operating results. We believe that management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, analyzing and comparing past, present and future periods.

These non-GAAP financial measures should not be considered a substitute for financial information presented in accordance with GAAP and you should not rely on non-GAAP financial measures alone as measures of our performance. The non-GAAP financial measures we present may differ from non-GAAP financial measures used by our peers or other companies. We compensate for these differences by providing the equivalent GAAP measures whenever we present the non-GAAP financial measures and by including a reconciliation of the impact of the components adjusted for in the non-GAAP financial measure so that both measures and the individual components may be considered when analyzing our performance. A reconciliation of non-GAAP financial measures to the comparable GAAP financial measures is included at the end of the financial statement tables.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements do not discuss historical facts but instead relate to expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance. Forward-looking statements are generally identified by words such as “anticipate,” “believe,” “can,” “would,” “should,” “could,” “may,” “predict,” “seek,” “potential,” “will,” “estimate,” “target,” “plan,” “projected,” “continuing,” “ongoing,” “expect,” “intend,” “goal,” “focus,” “maintains,” “future,” “ultimately,” “likely,” “ensure,” “strategy,” “objective,” and similar words or phrases. These statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties. We have based these statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, liquidity, results of operations, business strategy and growth prospects. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements due to a number of factors, including, but not limited to, business and economic conditions along with external events, both generally and in the financial services industry; susceptibility to credit risk and fluctuations in the value of real estate and other collateral securing a significant portion of our loan portfolio, including with regards to real estate acquired through foreclosure, and the accuracy of appraisals related to such real estate; changes impacting monetary supply and the businesses of our clients and counterparties, including levels of market interest rates, inflation, currency values, monetary, fiscal, and international trade policy, and the volatility of trading markets; our ability to maintain sufficient liquidity to meet the requirements of deposit withdrawals and other business needs; our desire to raise additional capital in connection with strategic growth initiatives and our ability to access the capital markets when desired or on favorable terms; changes in the fair value of our investment securities can fluctuate due to market conditions outside of our control; our investments in financial technology companies and initiatives may subject us to material financial, reputational and strategic risks; the allowance for credit losses and fair value adjustments may be insufficient to absorb losses in our loan portfolio (including due to fluctuations in collateral value, the ability of the borrower to repay and the results of outstanding litigation related to the realization of collateral); any service interruptions, cyber incidents or other breaches relating to our technology systems, security systems or infrastructure or those of our third-party providers; the occurrence of fraud or other financial crimes within our business; competition from other financial services providers, including traditional financial institutions and financial technology companies, and the effects of disintermediation within the banking business including consolidation within the industry; changes to federal government lending programs like the Small Business Administration’s Preferred Lender Program and the Federal Housing Administration’s insurance programs, including the impact of changes in regulations, budget appropriations and a prolonged government shutdown on such programs; impairment of our mortgage servicing rights, disruption in the secondary market for mortgage loans, declines in real estate values, or being required to repurchase mortgage loans or reimburse investors; claims and litigation related to our fiduciary responsibilities in connection with our trust and wealth business; our ability to manage and execute our organic growth and acquisition strategies, including our ability to realize the expected benefits of our acquisition strategies; developments in technology, such as artificial intelligence, the success of our digital growth strategy, and our ability to incorporate innovative technologies in our business and provide products and services that satisfy our clients’ expectations for convenience and security; our ability to integrate Vista Bank into our business may be more difficult, costly or time consuming than expected and we may fail to realize the anticipated benefits or cost savings of the merger; failure to obtain regulatory approvals or consummate attractive acquisitions or continue to increase organic loan growth would restrict our growth plans; the accuracy of projected operating results for assets and businesses we acquire as well as our ability to drive organic loan growth to replace loans in our existing portfolio with comparable loans as loans are paid down; our ability to comply with and manage costs related to extensive and potentially expanding government regulation and supervision, including current and future regulations affecting bank holding companies and depository institutions; our ability to execute our capital allocation strategy, including paying dividends or repurchasing shares, is subject to regulatory limitations; the application of any increased assessment rates imposed by the Federal Deposit Insurance Corporation; claims or legal action brought against us by third parties or government agencies; the loss of our executive officers and key personnel; changes to federal, state and local laws and regulations along with executive orders applicable to our business, including tax laws; and other factors, risks, trends and uncertainties described elsewhere in our other filings with the Securities and Exchange Commission. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events or circumstances, except as required by applicable law.

Contacts:
Analysts/Institutional Investors:
Emily Gooden, Chief Accounting Officer and Investor Relations Director, (720) 554-6640, ir@nationalbankholdings.com
Nicole Van Denabeele, Chief Financial Officer, (720) 529-3370, ir@nationalbankholdings.com

Media:
Dave Coons, SVP, Associate Director of Corporate Communications and Marketing, (816) 298-2214, dave.coons@nbhbank.com 

NATIONAL BANK HOLDINGS CORPORATION
FINANCIAL SUMMARY
Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except share and per share data)

  For the three months ended   For the nine months ended
  September 30,       June 30,       September 30,    September 30,       September 30, 
  2026   2026   2025   2026   2025
Total interest and dividend income $ 167,335     $ 162,004   $ 132,238     $ 488,490   $ 393,421
Total interest expense   54,435       52,712     44,038       157,496     131,121
Net interest income   112,900       109,292     88,200       330,994     262,300
Taxable equivalent adjustment   2,272       2,239     1,985       6,693     5,807
Net interest income FTE(1)   115,172       111,531     90,185       337,687     268,107
Provision expense (release) for credit losses   40,635       1,500     (1,500 )     46,135     8,700
Net interest income after provision for credit losses FTE(1)   74,537       110,031     91,685       291,552     259,407
Non-interest income:                            
Service charges   4,456       4,501     4,340       13,149     12,585
Bank card fees   4,929       4,616     4,505       13,879     13,431
Mortgage banking income   1,796       2,423     2,895       6,961     8,757
Other non-interest income   2,357       8,226     8,951       17,048     18,360
Gain on security sales   —       —     —       246     —
Total non-interest income   13,538       19,766     20,691       51,283     53,133
Non-interest expense:                            
Salaries and benefits   56,869       54,366     37,779       168,205     109,887
Occupancy and equipment   16,838       16,154     12,383       48,825     32,656
Professional fees   2,142       3,002     3,249       7,376     6,352
Data processing   7,663       7,945     4,751       23,261     13,604
Other non-interest expense   11,847       11,050     7,138       34,582     23,825
Other intangible assets amortization   2,433       2,433     1,946       7,330     5,870
Total non-interest expense   97,792       94,950     67,246       289,579     192,194
                             
(Loss) income before income taxes FTE(1)   (9,717 )     34,847     45,130       53,256     120,346
Taxable equivalent adjustment   2,272       2,239     1,985       6,693     5,807
(Loss) income before income taxes   (11,989 )     32,608     43,145       46,563     114,539
Income tax (benefit) expense   (3,228 )     6,118     7,860       8,041     21,001
Net (loss) income $ (8,761 )   $ 26,490   $ 35,285     $ 38,522   $ 93,538
(Loss) earnings per share – basic $ (0.20 )   $ 0.58   $ 0.92     $ 0.85   $ 2.44
(Loss) earnings per share – diluted   (0.20 )     0.58     0.92       0.84     2.43
Common stock dividend   0.32       0.32     0.30        0.96     0.89

____________                                 

(1 )      Net interest income is presented on a GAAP basis and fully taxable equivalent (FTE) basis, as the Company believes this non-GAAP measure is the preferred industry measurement for this item. The FTE adjustment is for the tax benefit on certain tax exempt loans using the federal tax rate of 21% for each period presented.

NATIONAL BANK HOLDINGS CORPORATION
Consolidated Statements of Financial Condition (Unaudited)
(Dollars in thousands, except share and per share data)

                       
  September 30,
2026

    June 30, 
2026
    December 31, 
2025
       September 30, 
2025
 
ASSETS                      
Cash and cash equivalents $ 364,798     $ 380,696     $ 417,058     $ 555,560  
Investment securities available-for-sale   638,085       585,533       528,639       612,719  
Investment securities held-to-maturity   725,921       758,223       651,732       689,486  
Other securities   100,134       99,184       80,634       80,526  
Loans   9,893,448       9,774,052       7,433,356       7,429,501  
Allowance for credit losses   (109,866 )     (110,271 )     (87,415 )     (88,280 )
Loans, net   9,783,582       9,663,781       7,345,941       7,341,221  
Loans held for sale   12,578       26,486       25,695       22,252  
Other real estate owned   5,082       4,174       1,674       658  
Premises and equipment, net   232,244       234,139       214,554       211,436  
Goodwill   459,481       455,408       306,043       306,043  
Intangible assets, net   61,881       64,631       48,337       50,331  
Other assets   343,354       313,881       263,211       282,454  
Total assets $ 12,727,140     $ 12,586,136     $ 9,883,518     $ 10,152,686  
LIABILITIES AND SHAREHOLDERS’ EQUITY                      
Liabilities:                      
Non-interest bearing demand deposits $ 2,656,315     $ 2,575,684     $ 2,204,241     $ 2,255,495  
Interest bearing demand deposits   1,626,488       1,568,250       1,237,006       1,223,602  
Savings and money market   4,994,262       4,975,841       3,701,616       3,832,460  
Total transaction deposits   9,277,065       9,119,775       7,142,863       7,311,557  
Time deposits   1,267,968       1,269,658       1,149,771       1,160,123  
Total deposits   10,545,033       10,389,433       8,292,634       8,471,680  
Securities sold under agreements to repurchase   22,479       20,239       17,350       21,303  
Long-term debt   201,884       202,003       54,540       54,743  
Federal Home Loan Bank advances   125,000       125,000       —       —  
Other liabilities   206,847       180,357       133,880       230,031  
Total liabilities   11,101,243       10,917,032       8,498,404       8,777,757  
Shareholders’ equity:                      
Common stock   588       588       515       515  
Additional paid in capital   1,467,649       1,460,627       1,171,581       1,169,982  
Retained earnings   567,146       590,437       572,461       568,276  
Treasury stock   (344,511 )     (333,131 )     (315,397 )     (312,873 )
Accumulated other comprehensive loss, net of tax   (64,975 )     (49,417 )     (44,046 )     (50,971 )
Total shareholders’ equity   1,625,897       1,669,104       1,385,114       1,374,929  
Total liabilities and shareholders’ equity $ 12,727,140     $ 12,586,136     $ 9,883,518     $ 10,152,686  
SHARE DATA                      
Average basic shares outstanding   44,451,388       44,665,184       37,803,728       37,911,643  
Average diluted shares outstanding   44,758,349       44,915,790       37,922,557       38,034,473  
Ending shares outstanding   44,285,618       44,537,718       37,772,516       37,815,589  
Common book value per share $ 36.71     $ 37.48     $ 36.67     $ 36.36  
Tangible book value per share (non-GAAP)(1)   25.37       26.23       27.80       27.45  
CAPITAL RATIOS                      
Average equity to average assets   13.50 %     13.53 %     14.21 %     13.94 %
Tangible common equity to tangible assets (non-GAAP)(1)   9.19 %     9.67 %     11.00 %     10.57 %
Tier 1 leverage ratio   10.00 %     10.30 %     11.56 %     11.49 %
Common equity tier 1 risk-based capital ratio   11.69 %     12.29 %     14.89 %     14.69 %
Tier 1 risk-based capital ratio   11.69 %     12.29 %     14.89 %     14.69 %
Total risk-based capital ratio   14.74 %     15.42 %     16.82 %     16.63 %

____________                        

(1 )      Represents a non-GAAP financial measure. See “Non-GAAP Financial Measures and Reconciliations” starting on page 15.
       

NATIONAL BANK HOLDINGS CORPORATION
Loan Portfolio
(Dollars in thousands)

Period End Loan Balances by Type

                         
          September 30, 2026       September 30, 2026
          vs. June 30, 2026       vs. September 30, 2025
  September 30, 2026   June 30, 2026   % Change   September 30, 2025   % Change
Originated:                        
Commercial:                        
Commercial and industrial $ 2,288,210   $ 2,193,328   4.3 %   $ 1,877,645   21.9 %
Municipal and non-profit   1,278,627     1,296,609   (1.4 %)     1,189,677   7.5 %
Owner-occupied commercial real estate   923,026     926,686   (0.4 %)     986,868   (6.5 %)
Food and agribusiness   218,896     207,031   5.7 %     211,940   3.3 %
Total commercial   4,708,759     4,623,654   1.8 %     4,266,130   10.4 %
Commercial real estate non-owner occupied   1,632,937     1,434,867   13.8 %     1,069,815   52.6 %
Residential real estate   1,142,226     1,033,943   10.5 %     914,168   24.9 %
Consumer   12,356     13,645   (9.4 %)     12,757   (3.1 %)
Total originated   7,496,278     7,106,109   5.5 %     6,262,870   19.7 %
                         
Acquired:                        
Commercial:                        
Commercial and industrial   478,692     566,984   (15.6 %)     95,015   403.8 %
Municipal and non-profit   234     240   (2.5 %)     259   (9.7 %)
Owner-occupied commercial real estate   361,778     382,970   (5.5 %)     189,408   91.0 %
Food and agribusiness   30,314     31,451   (3.6 %)     29,506   2.7 %
Total commercial   871,018     981,645   (11.3 %)     314,188   177.2 %
Commercial real estate non-owner occupied   1,088,408     1,215,762   (10.5 %)     570,062   90.9 %
Residential real estate   436,833     469,518   (7.0 %)     282,026   54.9 %
Consumer   911     1,018   (10.5 %)     355   156.6 %
Total acquired   2,397,170     2,667,943   (10.1 %)     1,166,631   105.5 %
Total loans $ 9,893,448   $ 9,774,052   1.2 %   $ 7,429,501   33.2 %

Loan Fundings(1)

                             
  Third quarter   Second quarter   First quarter   Fourth quarter   Third quarter
  2026   2026   2026   2025   2025
Commercial:                            
Commercial and industrial $ 286,624   $ 293,094   $ 346,250   $ 237,813   $ 159,250
Municipal and non-profit   15,852     50,506     45,000     119,918     81,418
Owner occupied commercial real estate   35,314     84,606     49,556     66,798     42,362
Food and agribusiness   13,371     24,251     5,697     4,437     5,015
Total commercial   351,161     452,457     446,503     428,966     288,045
Commercial real estate non-owner occupied   312,364     352,629     268,021     96,482     81,136
Residential real estate   154,868     120,340     89,375     64,161     49,877
Consumer   860     1,460     1,583     1,399     2,142
Total $ 819,253   $ 926,886   $ 805,482   $ 591,008   $ 421,200

____________                                                

(1 )      Loan fundings are defined as closed end funded loans and net fundings under revolving lines of credit. Net fundings (paydowns) under revolving lines of credit were $123,946, $178,133, $65,273, $95,744, and ($1,591) for the periods noted in the table above, respectively.
       

NATIONAL BANK HOLDINGS CORPORATION
Summary of Net Interest Margin
(Dollars in thousands)

                                                       
    For the three months ended   For the three months ended   For the three months ended
    September 30, 2026   June 30, 2026   September 30, 2025
    Average               Average      Average               Average      Average               Average
    balance   Interest   rate   balance   Interest   rate   balance   Interest   rate
Interest earning assets:                                                      
Originated loans FTE(1)(2)   $ 7,242,490     $ 110,606     6.06 %   $ 6,762,456     $ 102,709     6.09 %   $ 6,213,268     $ 103,600     6.62 %
Acquired loans     2,555,867       46,146     7.16 %     2,867,500       47,819     6.69 %     1,183,171       18,151     6.09 %
Loans held for sale     18,273       262     5.69 %     21,612       316     5.86 %     21,964       366     6.61 %
Investment securities available-for-sale     645,657       4,430     2.74 %     663,636       4,619     2.78 %     693,173       4,679     2.70 %
Investment securities held-to-maturity     774,413       6,249     3.23 %     791,847       6,327     3.20 %     705,927       5,313     3.01 %
Other securities     43,686       744     6.81 %     41,977       688     6.56 %     32,461       409     5.04 %
Interest earning deposits     132,863       1,170     3.49 %     194,358       1,765     3.64 %     149,867       1,705     4.51 %
Total interest earning assets FTE(2)   $ 11,413,249     $ 169,607     5.90 %   $ 11,343,386     $ 164,243     5.81 %   $ 8,999,831     $ 134,223     5.92 %
Cash and due from banks   $ 95,446                 $ 95,632                 $ 78,598              
Other assets     1,042,235                   1,054,388                   806,872              
Allowance for credit losses     (112,023 )                 (114,769 )                 (88,787 )            
Total assets   $ 12,438,907                 $ 12,378,637                 $ 9,796,514              
Interest bearing liabilities:                                                      
Interest bearing demand, savings and money market deposits   $ 6,474,638     $ 39,974     2.45 %   $ 6,393,003     $ 38,371     2.41 %   $ 4,929,785     $ 33,095     2.66 %
Time deposits     1,264,037       10,380     3.26 %     1,270,963       10,530     3.32 %     1,111,958       9,791     3.49 %
Federal Home Loan Bank advances     95,561       945     3.92 %     89,188       855     3.85 %     33,682       391     4.61 %
Other borrowings(3)     47,001       227     1.92 %     37,202       167     1.80 %     34,429       242     2.79 %
Long-term debt     202,011       2,909     5.71 %     202,144       2,789     5.53 %     54,471       519     3.78 %
Total interest bearing liabilities   $ 8,083,248     $ 54,435     2.67 %   $ 7,992,500     $ 52,712     2.65 %   $ 6,164,325     $ 44,038     2.83 %
Demand deposits   $ 2,542,154                 $ 2,520,897                 $ 2,150,330              
Other liabilities     134,269                   189,969                   116,548              
Total liabilities     10,759,671                   10,703,366                   8,431,203              
Shareholders’ equity     1,679,236                   1,675,271                   1,365,311              
Total liabilities and shareholders’ equity   $ 12,438,907                 $ 12,378,637                 $ 9,796,514              
Net interest income FTE(2)         $ 115,172               $ 111,531               $ 90,185      
Interest rate spread FTE(2)                 3.23 %                 3.16 %                 3.09 %
Net interest earning assets   $ 3,330,001                 $ 3,350,886                 $ 2,835,506              
Net interest margin FTE(2)                 4.00 %                 3.94 %                 3.98 %
Average transaction deposits   $ 9,016,792                 $ 8,913,900                 $ 7,080,115              
Average total deposits     10,280,829                   10,184,863                   8,192,073              
Ratio of average interest earning assets to average interest bearing liabilities     141.20 %                 141.93 %                 146.00 %            

____________                       

(1 )      Originated loans are net of deferred loan fees, less costs, which are included in interest income over the life of the loan.
(2 )      Presented on a fully taxable equivalent basis using the statutory tax rate of 21%. The tax equivalent adjustments included above are $2,272, $2,239 and $1,985 for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, respectively.
(3 )      Other borrowings includes securities sold under agreements to repurchase and cash collateral received from counterparties in connection with derivative swap agreements.
       

NATIONAL BANK HOLDINGS CORPORATION
Summary of Net Interest Margin
(Dollars in thousands)

                               
  For the nine months ended September 30, 2026   For the nine months ended September 30, 2025
  Average              Average   Average              Average
  balance   Interest   rate   balance   Interest   rate
Interest earning assets:                              
Originated loans FTE(1)(2) $ 6,779,938     $ 310,373   6.12 %   $ 6,279,001     $ 308,220   6.56 %
Acquired loans   2,789,118       143,780   6.89 %     1,265,326       57,095   6.03 %
Loans held for sale   19,479       862   5.92 %     20,953       1,069   6.82 %
Investment securities available-for-sale   667,603       14,050   2.81 %     703,442       13,957   2.65 %
Investment securities held-to-maturity   752,761       17,726   3.14 %     685,278       14,606   2.84 %
Other securities   40,949       1,948   6.34 %     31,473       1,355   5.74 %
Interest earning deposits   233,342       6,444   3.69 %     85,608       2,926   4.57 %
Total interest earning assets FTE(2) $ 11,283,190     $ 495,183   5.87 %   $ 9,071,081     $ 399,228   5.88 %
Cash and due from banks $ 96,870               $ 78,327            
Other assets   1,045,708                 803,544            
Allowance for credit losses   (108,018 )               (91,499 )          
Total assets $ 12,317,750               $ 9,861,453            
Interest bearing liabilities:                              
Interest bearing demand, savings and money market deposits $ 6,377,358     $ 115,532   2.42 %   $ 4,980,629     $ 98,364   2.64 %
Time deposits   1,287,835       32,092   3.33 %     1,070,419       27,634   3.45 %
Federal Home Loan Bank advances   64,607       1,952   4.04 %     77,900       2,666   4.58 %
Other borrowings(3)   38,196       518   1.81 %     41,944       902   2.88 %
Long-term debt   180,055       7,402   5.50 %     54,528       1,555   3.81 %
Total interest bearing liabilities $ 7,948,051     $ 157,496   2.65 %   $ 6,225,420     $ 131,121   2.82 %
Demand deposits $ 2,533,089               $ 2,166,671            
Other liabilities   158,689                 124,546            
Total liabilities   10,639,829                 8,516,637            
Shareholders’ equity   1,677,921                 1,344,816            
Total liabilities and shareholders’ equity $ 12,317,750               $ 9,861,453            
Net interest income FTE(2)       $ 337,687             $ 268,107    
Interest rate spread FTE(2)             3.22 %               3.06 %
Net interest earning assets $ 3,335,139               $ 2,845,661            
Net interest margin FTE(2)             4.00 %               3.95 %
Average transaction deposits $ 8,910,447               $ 7,147,300            
Average total deposits   10,198,282                 8,217,719            
Ratio of average interest earning assets to average interest bearing liabilities   141.96 %               145.71 %          

____________                     

(1 )      Originated loans are net of deferred loan fees, less costs, which are included in interest income over the life of the loan.
(2 )      Presented on a fully taxable equivalent basis using the statutory tax rate of 21%. The tax equivalent adjustments included above are $6,693 and $5,807 for the nine months ended September 30, 2026 and September 30, 2025, respectively.
(3 )      Other borrowings includes securities sold under agreements to repurchase and cash collateral received from counterparties in connection with derivative swap agreements.
       

NATIONAL BANK HOLDINGS CORPORATION
Allowance for Credit Losses and Asset Quality
(Dollars in thousands)

Allowance for Credit Losses Analysis

                 
  As of and for the three months ended
  September 30, 2026   June 30, 2026   September 30, 2025
Beginning allowance for credit losses $ 110,271     $ 113,477     $ 88,893  
Allowance for credit loss at acquisition   5,164       2,473       —  
Charge-offs   (47,208 )     (6,508 )     (1,617 )
Recoveries   888       79       2,504  
Provision expense (release) for credit losses on loans   40,751       750       (1,500 )
Ending allowance for credit losses (“ACL”) $ 109,866     $ 110,271     $ 88,280  
Ratio of annualized net charge-offs (recoveries) to average total loans during the period   1.88 %     0.27 %     (0.05 )%
Ratio of ACL to total loans outstanding at period end   1.11 %     1.13 %     1.19 %
Ratio of ACL to total non-performing loans at period end   250.17 %     365.97 %     330.45 %
Total loans $ 9,893,448     $ 9,774,052     $ 7,429,501  
Average total loans during the period   9,771,279       9,608,203       7,376,685  
Total non-performing loans   43,917       30,131       26,715  

Past Due and Non-accrual Loans

                 
  September 30, 2026   June 30, 2026   September 30, 2025
Loans 90 days past due and still accruing interest $ 16,762     $ 29,112     $ 12,120  
Non-accrual loans   43,917       30,131       26,715  
Total 90 days past due and non-accrual loans $ 60,679     $ 59,243     $ 38,835  
Total 90 days past due and still accruing interest and non-accrual loans to total loans   0.61 %     0.61 %     0.52 %
                 
Loans 30-89 days past due and still accruing interest $ 14,010     $ 17,169     $ 14,288  

     

Asset Quality Data

                 
  September 30, 2026   June 30, 2026   September 30, 2025
Non-performing loans $ 43,917     $ 30,131     $ 26,715  
OREO   5,082       4,174       658  
Total non-performing assets $ 48,999     $ 34,305     $ 27,373  
Total non-performing loans to total loans   0.44 %     0.31 %     0.36 %
Total non-performing assets to total loans and OREO   0.50 %     0.35 %     0.37 %

NATIONAL BANK HOLDINGS CORPORATION
Key Metrics(1)

                             
  As of and for the three months ended   As of and for the nine months ended
  September 30,    June 30,    September 30,    September 30,    September 30, 
  2026   2026   2025   2026   2025
Return on average assets   (0.28 )%     0.86 %     1.43 %     0.42 %     1.27 %
Return on average tangible assets(2)   (0.23 )%     0.96 %     1.54 %     0.50 %     1.38 %
Adjusted return on average tangible assets(2)   0.16 %     1.26 %     1.60 %     0.87 %     1.40 %
Return on average equity   (2.07 )%     6.34 %     10.25 %     3.07 %     9.30 %
Return on average tangible common equity(2)   (2.32 )%     9.70 %     14.21 %     5.01 %     13.05 %
Adjusted return on average tangible common equity(2)   1.62 %     12.71 %     14.72 %     8.67 %     13.23 %
Loan to deposit ratio (end of period)   93.82 %     94.08 %     87.70 %     93.82 %     87.70 %
Non-interest bearing deposits to total deposits (end of period)   25.19 %     24.79 %     26.62 %     25.19 %     26.62 %
Net interest margin(3)   3.92 %     3.86 %     3.89 %     3.92 %     3.87 %
Net interest margin FTE(3)(4)   4.00 %     3.94 %     3.98 %     4.00 %     3.95 %
Interest rate spread FTE(4)(5)   3.23 %     3.16 %     3.09 %     3.22 %     3.06 %
Yield on earning assets(6)   5.82 %     5.73 %     5.83 %     5.79 %     5.80 %
Yield on earning assets FTE(4)(6)   5.90 %     5.81 %     5.92 %     5.87 %     5.88 %
Cost of funds   2.03 %     2.01 %     2.10 %     2.01 %     2.09 %
Cost of deposits   1.94 %     1.93 %     2.08 %     1.94 %     2.05 %
Non-interest income to total revenue FTE(4)(7)   10.52 %     15.05 %     18.66 %     13.18 %     16.54 %
Efficiency ratio FTE(4)   75.98 %     72.32 %     60.65 %     74.45 %     59.83 %
Adjusted efficiency ratio FTE(2)(4)   62.28 %     61.81 %     57.32 %     61.79 %     57.46 %
Pre-provision net revenue FTE(2)(4)   30,918       36,347       43,630       99,391       129,046  
Adjusted pre-provision net revenue FTE(2)(4)   46,113       47,795       45,374       141,383       130,790  
                             
Total Loans Asset Quality Data(8)(9)                            
Non-performing loans to total loans   0.44 %     0.31 %     0.36 %     0.44 %     0.36 %
Non-performing assets to total loans and OREO   0.50 %     0.35 %     0.37 %     0.50 %     0.37 %
Allowance for credit losses to total loans   1.11 %     1.13 %     1.19 %     1.11 %     1.19 %
Allowance for credit losses to non-performing loans   250.17 %     365.97 %     330.45 %     250.17 %     330.45 %
Net charge-offs (recoveries) to average loans   1.88 %     0.27 %     (0.05 )%     0.85 %     0.27 %

____________                

(1 )      Ratios are annualized.
(2 )      Ratio represents non-GAAP financial measure. See “Non-GAAP Financial Measures and Reconciliations” starting on page 15.
(3 )   Net interest margin represents net interest income, including accretion income on interest earning assets, as a percentage of average interest earning assets.
(4 )   Presented on a fully taxable equivalent basis using the statutory tax rate of 21%. The tax equivalent adjustments included above are $2,272, $2,239 and $1,985 for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, respectively, and $6,693 and $5,807 for the nine months ended September 30, 2026 and September 30, 2025, respectively.
(5 )      Interest rate spread represents the difference between the weighted average yield on interest earning assets, including FTE income, and the weighted average cost of interest bearing liabilities. Ratio represents a non-GAAP financial measure.
(6 )   Interest earning assets include assets that earn interest/accretion or dividends. Any market value adjustments on investment securities or loans are excluded from interest earning assets.
(7 )   Non-interest income to total revenue represents non-interest income divided by the sum of net interest income FTE and non-interest income.
(8 )   Non-performing loans consist of non-accruing loans.
(9 )   Total loans are net of unearned discounts and fees.
       

NATIONAL BANK HOLDINGS CORPORATION
NON-GAAP FINANCIAL MEASURES AND RECONCILIATIONS
(Dollars in thousands, except share and per share data)

Tangible Book Value Ratios

                         
    September 30, 2026   June 30, 2026      December 31, 2025   September 30, 2025
Total shareholders’ equity   $ 1,625,897     $ 1,669,104     $ 1,385,114     $ 1,374,929  
Less: goodwill and other intangible assets, net     (516,615 )     (514,975 )     (348,961 )     (350,907 )
Add: deferred tax liability related to goodwill     14,257       14,154       13,947       13,844  
Tangible common equity (non-GAAP)   $ 1,123,539     $ 1,168,283     $ 1,050,100     $ 1,037,866  
                         
Total assets   $ 12,727,140     $ 12,586,136     $ 9,883,518     $ 10,152,686  
Less: goodwill and other intangible assets, net     (516,615 )     (514,975 )     (348,961 )     (350,907 )
Add: deferred tax liability related to goodwill     14,257       14,154       13,947       13,844  
Tangible assets (non-GAAP)   $ 12,224,782     $ 12,085,315     $ 9,548,504     $ 9,815,623  
                         
Tangible common equity to tangible assets calculations:                        
Total shareholders’ equity to total assets     12.78 %     13.26 %     14.01 %     13.54 %
Less: impact of goodwill and other intangible assets, net     (3.59 )%     (3.59 )%     (3.01 )%     (2.97 )%
Tangible common equity to tangible assets (non-GAAP)     9.19 %     9.67 %     11.00 %     10.57 %
                         
Tangible book value per share calculations:                        
Tangible common equity (non-GAAP)   $ 1,123,539     $ 1,168,283     $ 1,050,100     $ 1,037,866  
Divided by: ending shares outstanding     44,285,618       44,537,718       37,772,516       37,815,589  
Tangible book value per share (non-GAAP)   $ 25.37     $ 26.23     $ 27.80     $ 27.45  
                                 

NATIONAL BANK HOLDINGS CORPORATION
(Dollars in thousands, except share and per share data)
Return on Average Tangible Assets and Return on Average Tangible Equity

                               
    As of and for the three months ended   As of and for the nine months ended
    September 30,       June 30,       September 30,       September 30,       September 30, 
    2026      2026      2025      2026      2025
Net (loss) income   $ (8,761 )   $ 26,490     $ 35,285     $ 38,522     $ 93,538  
Add: adjustments, after tax (non-GAAP)(1)     11,702       8,813       1,336       32,338       1,336  
Adjusted net income (non-GAAP)(1)   $ 2,941     $ 35,303     $ 36,621     $ 70,860     $ 94,874  
                               
Net (loss) income   $ (8,761 )   $ 26,490     $ 35,285     $ 38,522     $ 93,538  
Add: impact of other intangible assets amortization expense, after tax (non-GAAP)     1,874       1,873       1,491       5,645       4,497  
Net (loss) income excluding the impact of other intangible assets amortization expense, after tax (non-GAAP)   $ (6,887 )   $ 28,363     $ 36,776     $ 44,167     $ 98,035  
                               
Net (loss) income excluding the impact of other intangible assets amortization expense, after tax (non-GAAP)   $ (6,887 )   $ 28,363     $ 36,776     $ 44,167     $ 98,035  
Add: adjustments, after tax (non-GAAP)(1)     11,702       8,813       1,336       32,338       1,336  
Adjusted net income excluding the impact of other intangible assets amortization expense (non-GAAP)(1)   $ 4,815     $ 37,176     $ 38,112     $ 76,505     $ 99,371  
                               
Average assets   $ 12,438,907     $ 12,378,637     $ 9,796,514     $ 12,317,750     $ 9,861,453  
Less: average goodwill and other intangible assets, net of deferred tax liability related to goodwill (non-GAAP)     (501,172 )     (502,057 )     (338,294 )     (498,106 )     (340,231 )
Average tangible assets (non-GAAP)   $ 11,937,735     $ 11,876,580     $ 9,458,220     $ 11,819,644     $ 9,521,222  
                               
Average shareholders’ equity   $ 1,679,236     $ 1,675,271     $ 1,365,311     $ 1,677,921     $ 1,344,816  
Less: average goodwill and other intangible assets, net of deferred tax liability related to goodwill (non-GAAP)     (501,172 )     (502,057 )     (338,294 )     (498,106 )     (340,231 )
Average tangible common equity (non-GAAP)   $ 1,178,064     $ 1,173,214     $ 1,027,017     $ 1,179,815     $ 1,004,585  
                               
Return on average assets     (0.28 )%     0.86 %     1.43 %     0.42 %     1.27 %
Adjusted return on average assets (non-GAAP)     0.09 %     1.14 %     1.48 %     0.77 %     1.29 %
Return on average tangible assets (non-GAAP)     (0.23 )%     0.96 %     1.54 %     0.50 %     1.38 %
Adjusted return on average tangible assets (non-GAAP)(1)     0.16 %     1.26 %     1.60 %     0.87 %     1.40 %
Return on average equity     (2.07 )%     6.34 %     10.25 %     3.07 %     9.30 %
Adjusted return on average equity (non-GAAP)     0.69 %     8.45 %     10.64 %     5.65 %     9.43 %
Return on average tangible common equity (non-GAAP)     (2.32 )%     9.70 %     14.21 %     5.01 %     13.05 %
Adjusted return on average tangible common equity (non-GAAP)(1)     1.62 %     12.71 %     14.72 %     8.67 %     13.23 %
                               
Adjustments:                              
Non-interest income adjustments:                              
Restructuring impairment(2)   $ —     $ 223     $ —     $ 223     $ —  
Non-interest expense adjustments:                              
Acquisition-related expenses(3)     14,696       10,890       1,744       39,928       1,744  
Restructuring expenses(2)     499       335       —       1,841       —  
Total non-interest expense adjustments, before tax (non-GAAP)     15,195       11,225       1,744       41,769       1,744  
                               
Total adjustments, before tax (non-GAAP)     15,195       11,448       1,744       41,992       1,744  
Tax benefit impact(4)     (3,493 )     (2,635 )     (408 )     (9,654 )     (408 )
Total adjustments, after tax (non-GAAP)   $ 11,702     $ 8,813     $ 1,336     $ 32,338     $ 1,336  

____________     

(1 )   For details, refer to the “Adjustments” section at the bottom of the table.
(2 )   Restructuring expenses and restructuring impairment are primarily related to banking center consolidation expenses and corporate personnel actions.
(3 )   Includes general acquisition-related expenses and Vista rebranding costs.
(4 )   Calculated using the company’s marginal tax rate of 23%. Certain acquisition-related expenses are non-deductible.
       

Efficiency Ratio and Pre-Provision Net Revenue

                               
    As of and for the three months ended   As of and for the nine months ended
       September 30,       June 30,       September 30,       September 30,       September 30, 
       2026      2026      2025      2026      2025
Net interest income FTE(1)   $ 115,172     $ 111,531     $ 90,185     $ 337,687     $ 268,107  
                               
Non-interest income   $ 13,538     $ 19,766     $ 20,691     $ 51,283     $ 53,133  
Add: restructuring impairment     —       223       —       223       —  
Adjusted non-interest income (non-GAAP)   $ 13,538     $ 19,989     $ 20,691     $ 51,506     $ 53,133  
                               
Non-interest expense   $ 97,792     $ 94,950     $ 67,246     $ 289,579     $ 192,194  
Less: other intangible assets amortization     (2,433 )     (2,433 )     (1,946 )     (7,330 )     (5,870 )
Less: acquisition-related expenses and restructuring expenses     (15,195 )     (11,225 )     (1,744 )     (41,769 )     (1,744 )
Adjusted non-interest expense, excluding other intangible assets amortization (non-GAAP)   $ 80,164     $ 81,292     $ 63,556     $ 240,480     $ 184,580  
                               
Non-interest expense   $ 97,792     $ 94,950     $ 67,246     $ 289,579     $ 192,194  
Less: acquisition-related expenses and restructuring expenses     (15,195 )     (11,225 )     (1,744 )     (41,769 )     (1,744 )
Adjusted non-interest expense (non-GAAP)   $ 82,597     $ 83,725     $ 65,502     $ 247,810     $ 190,450  
                               
Efficiency ratio FTE(1)     75.98 %     72.32 %     60.65 %     74.45 %     59.83 %
Adjusted efficiency ratio FTE (non-GAAP)(1)(2)     62.28 %     61.81 %     57.32 %     61.79 %     57.46 %
                               
Net (loss) income   $ (8,761 )   $ 26,490     $ 35,285     $ 38,522     $ 93,538  
Add: income tax (benefit) expense     (3,228 )     6,118       7,860       8,041       21,001  
Add: provision expense (release) for credit losses     40,635       1,500       (1,500 )     46,135       8,700  
Add: impact of taxable equivalent adjustment     2,272       2,239       1,985       6,693       5,807  
Pre-provision net revenue FTE (non-GAAP)(1)   $ 30,918     $ 36,347     $ 43,630     $ 99,391     $ 129,046  
                               
Pre-provision net revenue, FTE (non-GAAP)(1)   $ 30,918     $ 36,347     $ 43,630     $ 99,391     $ 129,046  
Add: acquisition-related expenses     14,696       10,890       1,744       39,928       1,744  
Add: restructuring expenses and impairment     499       558       —       2,064       —  
Adjusted pre-provision net revenue FTE (non-GAAP)(1)   $ 46,113     $ 47,795     $ 45,374     $ 141,383     $ 130,790  

____________     

(1 )      Presented on a fully taxable equivalent basis using the statutory tax rate of 21%. The tax equivalent adjustments included above are $2,272, $2,239 and $1,985 for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, respectively, and $6,693 and $5,807 for the nine months ended September 30, 2026 and September 30, 2025, respectively.
(2 )   Adjusted efficiency ratio FTE excludes other intangible assets amortization, acquisition-related expenses and restructuring expenses.
       

Adjusted Net Income and Adjusted Earnings Per Share

                               
    As of and for the three months ended   As of and for the nine months ended
       September 30,       June 30,       September 30,       September 30,       September 30, 
       2026      2026      2025      2026      2025
Adjustments to net income:                              
Net (loss) income   $ (8,761 )   $ 26,490   $ 35,285   $ 38,522   $ 93,538
Add: acquisition-related adjustments, after tax     11,318       8,383     1,336     30,749     1,336
Add: restructuring expenses and impairment, after tax     384       430     —     1,589     —
Adjusted net income (non-GAAP)   $ 2,941     $ 35,303   $ 36,621   $ 70,860   $ 94,874
                               
Adjustments to earnings per share:                              
(Loss) earnings per share diluted   $ (0.20 )   $ 0.58   $ 0.92   $ 0.84   $ 2.43
Add: acquisition-related adjustments, after tax     0.25       0.18     0.04     0.67     0.04
Add: restructuring expenses and impairment, after tax     0.01       0.02     —     0.05     —
Adjusted earnings per share – diluted (non-GAAP)   $ 0.06     $ 0.78   $ 0.96   $ 1.56   $ 2.47

DENVER, Oct. 27, 2026 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (the “Company” or “NBHC”) reported:

                                           
    For the quarter(1)   For the nine months ended September 30(1)   2026 Adjusted (1)(2)
    3Q26   2Q26   3Q25   2026   2025   QTD   YTD
Net (loss) income ($000’s)   $ (8,761 )   $ 26,490     $ 35,285     $ 38,522     $ 93,538     $ 2,941     $ 70,860  
(Loss) earnings per share – diluted   $ (0.20 )   $ 0.58     $ 0.92     $ 0.84     $ 2.43     $ 0.06     $ 1.56  
Return on average assets     (0.28 )%     0.86 %     1.43 %     0.42 %     1.27 %     0.09 %     0.77 %
Return on average tangible assets(2)     (0.23 )%     0.96 %     1.54 %     0.50 %     1.38 %     0.16 %     0.87 %
Return on average equity     (2.07 )%     6.34 %     10.25 %     3.07 %     9.30 %     0.69 %     5.65 %
Return on average tangible common equity(2)     (2.32 )%     9.70 %     14.21 %     5.01 %     13.05 %     1.62 %     8.67 %

____________                            

(1 )   Ratios are annualized.
(2 )   Represents a non-GAAP financial measure. See “Non-GAAP Financial Measures and Reconciliations” tables for reconciliations to the most directly comparable financial measures calculated and presented in accordance with GAAP.

In announcing these results, Chief Executive Officer Tim Laney shared, “This was a deeply disappointing quarter. We reported a net loss of $8.8 million, driven primarily by $40.6 million of provision expense tied to a handful of specifically identified commercial credits, mainly in the franchise and healthcare industries.  We take these credit events seriously and have made a series of both personnel and process improvements in these specific coverage areas of our business. To that end, none of these actions were driven by our regulators, and we will be relentless in our focus to meet the highest standards of credit risk management.”

Mr. Laney added, “Our margin expansion and deposit growth are positive, and all integration activity has been a success. Our responsibility is to protect the bank while driving to our target of a dollar plus of earnings per share in the fourth quarter. While the third quarter represented a painful setback, I believe our team is more than capable of delivering for our clients, communities and shareholders.”

Third Quarter 2026 Results
(All comparisons refer to the second quarter of 2026, except as noted)

As previously announced, third quarter results were impacted by elevated provision expense related to specifically identified credits addressed during the quarter. During the third quarter of 2026, net loss totaled $8.8 million, or ($0.20) per diluted share, compared to net income of $26.5 million, or $0.58 per diluted share. The quarter’s results were impacted by $40.6 million of provision expense, $15.2 million of pre-tax acquisition and restructuring expense, and a $4.0 million impairment on a third-party FinTech partnership investment classified within other securities. Fully taxable equivalent pre-provision net revenue totaled $30.9 million, compared to $36.3 million. The return on average tangible assets totaled (0.23)%, compared to 0.96%, and the return on average tangible common equity totaled (2.32)%, compared to 9.70%. Adjusting for the $15.2 million of pre-tax acquisition and restructuring related expenses in the third quarter, adjusted net income totaled $2.9 million, or $0.06 per diluted share, and adjusted fully taxable equivalent pre-provision net revenue totaled $46.1 million. The adjusted return on average tangible assets totaled 0.16%, and the adjusted return on average tangible common equity totaled 1.62%.

Net Interest Income
Fully taxable equivalent net interest income increased $3.6 million to $115.2 million, primarily due to average interest earning assets growth of $69.9 million and one additional day during the third quarter. The fully taxable equivalent net interest margin expanded six basis points to 4.00%, driven by a nine basis point increase in earning asset yields. The cost of deposits increased one basis point to 1.94%.

Loans
Loans increased $119.4 million, or 4.9% annualized, to $9.9 billion at September 30, 2026. We generated quarterly loan fundings of $819.3 million, led by commercial loan fundings of $351.2 million.

Asset Quality and Provision for Credit Losses
The Company recorded provision expense of $40.6 million during the quarter, compared to $1.5 million. The increase was primarily driven by write downs on specifically identified commercial loans, principally within the franchise and healthcare industries, related to credit events impacting the third quarter. Annualized net charge-offs for the nine months ended September 30, 2026 totaled 0.85% of average total loans. Non-performing loans totaled 0.44% of total loans at September 30, 2026, compared to 0.31%, and non-performing assets totaled 0.50% of total loans and OREO at September 30, 2026, compared to 0.35%. The allowance for credit losses as a percentage of loans was 1.11% at September 30, 2026, compared to 1.13%.

Deposits
The Company maintains a low cost, diversified deposit franchise. Average total deposits increased $96.0 million to $10.3 billion, and average transaction deposits (defined as total deposits less time deposits) increased $102.9 million to $9.0 billion. The loan to deposit ratio totaled 93.8% at September 30, 2026, compared to 94.1%. The mix of transaction deposits to total deposits increased 20 basis points to 88.0% at September 30, 2026.

Non-Interest Income
Non-interest income totaled $13.5 million, compared to $19.8 million, during the second quarter. Other non-interest income decreased $5.9 million and included $4.0 million of impairment on a third-party FinTech partnership investment classified within other securities. Mortgage banking income decreased $0.6 million driven by the current rate environment. These decreases were partially offset by a $0.3 million increase in bank card fee income.

Non-Interest Expense
Non-interest expense totaled $97.8 million, compared to $95.0 million. Included in the third and second quarters were acquisition and restructuring related expenses of $15.2 million and $11.2 million, respectively. Excluding these items, third quarter adjusted non-interest expense decreased $1.1 million, to $82.6 million, compared to $83.7 million. The linked-quarter decrease reflects management’s continued execution on operational synergies following the successful third-quarter integration of Vista’s core systems. Third quarter’s expenses include one additional payroll day compared to the second quarter and $1.4 million of OREO and problem loan expenses. The fully taxable equivalent efficiency ratio totaled 76.0%, compared to 72.3%. The adjusted fully taxable equivalent efficiency ratio totaled 62.3%, compared to 61.8%.

Income tax benefit totaled $3.2 million, compared to income tax expense of $6.1 million in the previous quarter. The effective tax rate for the nine months ended September 30, 2026 was 17.3%, compared to 18.3% for the same period prior year.

Capital
Common book value per share totaled $36.71 at September 30, 2026, compared to $37.48 at June 30, 2026. Tangible book value per share totaled $25.37, compared to $26.23, primarily reflecting the quarterly dividend payment, share repurchases and an increase in accumulated other comprehensive loss due to changes in the interest rate environment.

NBHC executed $11.9 million of share buybacks in the third quarter as part of its ongoing capital strategy. Capital ratios continue to be well in excess of federal bank regulatory agency “well capitalized” thresholds. The tier 1 leverage ratio totaled 10.00%, and the common equity tier 1 capital ratio totaled 11.69% at September 30, 2026. Shareholders’ equity totaled $1.6 billion at September 30, 2026, compared to $1.7 billion.

Recent Events
On October 24, 2026, NBH Bank (the “Bank”) entered into a definitive agreement to sell its Palm Beach, Florida banking center location, including the banking center’s loans and deposits. The sale is expected to result in a reduction of the Bank’s total assets of approximately $0.2 billion, including total loans of approximately $0.2 billion, and a reduction of total deposits of approximately $0.2 billion. The agreement provides for a deposit premium of 5.00%, subject to a minimum deposit premium of $8.8 million. The Bank expects to close the transaction in mid-2027.

Year-Over-Year Review
(All comparisons refer to the first nine months of 2025, except as noted)

Net income totaled $38.5 million, or $0.84 per diluted share, compared to $93.5 million or $2.43 per diluted share. Current year results were impacted by $46.1 million of provision expense, primarily due to third quarter credit events within the franchise and healthcare industries, $42.0 million of pre-tax acquisition and restructuring expense, and a $4.0 million impairment on a third-party FinTech partnership investment classified within other securities. Fully taxable equivalent pre-provision net revenue totaled $99.4 million, compared to $129.0 million. The return on average tangible assets totaled 0.50%, compared to 1.38%, and the return on average tangible common equity totaled 5.01%, compared to 13.05%. Adjusting for $42.0 million and $1.7 million of pre-tax acquisition and restructuring related charges for the nine months 2026 and 2025, respectively, adjusted net income totaled $70.9 million, or $1.56 per diluted share, compared to adjusted net income of $94.9 million, or $2.47 per diluted share. Adjusted, the fully taxable equivalent pre-provision net revenue increased $10.6 million, or 8.1%, to $141.4 million. The adjusted return on average tangible assets totaled 0.87%, and the adjusted return on average tangible common equity totaled 8.67%.

Fully taxable equivalent net interest income increased $69.6 million, or 26.0%, to $337.7 million. Average earning assets increased $2.2 billion, or 24.4%, driven by $500.9 million of average originated loan growth and loans acquired through the Vista acquisition. The Vista acquisition added $1.9 billion in total loans on January 7, 2026. The fully taxable equivalent net interest margin expanded five basis points to 4.00%, primarily driven by an eight basis point improvement in the cost of funds.

Loans outstanding increased $2.5 billion, or 33.2%, to $9.9 billion. New loan fundings over the trailing twelve months totaled a record $3.1 billion, led by commercial fundings of $1.7 billion.

The Company recorded $46.1 million of provision expense for credit losses, compared to $8.7 million. The increase was primarily driven by write downs on specifically identified commercial loans, primarily within the franchise and healthcare industries, related to credit events impacting the third quarter. Annualized net charge-offs totaled 0.85%, compared to 0.27%. Non-performing loans totaled 0.44% of total loans at September 30, 2026, compared to 0.36%, and non-performing assets totaled 0.50% of total loans and OREO at September 30, 2026, compared to 0.37%. The allowance for credit losses as a percentage of loans totaled 1.11% at September 30, 2026, compared to 1.19% at September 30, 2025.

Average deposits increased $2.0 billion to $10.2 billion, and average transaction deposits increased $1.8 billion to $8.9 billion compared to the same period prior year. The mix of transaction deposits to total deposits increased 167 basis points to 88.0% at September 30, 2026. The Vista acquisition added $2.2 billion of total deposits, including $2.0 billion of transaction deposits and $0.2 billion of time deposits on January 7, 2026.

Non-interest income totaled $51.3 million, compared to $53.1 million, decreasing due to $4.0 million of impairment on a third-party FinTech partnership investment within other securities and a $1.8 million decrease in mortgage banking income driven by the current rate environment. These decreases were mostly offset by increases in our diversified sources of fee income including service charges, bank card fees, trust income and swap fee income.

Non-interest expense totaled $289.6 million, compared to $192.2 million. Included in the periods were $42.0 million and $1.7 million of acquisition and restructuring expenses during the nine months ended September 30, 2026 and 2025, respectively. Excluding these items, the current period adjusted non-interest expense totaled $247.8 million, an increase from the same period prior year primarily due to our recent acquisition. Occupancy and equipment expense during the nine months ended September 30, 2026, included a full period of 2UniFiSM capitalized asset depreciation in connection with the launch of 2UniFi in the third quarter of 2025. The fully taxable equivalent efficiency ratio totaled 74.5%, compared to 59.8% in the same period prior year. The adjusted fully taxable equivalent efficiency ratio totaled 61.8% for the nine months ended September 30, 2026, compared to 57.5%.

Income tax expense decreased $13.0 million to $8.0 million driven by lower pre-tax income in the current period. The effective tax rate was 17.3%, compared to 18.3% in the prior year.

Conference Call
Management will host a conference call to review the results at 11:00 a.m. Eastern Time on Wednesday, October 28, 2026. The call may also include discussion of company developments, forward-looking statements and other material information about business and financial matters. Interested parties may listen to this call by dialing (800) 330-6710 using the participant passcode of 3883449 and asking for the NBHC Q3 2026 Earnings Call. The earnings release and a link to the replay of the call will be available on the Company’s website at www.nationalbankholdings.com by visiting the investor relations area.

About National Bank Holdings Corporation
National Bank Holdings Corporation is a bank holding company created to build a leading community bank franchise, delivering high quality client service and committed to stakeholder results. Through its bank subsidiaries, NBH Bank and 2UniFi Bank, National Bank Holdings Corporation operates a network of over 90 banking centers, serving individual consumers, small, medium and large businesses, and government and non-profit entities. Its banking centers are located in its core footprint of Colorado, the greater Kansas City region, Texas, Utah, Wyoming, New Mexico, Idaho, and Palm Beach, Florida. Its comprehensive residential mortgage banking group primarily serves the bank’s core footprint. Its trust and wealth management business is operated through its trust and wealth department under Bank of Jackson Hole Trust & Wealth, a division of NBH Bank. NBH Bank operates its core banking business under a single state charter through the following brand names as divisions of NBH Bank: in Colorado, Community Banks of Colorado and Community Banks Mortgage; in Kansas and Missouri, Bank Midwest and Bank Midwest Mortgage; in Texas, Utah, New Mexico, Idaho, in Palm Beach, Florida, Vista Bank; and in Wyoming, Bank of Jackson Hole, Bank of Jackson Hole Mortgage and Bank of Jackson Hole Trust & Wealth. Additional information about National Bank Holdings Corporation can be found at www.nationalbankholdings.com.

For more information visit: cobnks.com, bankmw.com, bankofjacksonhole.com, vistabank.com, or nbhbank.com, or connect with any of our brands on LinkedIn.

About Non-GAAP Financial Measures
Certain financial measures and ratios we present are supplemental measures that are not required by, or are not presented in accordance with, U.S. generally accepted accounting principles (GAAP). We refer to these financial measures and ratios as “non-GAAP financial measures.” We consider the use of select non-GAAP financial measures and ratios to be useful for financial and operational decision making and useful in evaluating period-to-period comparisons. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain expenditures or assets that we believe are not indicative of our primary business operating results. We believe that management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, analyzing and comparing past, present and future periods.

These non-GAAP financial measures should not be considered a substitute for financial information presented in accordance with GAAP and you should not rely on non-GAAP financial measures alone as measures of our performance. The non-GAAP financial measures we present may differ from non-GAAP financial measures used by our peers or other companies. We compensate for these differences by providing the equivalent GAAP measures whenever we present the non-GAAP financial measures and by including a reconciliation of the impact of the components adjusted for in the non-GAAP financial measure so that both measures and the individual components may be considered when analyzing our performance. A reconciliation of non-GAAP financial measures to the comparable GAAP financial measures is included at the end of the financial statement tables.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements do not discuss historical facts but instead relate to expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance. Forward-looking statements are generally identified by words such as “anticipate,” “believe,” “can,” “would,” “should,” “could,” “may,” “predict,” “seek,” “potential,” “will,” “estimate,” “target,” “plan,” “projected,” “continuing,” “ongoing,” “expect,” “intend,” “goal,” “focus,” “maintains,” “future,” “ultimately,” “likely,” “ensure,” “strategy,” “objective,” and similar words or phrases. These statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties. We have based these statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, liquidity, results of operations, business strategy and growth prospects. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements due to a number of factors, including, but not limited to, business and economic conditions along with external events, both generally and in the financial services industry; susceptibility to credit risk and fluctuations in the value of real estate and other collateral securing a significant portion of our loan portfolio, including with regards to real estate acquired through foreclosure, and the accuracy of appraisals related to such real estate; changes impacting monetary supply and the businesses of our clients and counterparties, including levels of market interest rates, inflation, currency values, monetary, fiscal, and international trade policy, and the volatility of trading markets; our ability to maintain sufficient liquidity to meet the requirements of deposit withdrawals and other business needs; our desire to raise additional capital in connection with strategic growth initiatives and our ability to access the capital markets when desired or on favorable terms; changes in the fair value of our investment securities can fluctuate due to market conditions outside of our control; our investments in financial technology companies and initiatives may subject us to material financial, reputational and strategic risks; the allowance for credit losses and fair value adjustments may be insufficient to absorb losses in our loan portfolio (including due to fluctuations in collateral value, the ability of the borrower to repay and the results of outstanding litigation related to the realization of collateral); any service interruptions, cyber incidents or other breaches relating to our technology systems, security systems or infrastructure or those of our third-party providers; the occurrence of fraud or other financial crimes within our business; competition from other financial services providers, including traditional financial institutions and financial technology companies, and the effects of disintermediation within the banking business including consolidation within the industry; changes to federal government lending programs like the Small Business Administration’s Preferred Lender Program and the Federal Housing Administration’s insurance programs, including the impact of changes in regulations, budget appropriations and a prolonged government shutdown on such programs; impairment of our mortgage servicing rights, disruption in the secondary market for mortgage loans, declines in real estate values, or being required to repurchase mortgage loans or reimburse investors; claims and litigation related to our fiduciary responsibilities in connection with our trust and wealth business; our ability to manage and execute our organic growth and acquisition strategies, including our ability to realize the expected benefits of our acquisition strategies; developments in technology, such as artificial intelligence, the success of our digital growth strategy, and our ability to incorporate innovative technologies in our business and provide products and services that satisfy our clients’ expectations for convenience and security; our ability to integrate Vista Bank into our business may be more difficult, costly or time consuming than expected and we may fail to realize the anticipated benefits or cost savings of the merger; failure to obtain regulatory approvals or consummate attractive acquisitions or continue to increase organic loan growth would restrict our growth plans; the accuracy of projected operating results for assets and businesses we acquire as well as our ability to drive organic loan growth to replace loans in our existing portfolio with comparable loans as loans are paid down; our ability to comply with and manage costs related to extensive and potentially expanding government regulation and supervision, including current and future regulations affecting bank holding companies and depository institutions; our ability to execute our capital allocation strategy, including paying dividends or repurchasing shares, is subject to regulatory limitations; the application of any increased assessment rates imposed by the Federal Deposit Insurance Corporation; claims or legal action brought against us by third parties or government agencies; the loss of our executive officers and key personnel; changes to federal, state and local laws and regulations along with executive orders applicable to our business, including tax laws; and other factors, risks, trends and uncertainties described elsewhere in our other filings with the Securities and Exchange Commission. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events or circumstances, except as required by applicable law.

Contacts:
Analysts/Institutional Investors:
Emily Gooden, Chief Accounting Officer and Investor Relations Director, (720) 554-6640, ir@nationalbankholdings.com
Nicole Van Denabeele, Chief Financial Officer, (720) 529-3370, ir@nationalbankholdings.com

Media:
Dave Coons, SVP, Associate Director of Corporate Communications and Marketing, (816) 298-2214, dave.coons@nbhbank.com 

NATIONAL BANK HOLDINGS CORPORATION
FINANCIAL SUMMARY
Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except share and per share data)

  For the three months ended   For the nine months ended
  September 30,       June 30,       September 30,    September 30,       September 30, 
  2026   2026   2025   2026   2025
Total interest and dividend income $ 167,335     $ 162,004   $ 132,238     $ 488,490   $ 393,421
Total interest expense   54,435       52,712     44,038       157,496     131,121
Net interest income   112,900       109,292     88,200       330,994     262,300
Taxable equivalent adjustment   2,272       2,239     1,985       6,693     5,807
Net interest income FTE(1)   115,172       111,531     90,185       337,687     268,107
Provision expense (release) for credit losses   40,635       1,500     (1,500 )     46,135     8,700
Net interest income after provision for credit losses FTE(1)   74,537       110,031     91,685       291,552     259,407
Non-interest income:                            
Service charges   4,456       4,501     4,340       13,149     12,585
Bank card fees   4,929       4,616     4,505       13,879     13,431
Mortgage banking income   1,796       2,423     2,895       6,961     8,757
Other non-interest income   2,357       8,226     8,951       17,048     18,360
Gain on security sales   —       —     —       246     —
Total non-interest income   13,538       19,766     20,691       51,283     53,133
Non-interest expense:                            
Salaries and benefits   56,869       54,366     37,779       168,205     109,887
Occupancy and equipment   16,838       16,154     12,383       48,825     32,656
Professional fees   2,142       3,002     3,249       7,376     6,352
Data processing   7,663       7,945     4,751       23,261     13,604
Other non-interest expense   11,847       11,050     7,138       34,582     23,825
Other intangible assets amortization   2,433       2,433     1,946       7,330     5,870
Total non-interest expense   97,792       94,950     67,246       289,579     192,194
                             
(Loss) income before income taxes FTE(1)   (9,717 )     34,847     45,130       53,256     120,346
Taxable equivalent adjustment   2,272       2,239     1,985       6,693     5,807
(Loss) income before income taxes   (11,989 )     32,608     43,145       46,563     114,539
Income tax (benefit) expense   (3,228 )     6,118     7,860       8,041     21,001
Net (loss) income $ (8,761 )   $ 26,490   $ 35,285     $ 38,522   $ 93,538
(Loss) earnings per share – basic $ (0.20 )   $ 0.58   $ 0.92     $ 0.85   $ 2.44
(Loss) earnings per share – diluted   (0.20 )     0.58     0.92       0.84     2.43
Common stock dividend   0.32       0.32     0.30        0.96     0.89

____________                                 

(1 )      Net interest income is presented on a GAAP basis and fully taxable equivalent (FTE) basis, as the Company believes this non-GAAP measure is the preferred industry measurement for this item. The FTE adjustment is for the tax benefit on certain tax exempt loans using the federal tax rate of 21% for each period presented.

NATIONAL BANK HOLDINGS CORPORATION
Consolidated Statements of Financial Condition (Unaudited)
(Dollars in thousands, except share and per share data)

                       
  September 30,
2026

    June 30, 
2026
    December 31, 
2025
       September 30, 
2025
 
ASSETS                      
Cash and cash equivalents $ 364,798     $ 380,696     $ 417,058     $ 555,560  
Investment securities available-for-sale   638,085       585,533       528,639       612,719  
Investment securities held-to-maturity   725,921       758,223       651,732       689,486  
Other securities   100,134       99,184       80,634       80,526  
Loans   9,893,448       9,774,052       7,433,356       7,429,501  
Allowance for credit losses   (109,866 )     (110,271 )     (87,415 )     (88,280 )
Loans, net   9,783,582       9,663,781       7,345,941       7,341,221  
Loans held for sale   12,578       26,486       25,695       22,252  
Other real estate owned   5,082       4,174       1,674       658  
Premises and equipment, net   232,244       234,139       214,554       211,436  
Goodwill   459,481       455,408       306,043       306,043  
Intangible assets, net   61,881       64,631       48,337       50,331  
Other assets   343,354       313,881       263,211       282,454  
Total assets $ 12,727,140     $ 12,586,136     $ 9,883,518     $ 10,152,686  
LIABILITIES AND SHAREHOLDERS’ EQUITY                      
Liabilities:                      
Non-interest bearing demand deposits $ 2,656,315     $ 2,575,684     $ 2,204,241     $ 2,255,495  
Interest bearing demand deposits   1,626,488       1,568,250       1,237,006       1,223,602  
Savings and money market   4,994,262       4,975,841       3,701,616       3,832,460  
Total transaction deposits   9,277,065       9,119,775       7,142,863       7,311,557  
Time deposits   1,267,968       1,269,658       1,149,771       1,160,123  
Total deposits   10,545,033       10,389,433       8,292,634       8,471,680  
Securities sold under agreements to repurchase   22,479       20,239       17,350       21,303  
Long-term debt   201,884       202,003       54,540       54,743  
Federal Home Loan Bank advances   125,000       125,000       —       —  
Other liabilities   206,847       180,357       133,880       230,031  
Total liabilities   11,101,243       10,917,032       8,498,404       8,777,757  
Shareholders’ equity:                      
Common stock   588       588       515       515  
Additional paid in capital   1,467,649       1,460,627       1,171,581       1,169,982  
Retained earnings   567,146       590,437       572,461       568,276  
Treasury stock   (344,511 )     (333,131 )     (315,397 )     (312,873 )
Accumulated other comprehensive loss, net of tax   (64,975 )     (49,417 )     (44,046 )     (50,971 )
Total shareholders’ equity   1,625,897       1,669,104       1,385,114       1,374,929  
Total liabilities and shareholders’ equity $ 12,727,140     $ 12,586,136     $ 9,883,518     $ 10,152,686  
SHARE DATA                      
Average basic shares outstanding   44,451,388       44,665,184       37,803,728       37,911,643  
Average diluted shares outstanding   44,758,349       44,915,790       37,922,557       38,034,473  
Ending shares outstanding   44,285,618       44,537,718       37,772,516       37,815,589  
Common book value per share $ 36.71     $ 37.48     $ 36.67     $ 36.36  
Tangible book value per share (non-GAAP)(1)   25.37       26.23       27.80       27.45  
CAPITAL RATIOS                      
Average equity to average assets   13.50 %     13.53 %     14.21 %     13.94 %
Tangible common equity to tangible assets (non-GAAP)(1)   9.19 %     9.67 %     11.00 %     10.57 %
Tier 1 leverage ratio   10.00 %     10.30 %     11.56 %     11.49 %
Common equity tier 1 risk-based capital ratio   11.69 %     12.29 %     14.89 %     14.69 %
Tier 1 risk-based capital ratio   11.69 %     12.29 %     14.89 %     14.69 %
Total risk-based capital ratio   14.74 %     15.42 %     16.82 %     16.63 %

____________                        

(1 )      Represents a non-GAAP financial measure. See “Non-GAAP Financial Measures and Reconciliations” starting on page 15.
       

NATIONAL BANK HOLDINGS CORPORATION
Loan Portfolio
(Dollars in thousands)

Period End Loan Balances by Type

                         
          September 30, 2026       September 30, 2026
          vs. June 30, 2026       vs. September 30, 2025
  September 30, 2026   June 30, 2026   % Change   September 30, 2025   % Change
Originated:                        
Commercial:                        
Commercial and industrial $ 2,288,210   $ 2,193,328   4.3 %   $ 1,877,645   21.9 %
Municipal and non-profit   1,278,627     1,296,609   (1.4 %)     1,189,677   7.5 %
Owner-occupied commercial real estate   923,026     926,686   (0.4 %)     986,868   (6.5 %)
Food and agribusiness   218,896     207,031   5.7 %     211,940   3.3 %
Total commercial   4,708,759     4,623,654   1.8 %     4,266,130   10.4 %
Commercial real estate non-owner occupied   1,632,937     1,434,867   13.8 %     1,069,815   52.6 %
Residential real estate   1,142,226     1,033,943   10.5 %     914,168   24.9 %
Consumer   12,356     13,645   (9.4 %)     12,757   (3.1 %)
Total originated   7,496,278     7,106,109   5.5 %     6,262,870   19.7 %
                         
Acquired:                        
Commercial:                        
Commercial and industrial   478,692     566,984   (15.6 %)     95,015   403.8 %
Municipal and non-profit   234     240   (2.5 %)     259   (9.7 %)
Owner-occupied commercial real estate   361,778     382,970   (5.5 %)     189,408   91.0 %
Food and agribusiness   30,314     31,451   (3.6 %)     29,506   2.7 %
Total commercial   871,018     981,645   (11.3 %)     314,188   177.2 %
Commercial real estate non-owner occupied   1,088,408     1,215,762   (10.5 %)     570,062   90.9 %
Residential real estate   436,833     469,518   (7.0 %)     282,026   54.9 %
Consumer   911     1,018   (10.5 %)     355   156.6 %
Total acquired   2,397,170     2,667,943   (10.1 %)     1,166,631   105.5 %
Total loans $ 9,893,448   $ 9,774,052   1.2 %   $ 7,429,501   33.2 %

Loan Fundings(1)

                             
  Third quarter   Second quarter   First quarter   Fourth quarter   Third quarter
  2026   2026   2026   2025   2025
Commercial:                            
Commercial and industrial $ 286,624   $ 293,094   $ 346,250   $ 237,813   $ 159,250
Municipal and non-profit   15,852     50,506     45,000     119,918     81,418
Owner occupied commercial real estate   35,314     84,606     49,556     66,798     42,362
Food and agribusiness   13,371     24,251     5,697     4,437     5,015
Total commercial   351,161     452,457     446,503     428,966     288,045
Commercial real estate non-owner occupied   312,364     352,629     268,021     96,482     81,136
Residential real estate   154,868     120,340     89,375     64,161     49,877
Consumer   860     1,460     1,583     1,399     2,142
Total $ 819,253   $ 926,886   $ 805,482   $ 591,008   $ 421,200

____________                                                

(1 )      Loan fundings are defined as closed end funded loans and net fundings under revolving lines of credit. Net fundings (paydowns) under revolving lines of credit were $123,946, $178,133, $65,273, $95,744, and ($1,591) for the periods noted in the table above, respectively.
       

NATIONAL BANK HOLDINGS CORPORATION
Summary of Net Interest Margin
(Dollars in thousands)

                                                       
    For the three months ended   For the three months ended   For the three months ended
    September 30, 2026   June 30, 2026   September 30, 2025
    Average               Average      Average               Average      Average               Average
    balance   Interest   rate   balance   Interest   rate   balance   Interest   rate
Interest earning assets:                                                      
Originated loans FTE(1)(2)   $ 7,242,490     $ 110,606     6.06 %   $ 6,762,456     $ 102,709     6.09 %   $ 6,213,268     $ 103,600     6.62 %
Acquired loans     2,555,867       46,146     7.16 %     2,867,500       47,819     6.69 %     1,183,171       18,151     6.09 %
Loans held for sale     18,273       262     5.69 %     21,612       316     5.86 %     21,964       366     6.61 %
Investment securities available-for-sale     645,657       4,430     2.74 %     663,636       4,619     2.78 %     693,173       4,679     2.70 %
Investment securities held-to-maturity     774,413       6,249     3.23 %     791,847       6,327     3.20 %     705,927       5,313     3.01 %
Other securities     43,686       744     6.81 %     41,977       688     6.56 %     32,461       409     5.04 %
Interest earning deposits     132,863       1,170     3.49 %     194,358       1,765     3.64 %     149,867       1,705     4.51 %
Total interest earning assets FTE(2)   $ 11,413,249     $ 169,607     5.90 %   $ 11,343,386     $ 164,243     5.81 %   $ 8,999,831     $ 134,223     5.92 %
Cash and due from banks   $ 95,446                 $ 95,632                 $ 78,598              
Other assets     1,042,235                   1,054,388                   806,872              
Allowance for credit losses     (112,023 )                 (114,769 )                 (88,787 )            
Total assets   $ 12,438,907                 $ 12,378,637                 $ 9,796,514              
Interest bearing liabilities:                                                      
Interest bearing demand, savings and money market deposits   $ 6,474,638     $ 39,974     2.45 %   $ 6,393,003     $ 38,371     2.41 %   $ 4,929,785     $ 33,095     2.66 %
Time deposits     1,264,037       10,380     3.26 %     1,270,963       10,530     3.32 %     1,111,958       9,791     3.49 %
Federal Home Loan Bank advances     95,561       945     3.92 %     89,188       855     3.85 %     33,682       391     4.61 %
Other borrowings(3)     47,001       227     1.92 %     37,202       167     1.80 %     34,429       242     2.79 %
Long-term debt     202,011       2,909     5.71 %     202,144       2,789     5.53 %     54,471       519     3.78 %
Total interest bearing liabilities   $ 8,083,248     $ 54,435     2.67 %   $ 7,992,500     $ 52,712     2.65 %   $ 6,164,325     $ 44,038     2.83 %
Demand deposits   $ 2,542,154                 $ 2,520,897                 $ 2,150,330              
Other liabilities     134,269                   189,969                   116,548              
Total liabilities     10,759,671                   10,703,366                   8,431,203              
Shareholders’ equity     1,679,236                   1,675,271                   1,365,311              
Total liabilities and shareholders’ equity   $ 12,438,907                 $ 12,378,637                 $ 9,796,514              
Net interest income FTE(2)         $ 115,172               $ 111,531               $ 90,185      
Interest rate spread FTE(2)                 3.23 %                 3.16 %                 3.09 %
Net interest earning assets   $ 3,330,001                 $ 3,350,886                 $ 2,835,506              
Net interest margin FTE(2)                 4.00 %                 3.94 %                 3.98 %
Average transaction deposits   $ 9,016,792                 $ 8,913,900                 $ 7,080,115              
Average total deposits     10,280,829                   10,184,863                   8,192,073              
Ratio of average interest earning assets to average interest bearing liabilities     141.20 %                 141.93 %                 146.00 %            

____________                       

(1 )      Originated loans are net of deferred loan fees, less costs, which are included in interest income over the life of the loan.
(2 )      Presented on a fully taxable equivalent basis using the statutory tax rate of 21%. The tax equivalent adjustments included above are $2,272, $2,239 and $1,985 for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, respectively.
(3 )      Other borrowings includes securities sold under agreements to repurchase and cash collateral received from counterparties in connection with derivative swap agreements.
       

NATIONAL BANK HOLDINGS CORPORATION
Summary of Net Interest Margin
(Dollars in thousands)

                               
  For the nine months ended September 30, 2026   For the nine months ended September 30, 2025
  Average              Average   Average              Average
  balance   Interest   rate   balance   Interest   rate
Interest earning assets:                              
Originated loans FTE(1)(2) $ 6,779,938     $ 310,373   6.12 %   $ 6,279,001     $ 308,220   6.56 %
Acquired loans   2,789,118       143,780   6.89 %     1,265,326       57,095   6.03 %
Loans held for sale   19,479       862   5.92 %     20,953       1,069   6.82 %
Investment securities available-for-sale   667,603       14,050   2.81 %     703,442       13,957   2.65 %
Investment securities held-to-maturity   752,761       17,726   3.14 %     685,278       14,606   2.84 %
Other securities   40,949       1,948   6.34 %     31,473       1,355   5.74 %
Interest earning deposits   233,342       6,444   3.69 %     85,608       2,926   4.57 %
Total interest earning assets FTE(2) $ 11,283,190     $ 495,183   5.87 %   $ 9,071,081     $ 399,228   5.88 %
Cash and due from banks $ 96,870               $ 78,327            
Other assets   1,045,708                 803,544            
Allowance for credit losses   (108,018 )               (91,499 )          
Total assets $ 12,317,750               $ 9,861,453            
Interest bearing liabilities:                              
Interest bearing demand, savings and money market deposits $ 6,377,358     $ 115,532   2.42 %   $ 4,980,629     $ 98,364   2.64 %
Time deposits   1,287,835       32,092   3.33 %     1,070,419       27,634   3.45 %
Federal Home Loan Bank advances   64,607       1,952   4.04 %     77,900       2,666   4.58 %
Other borrowings(3)   38,196       518   1.81 %     41,944       902   2.88 %
Long-term debt   180,055       7,402   5.50 %     54,528       1,555   3.81 %
Total interest bearing liabilities $ 7,948,051     $ 157,496   2.65 %   $ 6,225,420     $ 131,121   2.82 %
Demand deposits $ 2,533,089               $ 2,166,671            
Other liabilities   158,689                 124,546            
Total liabilities   10,639,829                 8,516,637            
Shareholders’ equity   1,677,921                 1,344,816            
Total liabilities and shareholders’ equity $ 12,317,750               $ 9,861,453            
Net interest income FTE(2)       $ 337,687             $ 268,107    
Interest rate spread FTE(2)             3.22 %               3.06 %
Net interest earning assets $ 3,335,139               $ 2,845,661            
Net interest margin FTE(2)             4.00 %               3.95 %
Average transaction deposits $ 8,910,447               $ 7,147,300            
Average total deposits   10,198,282                 8,217,719            
Ratio of average interest earning assets to average interest bearing liabilities   141.96 %               145.71 %          

____________                     

(1 )      Originated loans are net of deferred loan fees, less costs, which are included in interest income over the life of the loan.
(2 )      Presented on a fully taxable equivalent basis using the statutory tax rate of 21%. The tax equivalent adjustments included above are $6,693 and $5,807 for the nine months ended September 30, 2026 and September 30, 2025, respectively.
(3 )      Other borrowings includes securities sold under agreements to repurchase and cash collateral received from counterparties in connection with derivative swap agreements.
       

NATIONAL BANK HOLDINGS CORPORATION
Allowance for Credit Losses and Asset Quality
(Dollars in thousands)

Allowance for Credit Losses Analysis

                 
  As of and for the three months ended
  September 30, 2026   June 30, 2026   September 30, 2025
Beginning allowance for credit losses $ 110,271     $ 113,477     $ 88,893  
Allowance for credit loss at acquisition   5,164       2,473       —  
Charge-offs   (47,208 )     (6,508 )     (1,617 )
Recoveries   888       79       2,504  
Provision expense (release) for credit losses on loans   40,751       750       (1,500 )
Ending allowance for credit losses (“ACL”) $ 109,866     $ 110,271     $ 88,280  
Ratio of annualized net charge-offs (recoveries) to average total loans during the period   1.88 %     0.27 %     (0.05 )%
Ratio of ACL to total loans outstanding at period end   1.11 %     1.13 %     1.19 %
Ratio of ACL to total non-performing loans at period end   250.17 %     365.97 %     330.45 %
Total loans $ 9,893,448     $ 9,774,052     $ 7,429,501  
Average total loans during the period   9,771,279       9,608,203       7,376,685  
Total non-performing loans   43,917       30,131       26,715  

Past Due and Non-accrual Loans

                 
  September 30, 2026   June 30, 2026   September 30, 2025
Loans 90 days past due and still accruing interest $ 16,762     $ 29,112     $ 12,120  
Non-accrual loans   43,917       30,131       26,715  
Total 90 days past due and non-accrual loans $ 60,679     $ 59,243     $ 38,835  
Total 90 days past due and still accruing interest and non-accrual loans to total loans   0.61 %     0.61 %     0.52 %
                 
Loans 30-89 days past due and still accruing interest $ 14,010     $ 17,169     $ 14,288  

     

Asset Quality Data

                 
  September 30, 2026   June 30, 2026   September 30, 2025
Non-performing loans $ 43,917     $ 30,131     $ 26,715  
OREO   5,082       4,174       658  
Total non-performing assets $ 48,999     $ 34,305     $ 27,373  
Total non-performing loans to total loans   0.44 %     0.31 %     0.36 %
Total non-performing assets to total loans and OREO   0.50 %     0.35 %     0.37 %

NATIONAL BANK HOLDINGS CORPORATION
Key Metrics(1)

                             
  As of and for the three months ended   As of and for the nine months ended
  September 30,    June 30,    September 30,    September 30,    September 30, 
  2026   2026   2025   2026   2025
Return on average assets   (0.28 )%     0.86 %     1.43 %     0.42 %     1.27 %
Return on average tangible assets(2)   (0.23 )%     0.96 %     1.54 %     0.50 %     1.38 %
Adjusted return on average tangible assets(2)   0.16 %     1.26 %     1.60 %     0.87 %     1.40 %
Return on average equity   (2.07 )%     6.34 %     10.25 %     3.07 %     9.30 %
Return on average tangible common equity(2)   (2.32 )%     9.70 %     14.21 %     5.01 %     13.05 %
Adjusted return on average tangible common equity(2)   1.62 %     12.71 %     14.72 %     8.67 %     13.23 %
Loan to deposit ratio (end of period)   93.82 %     94.08 %     87.70 %     93.82 %     87.70 %
Non-interest bearing deposits to total deposits (end of period)   25.19 %     24.79 %     26.62 %     25.19 %     26.62 %
Net interest margin(3)   3.92 %     3.86 %     3.89 %     3.92 %     3.87 %
Net interest margin FTE(3)(4)   4.00 %     3.94 %     3.98 %     4.00 %     3.95 %
Interest rate spread FTE(4)(5)   3.23 %     3.16 %     3.09 %     3.22 %     3.06 %
Yield on earning assets(6)   5.82 %     5.73 %     5.83 %     5.79 %     5.80 %
Yield on earning assets FTE(4)(6)   5.90 %     5.81 %     5.92 %     5.87 %     5.88 %
Cost of funds   2.03 %     2.01 %     2.10 %     2.01 %     2.09 %
Cost of deposits   1.94 %     1.93 %     2.08 %     1.94 %     2.05 %
Non-interest income to total revenue FTE(4)(7)   10.52 %     15.05 %     18.66 %     13.18 %     16.54 %
Efficiency ratio FTE(4)   75.98 %     72.32 %     60.65 %     74.45 %     59.83 %
Adjusted efficiency ratio FTE(2)(4)   62.28 %     61.81 %     57.32 %     61.79 %     57.46 %
Pre-provision net revenue FTE(2)(4)   30,918       36,347       43,630       99,391       129,046  
Adjusted pre-provision net revenue FTE(2)(4)   46,113       47,795       45,374       141,383       130,790  
                             
Total Loans Asset Quality Data(8)(9)                            
Non-performing loans to total loans   0.44 %     0.31 %     0.36 %     0.44 %     0.36 %
Non-performing assets to total loans and OREO   0.50 %     0.35 %     0.37 %     0.50 %     0.37 %
Allowance for credit losses to total loans   1.11 %     1.13 %     1.19 %     1.11 %     1.19 %
Allowance for credit losses to non-performing loans   250.17 %     365.97 %     330.45 %     250.17 %     330.45 %
Net charge-offs (recoveries) to average loans   1.88 %     0.27 %     (0.05 )%     0.85 %     0.27 %

____________                

(1 )      Ratios are annualized.
(2 )      Ratio represents non-GAAP financial measure. See “Non-GAAP Financial Measures and Reconciliations” starting on page 15.
(3 )   Net interest margin represents net interest income, including accretion income on interest earning assets, as a percentage of average interest earning assets.
(4 )   Presented on a fully taxable equivalent basis using the statutory tax rate of 21%. The tax equivalent adjustments included above are $2,272, $2,239 and $1,985 for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, respectively, and $6,693 and $5,807 for the nine months ended September 30, 2026 and September 30, 2025, respectively.
(5 )      Interest rate spread represents the difference between the weighted average yield on interest earning assets, including FTE income, and the weighted average cost of interest bearing liabilities. Ratio represents a non-GAAP financial measure.
(6 )   Interest earning assets include assets that earn interest/accretion or dividends. Any market value adjustments on investment securities or loans are excluded from interest earning assets.
(7 )   Non-interest income to total revenue represents non-interest income divided by the sum of net interest income FTE and non-interest income.
(8 )   Non-performing loans consist of non-accruing loans.
(9 )   Total loans are net of unearned discounts and fees.
       

NATIONAL BANK HOLDINGS CORPORATION
NON-GAAP FINANCIAL MEASURES AND RECONCILIATIONS
(Dollars in thousands, except share and per share data)

Tangible Book Value Ratios

                         
    September 30, 2026   June 30, 2026      December 31, 2025   September 30, 2025
Total shareholders’ equity   $ 1,625,897     $ 1,669,104     $ 1,385,114     $ 1,374,929  
Less: goodwill and other intangible assets, net     (516,615 )     (514,975 )     (348,961 )     (350,907 )
Add: deferred tax liability related to goodwill     14,257       14,154       13,947       13,844  
Tangible common equity (non-GAAP)   $ 1,123,539     $ 1,168,283     $ 1,050,100     $ 1,037,866  
                         
Total assets   $ 12,727,140     $ 12,586,136     $ 9,883,518     $ 10,152,686  
Less: goodwill and other intangible assets, net     (516,615 )     (514,975 )     (348,961 )     (350,907 )
Add: deferred tax liability related to goodwill     14,257       14,154       13,947       13,844  
Tangible assets (non-GAAP)   $ 12,224,782     $ 12,085,315     $ 9,548,504     $ 9,815,623  
                         
Tangible common equity to tangible assets calculations:                        
Total shareholders’ equity to total assets     12.78 %     13.26 %     14.01 %     13.54 %
Less: impact of goodwill and other intangible assets, net     (3.59 )%     (3.59 )%     (3.01 )%     (2.97 )%
Tangible common equity to tangible assets (non-GAAP)     9.19 %     9.67 %     11.00 %     10.57 %
                         
Tangible book value per share calculations:                        
Tangible common equity (non-GAAP)   $ 1,123,539     $ 1,168,283     $ 1,050,100     $ 1,037,866  
Divided by: ending shares outstanding     44,285,618       44,537,718       37,772,516       37,815,589  
Tangible book value per share (non-GAAP)   $ 25.37     $ 26.23     $ 27.80     $ 27.45  
                                 

NATIONAL BANK HOLDINGS CORPORATION
(Dollars in thousands, except share and per share data)
Return on Average Tangible Assets and Return on Average Tangible Equity

                               
    As of and for the three months ended   As of and for the nine months ended
    September 30,       June 30,       September 30,       September 30,       September 30, 
    2026      2026      2025      2026      2025
Net (loss) income   $ (8,761 )   $ 26,490     $ 35,285     $ 38,522     $ 93,538  
Add: adjustments, after tax (non-GAAP)(1)     11,702       8,813       1,336       32,338       1,336  
Adjusted net income (non-GAAP)(1)   $ 2,941     $ 35,303     $ 36,621     $ 70,860     $ 94,874  
                               
Net (loss) income   $ (8,761 )   $ 26,490     $ 35,285     $ 38,522     $ 93,538  
Add: impact of other intangible assets amortization expense, after tax (non-GAAP)     1,874       1,873       1,491       5,645       4,497  
Net (loss) income excluding the impact of other intangible assets amortization expense, after tax (non-GAAP)   $ (6,887 )   $ 28,363     $ 36,776     $ 44,167     $ 98,035  
                               
Net (loss) income excluding the impact of other intangible assets amortization expense, after tax (non-GAAP)   $ (6,887 )   $ 28,363     $ 36,776     $ 44,167     $ 98,035  
Add: adjustments, after tax (non-GAAP)(1)     11,702       8,813       1,336       32,338       1,336  
Adjusted net income excluding the impact of other intangible assets amortization expense (non-GAAP)(1)   $ 4,815     $ 37,176     $ 38,112     $ 76,505     $ 99,371  
                               
Average assets   $ 12,438,907     $ 12,378,637     $ 9,796,514     $ 12,317,750     $ 9,861,453  
Less: average goodwill and other intangible assets, net of deferred tax liability related to goodwill (non-GAAP)     (501,172 )     (502,057 )     (338,294 )     (498,106 )     (340,231 )
Average tangible assets (non-GAAP)   $ 11,937,735     $ 11,876,580     $ 9,458,220     $ 11,819,644     $ 9,521,222  
                               
Average shareholders’ equity   $ 1,679,236     $ 1,675,271     $ 1,365,311     $ 1,677,921     $ 1,344,816  
Less: average goodwill and other intangible assets, net of deferred tax liability related to goodwill (non-GAAP)     (501,172 )     (502,057 )     (338,294 )     (498,106 )     (340,231 )
Average tangible common equity (non-GAAP)   $ 1,178,064     $ 1,173,214     $ 1,027,017     $ 1,179,815     $ 1,004,585  
                               
Return on average assets     (0.28 )%     0.86 %     1.43 %     0.42 %     1.27 %
Adjusted return on average assets (non-GAAP)     0.09 %     1.14 %     1.48 %     0.77 %     1.29 %
Return on average tangible assets (non-GAAP)     (0.23 )%     0.96 %     1.54 %     0.50 %     1.38 %
Adjusted return on average tangible assets (non-GAAP)(1)     0.16 %     1.26 %     1.60 %     0.87 %     1.40 %
Return on average equity     (2.07 )%     6.34 %     10.25 %     3.07 %     9.30 %
Adjusted return on average equity (non-GAAP)     0.69 %     8.45 %     10.64 %     5.65 %     9.43 %
Return on average tangible common equity (non-GAAP)     (2.32 )%     9.70 %     14.21 %     5.01 %     13.05 %
Adjusted return on average tangible common equity (non-GAAP)(1)     1.62 %     12.71 %     14.72 %     8.67 %     13.23 %
                               
Adjustments:                              
Non-interest income adjustments:                              
Restructuring impairment(2)   $ —     $ 223     $ —     $ 223     $ —  
Non-interest expense adjustments:                              
Acquisition-related expenses(3)     14,696       10,890       1,744       39,928       1,744  
Restructuring expenses(2)     499       335       —       1,841       —  
Total non-interest expense adjustments, before tax (non-GAAP)     15,195       11,225       1,744       41,769       1,744  
                               
Total adjustments, before tax (non-GAAP)     15,195       11,448       1,744       41,992       1,744  
Tax benefit impact(4)     (3,493 )     (2,635 )     (408 )     (9,654 )     (408 )
Total adjustments, after tax (non-GAAP)   $ 11,702     $ 8,813     $ 1,336     $ 32,338     $ 1,336  

____________     

(1 )   For details, refer to the “Adjustments” section at the bottom of the table.
(2 )   Restructuring expenses and restructuring impairment are primarily related to banking center consolidation expenses and corporate personnel actions.
(3 )   Includes general acquisition-related expenses and Vista rebranding costs.
(4 )   Calculated using the company’s marginal tax rate of 23%. Certain acquisition-related expenses are non-deductible.
       

Efficiency Ratio and Pre-Provision Net Revenue

                               
    As of and for the three months ended   As of and for the nine months ended
       September 30,       June 30,       September 30,       September 30,       September 30, 
       2026      2026      2025      2026      2025
Net interest income FTE(1)   $ 115,172     $ 111,531     $ 90,185     $ 337,687     $ 268,107  
                               
Non-interest income   $ 13,538     $ 19,766     $ 20,691     $ 51,283     $ 53,133  
Add: restructuring impairment     —       223       —       223       —  
Adjusted non-interest income (non-GAAP)   $ 13,538     $ 19,989     $ 20,691     $ 51,506     $ 53,133  
                               
Non-interest expense   $ 97,792     $ 94,950     $ 67,246     $ 289,579     $ 192,194  
Less: other intangible assets amortization     (2,433 )     (2,433 )     (1,946 )     (7,330 )     (5,870 )
Less: acquisition-related expenses and restructuring expenses     (15,195 )     (11,225 )     (1,744 )     (41,769 )     (1,744 )
Adjusted non-interest expense, excluding other intangible assets amortization (non-GAAP)   $ 80,164     $ 81,292     $ 63,556     $ 240,480     $ 184,580  
                               
Non-interest expense   $ 97,792     $ 94,950     $ 67,246     $ 289,579     $ 192,194  
Less: acquisition-related expenses and restructuring expenses     (15,195 )     (11,225 )     (1,744 )     (41,769 )     (1,744 )
Adjusted non-interest expense (non-GAAP)   $ 82,597     $ 83,725     $ 65,502     $ 247,810     $ 190,450  
                               
Efficiency ratio FTE(1)     75.98 %     72.32 %     60.65 %     74.45 %     59.83 %
Adjusted efficiency ratio FTE (non-GAAP)(1)(2)     62.28 %     61.81 %     57.32 %     61.79 %     57.46 %
                               
Net (loss) income   $ (8,761 )   $ 26,490     $ 35,285     $ 38,522     $ 93,538  
Add: income tax (benefit) expense     (3,228 )     6,118       7,860       8,041       21,001  
Add: provision expense (release) for credit losses     40,635       1,500       (1,500 )     46,135       8,700  
Add: impact of taxable equivalent adjustment     2,272       2,239       1,985       6,693       5,807  
Pre-provision net revenue FTE (non-GAAP)(1)   $ 30,918     $ 36,347     $ 43,630     $ 99,391     $ 129,046  
                               
Pre-provision net revenue, FTE (non-GAAP)(1)   $ 30,918     $ 36,347     $ 43,630     $ 99,391     $ 129,046  
Add: acquisition-related expenses     14,696       10,890       1,744       39,928       1,744  
Add: restructuring expenses and impairment     499       558       —       2,064       —  
Adjusted pre-provision net revenue FTE (non-GAAP)(1)   $ 46,113     $ 47,795     $ 45,374     $ 141,383     $ 130,790  

____________     

(1 )      Presented on a fully taxable equivalent basis using the statutory tax rate of 21%. The tax equivalent adjustments included above are $2,272, $2,239 and $1,985 for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, respectively, and $6,693 and $5,807 for the nine months ended September 30, 2026 and September 30, 2025, respectively.
(2 )   Adjusted efficiency ratio FTE excludes other intangible assets amortization, acquisition-related expenses and restructuring expenses.
       

Adjusted Net Income and Adjusted Earnings Per Share

                               
    As of and for the three months ended   As of and for the nine months ended
       September 30,       June 30,       September 30,       September 30,       September 30, 
       2026      2026      2025      2026      2025
Adjustments to net income:                              
Net (loss) income   $ (8,761 )   $ 26,490   $ 35,285   $ 38,522   $ 93,538
Add: acquisition-related adjustments, after tax     11,318       8,383     1,336     30,749     1,336
Add: restructuring expenses and impairment, after tax     384       430     —     1,589     —
Adjusted net income (non-GAAP)   $ 2,941     $ 35,303   $ 36,621   $ 70,860   $ 94,874
                               
Adjustments to earnings per share:                              
(Loss) earnings per share diluted   $ (0.20 )   $ 0.58   $ 0.92   $ 0.84   $ 2.43
Add: acquisition-related adjustments, after tax     0.25       0.18     0.04     0.67     0.04
Add: restructuring expenses and impairment, after tax     0.01       0.02     —     0.05     —
Adjusted earnings per share – diluted (non-GAAP)   $ 0.06     $ 0.78   $ 0.96   $ 1.56   $ 2.47

FORT WORTH, Texas, Oct. 27, 2026 (GLOBE NEWSWIRE) — RANGE RESOURCES CORPORATION (NYSE: RRC) today announced its third quarter 2026 financial results.

Third Quarter 2026 Highlights –

  • Cash flow from operating activities of $308 million
  • Cash flow from operations, before working capital changes, of $347 million
  • Capital spending was $170 million, approximately 25% of the annual 2026 budget
  • Realized price, including hedges, was $3.43 per mcfe – a $0.48 premium versus NYMEX natural gas
  • Pre-hedge NGL realizations of $27.54 per barrel, a premium of $1.54 over the Mont Belvieu equivalent
  • Production averaged 2.50 Bcfe per day, approximately 68% natural gas
  • Record liquids production of 133,173 barrels per day

Dennis Degner, the Company’s CEO said, “Our third quarter results showed consistent progress on our multi-year development plan, as key infrastructure was commissioned in Range’s liquids-rich area. As a result of strong well performance and expanded infrastructure, Range’s liquids production increased to a Company record of over 130,000 barrels per day. Increased liquids production, paired with strategic access to international markets, drove strong cash margins and free cash flow during the quarter, further bolstering Range’s financial position.

“We have considerable momentum across our business and will be exiting 2026 in the strongest position in Range’s history. We believe our pending transaction with EQT Corporation is a natural next step in our journey that will allow us to scale our business, expand our reach to meet demand and accelerate our mission. With EQT, we will have improved market access, best-in-class inventory, enhanced cash flow generation, and fortified resiliency to drive profitable growth and shareholder value creation through commodity cycles. We look forward to completing the transaction and unlocking its compelling benefits for our team, customers, partners and shareholders.”

Financial Discussion

Except for generally accepted accounting principles (“GAAP”) reported amounts, specific expense categories exclude non-cash impairments, unrealized mark-to-market adjustment on derivatives, non-cash stock compensation and other items shown separately on the attached tables. “Unit costs” as used in this release are composed of direct operating, transportation, gathering, processing and compression, taxes other than income, general and administrative, interest and depletion, depreciation and amortization costs divided by production. See “Non-GAAP Financial Measures” for a definition of non-GAAP financial measures and the accompanying tables that reconcile each non-GAAP measure to its most directly comparable GAAP financial measure.

Third Quarter 2026 Results

GAAP revenues and other income for third quarter 2026 totaled $843 million, GAAP net cash provided from operating activities (including changes in working capital) was $308 million, and GAAP net income was $175 million ($0.75 per diluted share). Third quarter earnings results include a $58 million mark-to-market derivative gain due to decreases in commodity prices.

Cash flow from operations before changes in working capital, a non-GAAP measure, was $347 million. Adjusted net income comparable to analysts’ estimates, a non-GAAP measure, was $191 million ($0.81 per diluted share) in third quarter 2026.

The following table details Range’s third quarter 2026 unit costs per mcfe(a):

Expenses   3Q 2026
(per mcfe)
    3Q 2025
(per mcfe)
    Increase (Decrease)  
                 
Direct operating(a)   $ 0.13     $ 0.11     18 %
Transportation, gathering, processing and compression(a)     1.52       1.47     3 %
Taxes other than income     0.03       0.04     (25 )%
General and administrative(a)     0.16       0.17     (6 )%
Interest expense(a)     0.06       0.11     (45 )%
Total cash unit costs(b)     1.91       1.91     0 %
Depletion, depreciation and amortization (DD&A)     0.44       0.46     (4 )%
Total unit costs plus DD&A(b)   $ 2.35     $ 2.37     (1 )%

(a) Excludes stock-based compensation, one-time settlements, and amortization of debt issuance costs.
(b) Totals may not add due to rounding.

The following table details Range’s average production and realized pricing for third quarter 2026(a):

    3Q26 Production & Realized Pricing  
    Natural Gas
(mcf)
  Oil (bbl)   NGLs
(bbl)
  Natural Gas
Equivalent (mcfe)
 
                   
Net production per day   1,700,068   6,499   126,674   2,499,104  
                   
Average NYMEX price   $ 2.95   $ 85.60   $ 26.00      
Differential, including basis hedging   (0.55)   (10.03)   1.54      
Realized prices before NYMEX hedges   2.40   75.57   27.54   3.23  
Settled NYMEX hedges   0.34   (6.24)   (0.07)   0.21  
Average realized prices after hedges   $ 2.74   $ 69.33   $ 27.47   $ 3.43  

(a) Totals may not add due to rounding.

Third quarter 2026 natural gas, NGLs and oil price realizations (including the impact of cash-settled hedges and derivative settlements) averaged $3.43 per mcfe.

  • The average natural gas price, including the impact of basis hedging, was $2.40 per mcf, or a ($0.55) per mcf differential to NYMEX.
  • Range’s pre-hedge NGL price during the quarter was $27.54 per barrel, approximately $1.54 above the Mont Belvieu weighted equivalent.
  • Crude oil and condensate price realizations, before realized hedges, averaged $75.57 per barrel, or $10.03 below WTI (West Texas Intermediate).

Financial Position and Repurchase Activity

As of September 30, 2026, Range had net debt outstanding of approximately $794 million, consisting of $500 million of senior notes and $294 million on the credit facility.

During the quarter, Range did not repurchase shares. As of September 30, 2026, the Company had $1.4 billion of availability under the share repurchase program previously authorized by the Board of Directors.

Capital Expenditures and Operational Activity

Third quarter 2026 drilling and completion expenditures were $160 million. In addition, during the quarter, approximately $5 million was invested in acreage, and $5 million was invested in infrastructure, pneumatic upgrades, and other investments. Third quarter capital spending represented approximately 25% of Range’s total capital budget in 2026.

During the quarter, Range drilled ~178,000 lateral feet across 10 wells, while turning to sales ~240,000 feet across 17 wells. The table below summarizes expected 2026 activity plans regarding the number of wells to sales in each area.

    2026 YTD Wells TIL   Remaining
2026
  Planned Wells TIL in 2026  
Liquids Rich   43   7   50  
Dry Gas   12   6   18  
Total Appalachia   55   13   68  


Hedging Status

Range hedges portions of its expected future production volumes to increase the predictability of cash flow and maintain a strong, flexible financial position. Please see the detailed hedging schedule posted on the Range website under Investor Relations – Financial Information.

Range has also hedged basis across the Company’s numerous natural gas sales points to limit volatility between benchmark and regional prices. The combined fair value of natural gas basis hedges as of September 30, 2026, was a net loss of $8.4 million.

Conference Call Information

Due to the pending merger with EQT, Range will not host a conference call or webcast to discuss its third quarter 2026 results.

Non-GAAP Financial Measures

To supplement the presentation of its financial results prepared in accordance with generally accepted accounting principles (GAAP), the Company’s earnings press release contains certain financial measures that are not presented in accordance with GAAP. Management believes certain non-GAAP measures may provide financial statement users with meaningful supplemental information for comparisons within the industry. These non-GAAP financial measures may include, but are not limited to Net Income, excluding certain items, Cash flow from operations before changes in working capital, realized prices, Net debt and Cash margin.

Adjusted net income comparable to analysts’ estimates as set forth in this release represents income or loss from operations before income taxes adjusted for certain non-cash items (detailed in the accompanying table) less income taxes. We believe adjusted net income comparable to analysts’ estimates is calculated on the same basis as analysts’ estimates and that many investors use this published research in making investment decisions and evaluating operational trends of the Company and its performance relative to other oil and gas producing companies. Diluted earnings per share (adjusted) as set forth in this release represents adjusted net income comparable to analysts’ estimates on a diluted per share basis. A table is included which reconciles income or loss from operations to adjusted net income comparable to analysts’ estimates and diluted earnings per share (adjusted). On its website, the Company provides additional comparative information on prior periods.

Cash flow from operations before changes in working capital represents net cash provided by operations before changes in working capital and exploration expense adjusted for certain non-cash compensation items. Cash flow from operations before changes in working capital (sometimes referred to as “adjusted cash flow”) is widely accepted by the investment community as a financial indicator of an oil and gas company’s ability to generate cash to internally fund exploration and development activities and to service debt. Cash flow from operations before changes in working capital is also useful because it is widely used by professional research analysts in valuing, comparing, rating and providing investment recommendations of companies in the oil and gas exploration and production industry. In turn, many investors use this published research in making investment decisions. Cash flow from operations before changes in working capital is not a measure of financial performance under GAAP and should not be considered as an alternative to cash flows from operations, investing, or financing activities as an indicator of cash flows, or as a measure of liquidity. A table is included which reconciles net cash provided by operations to cash flow from operations before changes in working capital as used in this release. On its website, the Company provides additional comparative information on prior periods for cash flow, cash margins and non-GAAP earnings as used in this release.

The cash prices realized for oil and natural gas production, including the amounts realized on cash-settled derivatives and net of transportation, gathering, processing and compression expense, is a critical component in the Company’s performance tracked by investors and professional research analysts in valuing, comparing, rating and providing investment recommendations and forecasts of companies in the oil and gas exploration and production industry. In turn, many investors use this published research in making investment decisions. Due to the GAAP disclosures of various derivative transactions and third-party transportation, gathering, processing and compression expense, such information is now reported in various lines of the income statement. The Company believes that it is important to furnish a table reflecting the details of the various components of each income statement line to better inform the reader of the details of each amount and provide a summary of the realized cash-settled amounts and third-party transportation, gathering, processing and compression expense, which were historically reported as natural gas, NGLs and oil sales. This information is intended to bridge the gap between various readers’ understanding and fully disclose the information needed.

Net debt is calculated as total debt less cash and cash equivalents. The Company believes this measure is helpful to investors and industry analysts who utilize Net debt for comparative purposes across the industry.

The Company discloses in this release the detailed components of many of the single line items shown in the GAAP financial statements included in the Company’s Annual or Quarterly Reports on Form 10-K or 10-Q. The Company believes that it is important to furnish this detail of the various components comprising each line of the Statements of Operations to better inform the reader of the details of each amount, the changes between periods and the effect on its financial results.

We believe that the presentation of PV10 value of our proved reserves is a relevant and useful metric for our investors as supplemental disclosure to the standardized measure, or after-tax amount, because it presents the discounted future net cash flows attributable to our proved reserves before taking into account future corporate income taxes and our current tax structure. While the standardized measure is dependent on the unique tax situation of each company, PV10 is based on prices and discount factors that are consistent for all companies. Because of this, PV10 can be used within the industry and by credit and security analysts to evaluate estimated net cash flows from proved reserves on a more comparable basis.

RANGE RESOURCES CORPORATION (NYSE: RRC) is a leading U.S. independent natural gas and NGL producer with operations focused in the Appalachian Basin. The Company is headquartered in Fort Worth, Texas. More information about Range can be found at www.rangeresources.com.

This release contains “forward-looking statements” within the meaning of the federal securities laws. Statements that do not relate strictly to historical or current facts are forward-looking and are usually identified by the use of words such as “anticipates,” “believes,” “cause,” “continue,” “could,” “depend,” “develop,” “estimates,” “expects,” “forecasts,” “goal,” “guidance,” “have,” “impact,” “implement,” “increase,” “intends,” “lead,” “maintain,” “may,” “might,” “plans,” “potential,” “possible,” “projected,” “reduce,” “remain,” “result,” “scheduled,” “seek,” “should,” “will,” “would” and other similar words or expressions. The absence of such words or expressions does not necessarily mean the statements are not forward-looking. Without limiting the generality of the foregoing, forward-looking statements in this release may include statements regarding the proposed transaction (the “proposed transaction”) between EQT Corporation (“EQT”) and Range Resources Corporation (“Range”), the expected closing of the proposed transaction and the timing thereof and the pro forma combined company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, synergies, opportunities and anticipated future performance, expected accretion to earnings and free cash flow and anticipated dividends. Information adjusted for the proposed transaction should not be considered a forecast of future results.

Forward-looking statements contained herein reflect the current views of EQT and Range about future events. Although Range believes its forward-looking statements are based on reasonable expectations and assumptions, statements made regarding future results are not guarantees of future performance and are inherently subject to significant business, economic, competitive, regulatory and other risks and uncertainties, many of which are difficult to predict and beyond EQT’s and Range’s control. Actual outcomes and results may be materially different from the results stated or implied in the forward-looking statements included in this release due to a number of factors, including, but not limited to: the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement related to the proposed transaction (the “Merger Agreement”); the possibility that shareholders of EQT may not approve the issuance of EQT shares required in the proposed transaction; the possibility that the shareholders of Range may not adopt the Merger Agreement; the risk that EQT or Range may be unable to obtain governmental and regulatory approvals required for the proposed transaction, or required governmental and regulatory approvals may delay the proposed transaction or result in the imposition of conditions that could cause the parties to abandon the proposed transaction; the risk that the parties may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all; risks related to disruption of management’s time from ongoing business operations due to the proposed transaction; the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of EQT’s or Range’s common stock; the risk of any unexpected costs or expenses resulting from the proposed transaction; the risk of any litigation relating to the proposed transaction; the risk that the proposed transaction and its announcement could have an adverse effect on the ability of EQT and Range to retain and hire key personnel, on the ability of EQT or Range to attract third-party customers and maintain their relationships with derivatives and joint venture counterparties and on EQT’s and Range’s operating results and businesses generally; the risk that problems may arise in successfully integrating the businesses of EQT and Range, which may result in the combined company not operating as effectively and efficiently as expected; the risk that the combined company may be unable to achieve synergies or other anticipated benefits of the proposed transaction or it may take longer than expected to achieve those synergies or benefits and other important factors that could cause actual results to differ materially from those projected; the volatility in commodity prices for crude oil and natural gas; the effect of future regulatory or legislative actions on EQT and Range or the industry in which they operate, including the risk of new restrictions with respect to oil and natural gas development activities; the risk that the credit ratings of the combined business may be different from what EQT and Range expect; the ability of management to execute its plans to meet its goals and other risks inherent in EQT’s and Range’s businesses; public health crises and any related government policies and actions; the potential disruption or interruption of EQT’s or Range’s operations due to war, accidents, political events, civil unrest, severe weather, cyber threats, terrorist acts, or other natural or human causes beyond EQT’s or Range’s control; the combined company’s ability to identify and mitigate the risks and hazards inherent in operating in the global energy industry; and other factors detailed in EQT’s and Range’s Annual Reports on Form 10-K for the year ended December 31, 2025 and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

All such factors are difficult to predict and are beyond EQT’s and Range’s control. Additional risks or uncertainties that are not currently known to EQT or Range, that EQT or Range currently deem to be immaterial, or that could apply to any company could also cause actual outcomes and results to differ materially from those included in the forward-looking statements in this release.

Any forward-looking statement speaks only as of the date on which such statement is made. EQT and Range undertake no obligation to publicly correct or update the forward-looking statements in this release, in other documents or on their respective websites to reflect new information, future events or otherwise, except as required by applicable law. All such statements are expressly qualified by this cautionary statement. Readers are cautioned not to place undue reliance on these forward-looking statements as a prediction of actual results.

The SEC permits oil and gas companies, in filings made with the SEC, to disclose proved reserves, which are estimates that geological and engineering data demonstrate with reasonable certainty to be recoverable in future years from known reservoirs under existing economic and operating conditions as well as the option to disclose probable and possible reserves. Range has elected not to disclose its probable and possible reserves in its filings with the SEC. Range uses certain broader terms such as “resource potential,” “unrisked resource potential,” “unproved resource potential” or “upside” or other descriptions of volumes of resources potentially recoverable through additional drilling or recovery techniques that may include probable and possible reserves as defined by the SEC’s guidelines. Range has not attempted to distinguish probable and possible reserves from these broader classifications. The SEC’s rules prohibit us from including in filings with the SEC these broader classifications of reserves. These estimates are by their nature more speculative than estimates of proved, probable and possible reserves and accordingly are subject to substantially greater risk of actually being realized. Unproved resource potential refers to Range’s internal estimates of hydrocarbon quantities that may be potentially discovered through exploratory drilling or recovered with additional drilling or recovery techniques and have not been reviewed by independent engineers. Unproved resource potential does not constitute reserves within the meaning of the Society of Petroleum Engineer’s Petroleum Resource Management System and does not include proved reserves. Area wide unproven resource potential has not been fully risked by Range’s management. “EUR”, or estimated ultimate recovery, refers to our management’s estimates of hydrocarbon quantities that may be recovered from a well completed as a producer in the area. These quantities may not necessarily constitute or represent reserves within the meaning of the Society of Petroleum Engineer’s Petroleum Resource Management System or the SEC’s oil and natural gas disclosure rules. Actual quantities that may be recovered from Range’s interests could differ substantially. Factors affecting ultimate recovery include the scope of Range’s drilling program, which will be directly affected by the availability of capital, drilling and production costs, commodity prices, availability of drilling services and equipment, drilling results, lease expirations, transportation constraints, regulatory approvals, field spacing rules, recoveries of gas in place, length of horizontal laterals, actual drilling results, including geological and mechanical factors affecting recovery rates and other factors. Estimates of resource potential may change significantly as development of our resource plays provides additional data.

In addition, our production forecasts and expectations for future periods are dependent upon many assumptions, including estimates of production decline rates from existing wells and the undertaking and outcome of future drilling activity, which may be affected by significant commodity price or drilling cost changes. Investors are urged to consider closely the disclosure in our most recent Annual Report on Form 10-K, available from our website at www.rangeresources.com or by written request to 100 Throckmorton Street, Suite 1200, Fort Worth, Texas 76102. You can also obtain this Form 10-K on the SEC’s website at www.sec.gov or by calling the SEC at 1-800-SEC-0330.

SOURCE:   Range Resources Corporation

Range Investor Contacts:

Laith Sando
817-869-4267

Matt Schmid
817-869-1538

Range Media Contact:

Mark Windle
724-873-3223

RANGE RESOURCES CORPORATION  
                                     
STATEMENTS OF OPERATIONS
 
Based on GAAP reported earnings with additional  
details of items included in each line in Form 10-Q  
(Unaudited, In thousands, except per share data)  
                                     
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     %     2026     2025     %  
Revenues and other income:                                    
Natural gas, NGLs and oil sales (a)   $ 737,919     $ 611,491           $ 2,450,258     $ 2,070,049        
Derivative fair value income     58,118       92,946             98,229       88,736        
Brokered natural gas and marketing     46,523       43,807             161,248       131,224        
ARO settlement gain (b)     –       –             –       1        
Interest income (b)     39       52             121       4,867        
(Gain) loss on sale of assets (b)     3       (6 )           32       158        
Other (b)     224       238             679       322        
Total revenues and other income     842,826       748,528       13 %     2,710,567       2,295,357       18 %
                                     
Costs and expenses:                                    
Direct operating     30,395       23,305             85,796       70,757        
Direct operating – stock-based compensation (c)     537       525             1,601       1,566        
Transportation, gathering, processing and compression     349,934       301,110             990,075       911,933        
Taxes other than income     7,354       8,265             20,103       23,087        
Brokered natural gas, NGLs and marketing     47,530       48,256             163,389       139,800        
Brokered natural gas, NGLs and marketing – stock-based compensation (c)     676       626             2,277       2,268        
Exploration     5,557       7,820             17,365       21,426        
Exploration – stock-based compensation (c)     396       285             1,116       998        
Abandonment and impairment of unproved properties     5,774       4,899             14,232       16,254        
General and administrative     37,588       35,253             108,620       99,563        
General and administrative – stock-based compensation (c)     9,952       9,448             31,048       28,885        
General and administrative – lawsuit settlements and other     151       11             1,081       101        
Exit costs     6,334       8,085             22,853       25,484        
Deferred compensation plan (d)     (52 )     (765 )           735       2,026        
Interest expense     13,791       23,200             45,970       76,615        
Interest expense – amortization of debt issuance costs (e)     833       1,068             2,490       3,610        
Loss (gain) on early extinguishment of debt     –       –             12,344       (3 )      
Depletion, depreciation and amortization     102,049       93,793             283,657       275,866        
Total costs and expenses     618,799       565,184       9 %     1,804,752       1,700,236       6 %
                                     
Income before income taxes     224,027       183,344       22 %     905,815       595,121       52 %
                                     
Income tax expense (benefit)                                    
Current     2,775       (1,022 )           11,205       5,623        
Deferred     45,929       40,059             182,334       110,561        
      48,704       39,037             193,539       116,184        
                                     
Net income   $ 175,323     $ 144,307       21 %   $ 712,276     $ 478,937       49 %
                                     
                                     
Net income Per Common Share                                    
Basic   $ 0.75     $ 0.61           $ 3.04     $ 2.00        
Diluted   $ 0.75     $ 0.60           $ 3.02     $ 1.99        
                                     
Weighted average common shares outstanding, as reported                                    
Basic     233,487       237,378       -2 %     234,419       238,523       -2 %
Diluted     235,035       239,026       -2 %     235,958       240,255       -2 %
                                     
                                     
(a) See separate natural gas, NGLs and oil sales information table.  
(b) Included in Other income in the 10-Q.  
(c) Costs associated with stock compensation and amortization, which have been reflected in the categories associated with the direct personnel costs, are combined with the cash costs in the 10-Q.  
(d) Reflects the change in market value of the vested Company stock held in the deferred compensation plan.  
(e) Included in interest expense in the 10-Q.  

RANGE RESOURCES CORPORATION  
             
BALANCE SHEET            
(Unaudited, In thousands)   September 30,     December 31,  
    2026     2025  
             
Assets            
Current assets   $ 345,035     $ 390,835  
Derivative assets     131,367       69,397  
Natural gas, NGLs and oil properties, net (successful efforts method)     6,941,366       6,708,366  
Other property and equipment, net     17,609       4,935  
Operating lease right-of-use assets     130,583       173,477  
Other     78,466       74,938  
    $ 7,644,426     $ 7,421,948  
             
Liabilities and Stockholders’ Equity            
Current liabilities   $ 625,590     $ 658,783  
Asset retirement obligations     1,173       1,173  
Derivative liabilities     2,547       1,196  
             
Bank debt, net of unamortized debt issuance costs     284,484       106,700  
Senior notes, net of unamortized debt issuance costs     496,434       1,091,634  
Deferred tax liabilities     883,926       701,601  
Derivative liabilities     2,602       2,363  
Deferred compensation liabilities     70,773       68,635  
Operating lease liabilities     77,345       115,515  
Asset retirement obligations and other liabilities     161,376       153,081  
Divestiture contract obligation     166,225       202,586  
      2,772,475       3,103,267  
             
Common stock and retained deficit     5,724,195       5,064,743  
Accumulated other comprehensive income     389       424  
Common stock held in treasury     (852,633 )     (746,486 )
Total stockholders’ equity     4,871,951       4,318,681  
    $ 7,644,426     $ 7,421,948  

RECONCILIATION OF TOTAL DEBT AS REPORTED  
TO NET DEBT, a non-GAAP measure  
(Unaudited, in thousands)  
                   
    September 30,     December 31,        
    2026     2025     %  
                   
Total debt, net of deferred financing costs, as reported   $ 780,918     $ 1,198,334       -35 %
Unamortized debt issuance costs, as reported     13,082       19,666        
Less cash and cash equivalents, as reported     (12 )     (204 )      
Net debt, a non-GAAP measure   $ 793,988     $ 1,217,796       -35 %

RANGE RESOURCES CORPORATION  
                         
CASH FLOWS FROM OPERATING ACTIVITIES  
(Unaudited, in thousands)  
                         
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
                         
Net income   $ 175,323     $ 144,307     $ 712,276     $ 478,937  
Adjustments to reconcile net cash provided from continuing operations:                        
Deferred income tax expense     45,929       40,059       182,334       110,561  
Depletion, depreciation and amortization     102,049       93,793       283,657       275,866  
Abandonment and impairment of unproved properties     5,774       4,899       14,232       16,254  
Derivative fair value income     (58,118 )     (92,946 )     (98,229 )     (88,736 )
Cash settlements on derivative financial instruments     51,855       62,033       37,849       98,072  
Divestiture contract obligation, including accretion     6,334       8,085       22,853       25,484  
Amortization of deferred financing costs and other     1,274       852       3,464       2,996  
Deferred and stock-based compensation     11,612       10,248       37,435       36,378  
(Gain) loss on sale of assets     (3 )     6       (32 )     (158 )
Loss (gain) on early extinguishment of debt     –       –       12,344       (3 )
                         
Changes in working capital:                        
Accounts receivable     (12,265 )     (5,001 )     56,514       63,063  
Other current assets     (10,709 )     3,426       (10,794 )     (5,084 )
Accounts payable     (21,739 )     (1,142 )     (15,418 )     8,016  
Accrued liabilities and other     10,285       (21,074 )     (76,733 )     (107,828 )
Net changes in working capital     (34,428 )     (23,791 )     (46,431 )     (41,833 )
Net cash provided from operating activities   $ 307,601     $ 247,545     $ 1,161,752     $ 913,818  
                         
                         
RECONCILIATION OF NET CASH PROVIDED FROM OPERATING
 
ACTIVITIES, AS REPORTED, TO CASH FLOW FROM OPERATIONS
 
BEFORE CHANGES IN WORKING CAPITAL, a non-GAAP measure
 
(Unaudited, in thousands)  
                         
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
Net cash provided from operating activities, as reported   $ 307,601     $ 247,545     $ 1,161,752     $ 913,818  
Net changes in working capital     34,428       23,791       46,431       41,833  
Exploration expense     5,557       7,820       17,365       21,426  
Lawsuit settlements     (257 )     11       169       101  
Sale of seismic data     –       –       (360 )     –  
Non-cash compensation adjustment and other     (136 )     87       (720 )     (22 )
Cash flow from operations before changes in working capital – non-GAAP measure   $ 347,193     $ 279,254     $ 1,224,637     $ 977,156  
                         
                         
ADJUSTED WEIGHTED AVERAGE SHARES OUTSTANDING
 
(Unaudited, in thousands)  
   
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
Basic:                        
Weighted average shares outstanding     233,686       237,643       234,657       239,063  
Stock held by deferred compensation plan     (199 )     (265 )     (238 )     (540 )
Adjusted basic     233,487       237,378       234,419       238,523  
                         
Dilutive:                        
Weighted average shares outstanding     233,686       237,643       234,657       239,063  
Dilutive stock options under treasury method     1,349       1,383       1,301       1,192  
Adjusted dilutive     235,035       239,026       235,958       240,255  

RANGE RESOURCES CORPORATION  
                                     
RECONCILIATION OF NATURAL GAS, NGLs AND OIL SALES  
AND DERIVATIVE FAIR VALUE INCOME (LOSS) TO  
CALCULATED CASH REALIZED NATURAL GAS, NGLs AND  
OIL PRICES WITH AND WITHOUT THIRD-PARTY  
TRANSPORTATION, GATHERING, PROCESSING AND  
COMPRESSION COSTS, a non-GAAP measure  
(Unaudited, In thousands, except per unit data)  
                         
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     %     2026     2025     %  
Natural gas, NGLs and Oil Sales components:                                    
Natural gas sales   $ 371,772     $ 361,124           $ 1,415,649     $ 1,249,456        
NGLs sales     320,962       224,376             893,016       738,064        
Oil sales     45,185       25,991             141,593       82,529        
Total Natural Gas, NGLs and Oil Sales, as reported   $ 737,919     $ 611,491       21 %   $ 2,450,258     $ 2,070,049       18 %
                                     
Derivative Fair Value Income, as reported   $ 58,118     $ 92,946           $ 98,229     $ 88,736        
Cash settlements on derivative financial instruments – (gain) loss:                                    
Natural gas     (56,384 )     (56,420 )           (63,504 )     (90,263 )      
NGLs     797       (4,000 )           7,986       (5,096 )      
Oil     3,732       (1,613 )           17,669       (2,713 )      
Total change in fair value related to commodity derivatives prior to settlement, a non-GAAP measure   $ 6,263     $ 30,913           $ 60,380     $ (9,336 )      
                                     
Transportation, gathering, processing and compression components:                                    
Natural Gas   $ 170,125     $ 157,193           $ 491,422     $ 469,416        
NGLs     179,054       142,815             496,252       439,862        
Oil     755       1,102             2,401       2,655        
Total transportation, gathering, processing and compression, as reported   $ 349,934     $ 301,110           $ 990,075     $ 911,933        
                                     
Natural gas, NGL and Oil sales, including cash-settled derivatives: (c)                                    
Natural gas sales   $ 428,156     $ 417,544           $ 1,479,153     $ 1,339,719        
NGLs sales     320,165       228,376             885,030       743,160        
Oil Sales     41,453       27,604             123,924       85,242        
Total   $ 789,774     $ 673,524       17 %   $ 2,488,107     $ 2,168,121       15 %
                                     
Production of natural gas, NGLs and oil during the periods (a):                                    
Natural Gas (mcf)     156,406,269       141,133,949       11 %     433,149,336       413,394,538       5 %
NGLs (bbls)     11,653,966       10,158,612       15 %     32,139,618       30,107,652       7 %
Oil (bbls)     597,916       479,142       25 %     1,928,670       1,483,512       30 %
Gas equivalent (mcfe) (b)     229,917,561       204,960,473       12 %     637,559,064       602,941,522       6 %
                                     
Production of natural gas, NGLs and oil – average per day (a):                                    
Natural Gas (mcf)     1,700,068       1,534,065       11 %     1,586,628       1,514,266       5 %
NGLs (bbls)     126,674       110,420       15 %     117,728       110,284       7 %
Oil (bbls)     6,499       5,208       25 %     7,065       5,434       30 %
Gas equivalent (mcfe) (b)     2,499,104       2,227,831       12 %     2,335,381       2,208,577       6 %
                                     
Average prices, excluding derivative settlements and before third-party transportation costs:                                    
Natural Gas (per mcf)   $ 2.38     $ 2.56       -7 %   $ 3.27     $ 3.02       8 %
NGLs (per bbl)   $ 27.54     $ 22.09       25 %   $ 27.79     $ 24.51       13 %
Oil (per bbl)   $ 75.57     $ 54.25       39 %   $ 73.41     $ 55.63       32 %
Gas equivalent (per mcfe) (b)   $ 3.21     $ 2.98       8 %   $ 3.84     $ 3.43       12 %
                                     
Average prices, including derivative settlements before third-party transportation costs: (c)                                    
Natural Gas (per mcf)   $ 2.74     $ 2.96       -7 %   $ 3.41     $ 3.24       5 %
NGLs (per bbl)   $ 27.47     $ 22.48       22 %   $ 27.54     $ 24.68       12 %
Oil (per bbl)   $ 69.33     $ 57.61       20 %   $ 64.25     $ 57.46       12 %
Gas equivalent (per mcfe) (b)   $ 3.43     $ 3.29       4 %   $ 3.90     $ 3.59       9 %
                                     
Average prices, including derivative settlements and after third-party transportation costs: (d)                                    
Natural Gas (per mcf)   $ 1.65     $ 1.84       -10 %   $ 2.28     $ 2.11       8 %
NGLs (per bbl)   $ 12.11     $ 8.42       44 %   $ 12.10     $ 10.07       20 %
Oil (per bbl)   $ 68.07     $ 55.31       23 %   $ 63.01     $ 55.67       13 %
Gas equivalent (per mcfe) (b)   $ 1.91     $ 1.82       5 %   $ 2.35     $ 2.08       13 %
                                     
Transportation, gathering and compression expense per mcfe   $ 1.52     $ 1.47       3 %   $ 1.55     $ 1.51       3 %
(a) Represents volumes sold regardless of when produced.
(b) Oil and NGLs are converted at the rate of one barrel equals six mcfe based upon the approximate relative energy content of oil to natural gas, which is not necessarily indicative of the relationship of oil and natural gas prices.
(c) Excluding third-party transportation, gathering, processing and compression costs.
(d) Net of transportation, gathering, processing and compression costs.
 

RANGE RESOURCES CORPORATION
 
                                   
RECONCILIATION OF INCOME BEFORE INCOME
 
TAXES AS REPORTED TO INCOME BEFORE INCOME TAXES
 
EXCLUDING CERTAIN ITEMS, a non-GAAP measure
 
(Unaudited, In thousands, except per share data)  
                                   
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     %     2026     2025     %  
                                   
Income from operations before income taxes, as reported   $ 224,027     $ 183,344       22 %   $ 905,815     $ 595,121       52 %
Adjustment for certain special items:                                  
(Gain) loss on the sale of assets     (3 )     6             (32 )     (158 )    
ARO settlement gain     –       –             –       (1 )    
Sale of seismic data     –       –             (360 )     –      
Change in fair value related to derivatives prior to settlement     (6,263 )     (30,913 )           (60,380 )     9,336      
Abandonment and impairment of unproved properties     5,774       4,899             14,232       16,254      
Loss (gain) on early extinguishment of debt     –       –             12,344       (3 )    
Lawsuit settlements and other     151       11             1,081       101      
Exit costs     6,334       8,085             22,853       25,484      
Direct operating – stock-based compensation     537       525             1,601       1,566      
Brokered natural gas, NGLs and marketing – stock-based compensation     676       626             2,277       2,268      
Exploration expenses – stock-based compensation     396       285             1,116       998      
General & administrative – stock-based compensation     9,952       9,448             31,048       28,885      
Deferred compensation plan – non-cash adjustment     (52 )     (765 )           735       2,026      
                                   
Income before income taxes, as adjusted     241,529       175,551       38 %     932,330       681,877       37 %
                                   
Income tax expense (benefit), as adjusted                                  
Current     2,775       (1,022 )           11,205       5,623      
Deferred (a)     47,946       41,399             184,584       151,209      
                                   
Net income, excluding certain items, a non-GAAP measure   $ 190,808     $ 135,174       41 %   $ 736,541     $ 525,045       40 %
                                   
Non-GAAP income per common share                                  
Basic   $ 0.82     $ 0.57       44 %   $ 3.14     $ 2.20       43 %
Diluted   $ 0.81     $ 0.57       42 %   $ 3.12     $ 2.19       42 %
                                   
Non-GAAP diluted shares outstanding, if dilutive     235,035       239,026             235,958       240,255      
                                   
(a) Taxes are estimated to be approximately 21% for 2026 and 23% for 2025.  

RANGE RESOURCES CORPORATION  
                         
RECONCILIATION OF NET INCOME, EXCLUDING
 
CERTAIN ITEMS AND ADJUSTED EARNINGS PER
 
SHARE, non-GAAP measures
 
(In thousands, except per share data)  
                         
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
                         
Net income, as reported   $ 175,323     $ 144,307     $ 712,276     $ 478,937  
Adjustments for certain special items:                        
(Gain) loss on the sale of assets     (3 )     6       (32 )     (158 )
ARO settlement gain     –       –       –       (1 )
Sale of seismic data     –       –       (360 )     –  
Loss (gain) on early extinguishment of debt     –       –       12,344       (3 )
Change in fair value related to derivatives prior to settlement     (6,263 )     (30,913 )     (60,380 )     9,336  
Abandonment and impairment of unproved properties     5,774       4,899       14,232       16,254  
Lawsuit settlements and other     151       11       1,081       101  
Exit costs     6,334       8,085       22,853       25,484  
Stock-based compensation     11,561       10,884       36,042       33,717  
Deferred compensation plan     (52 )     (765 )     735       2,026  
Tax impact     (2,017 )     (1,340 )     (2,250 )     (40,648 )
                         
Net income, excluding certain items, a non-GAAP measure   $ 190,808     $ 135,174     $ 736,541     $ 525,045  
                         
Net income per diluted share, as reported   $ 0.75     $ 0.60     $ 3.02     $ 1.99  
Adjustments for certain special items per diluted share:                        
(Gain) loss on the sale of assets     –       –       –       –  
ARO settlement gain     –       –       –       –  
Sale of seismic data     –       –       –       –  
Loss (gain) on early extinguishment of debt     –       –       0.05       –  
Change in fair value related to derivatives prior to settlement     (0.03 )     (0.13 )     (0.26 )     0.04  
Abandonment and impairment of unproved properties     0.02       0.02       0.06       0.07  
Lawsuit settlements and other     –       –       –       –  
Exit costs     0.03       0.03       0.10       0.11  
Stock-based compensation     0.05       0.05       0.15       0.14  
Deferred compensation plan     –       –       –       0.01  
Adjustment for rounding differences     –       0.01       0.01       –  
Tax impact     (0.01 )     (0.01 )     (0.01 )     (0.17 )
Dilutive share impact (rabbi trust and other)     –       –       –       –  
                         
Net income per diluted share, excluding certain items, a non-GAAP measure   $ 0.81     $ 0.57     $ 3.12     $ 2.19  
                         
Adjusted earnings per share, a non-GAAP measure:                        
Basic   $ 0.82     $ 0.57     $ 3.14     $ 2.20  
Diluted   $ 0.81     $ 0.57     $ 3.12     $ 2.19  

RANGE RESOURCES CORPORATION
 
   
RECONCILIATION OF CASH MARGIN PER MCFE, a non-GAAP measure  
(Unaudited, In thousands, except per unit data)  
             
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
                         
Revenues                        
Natural gas, NGLs and oil sales, as reported   $ 737,919     $ 611,491     $ 2,450,258     $ 2,070,049  
Derivative fair value income, as reported     58,118       92,946       98,229       88,736  
Less non-cash fair value (gain) loss     (6,263 )     (30,913 )     (60,380 )     9,336  
Brokered natural gas and marketing, as reported     46,523       43,807       161,248       131,224  
Other income, as reported     266       284       832       5,348  
Less (gain) loss on sale of assets     (3 )     6       (32 )     (158 )
Less ARO settlement     –       –       –       (1 )
Cash revenues and other income     836,560       717,621       2,650,155       2,304,534  
                         
Expenses                        
Direct operating, as reported     30,932       23,830       87,397       72,323  
Less direct operating stock-based compensation     (537 )     (525 )     (1,601 )     (1,566 )
Transportation, gathering and compression, as reported     349,934       301,110       990,075       911,933  
Taxes other than income, as reported     7,354       8,265       20,103       23,087  
Brokered natural gas, NGLs and marketing, as reported     48,206       48,882       165,666       142,068  
Less brokered natural gas, NGLs and marketing stock-based compensation     (676 )     (626 )     (2,277 )     (2,268 )
General and administrative, as reported     47,691       44,712       140,749       128,549  
Less G&A stock-based compensation     (9,952 )     (9,448 )     (31,048 )     (28,885 )
Less lawsuit settlements and other     (151 )     (11 )     (1,081 )     (101 )
Interest expense, as reported     14,624       24,268       48,460       80,225  
Less amortization of debt issuance costs     (833 )     (1,068 )     (2,490 )     (3,610 )
Cash expenses     486,592       439,389       1,413,953       1,321,755  
                         
Cash margin, a non-GAAP measure   $ 349,968     $ 278,232     $ 1,236,202     $ 982,779  
                         
Mmcfe produced during period     229,918       204,961       637,559       602,942  
                         
Cash margin per mcfe   $ 1.52     $ 1.36     $ 1.94     $ 1.63  
                         
                         
RECONCILIATION OF INCOME BEFORE INCOME TAXES TO CASH MARGIN, a non-GAAP measure                        
(Unaudited, in thousands, except per unit data)                        
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
                         
Income before income taxes, as reported   $ 224,027     $ 183,344     $ 905,815     $ 595,121  
Adjustments to reconcile income before income taxes to cash margin:                        
ARO settlements     –       –       –       (1 )
Derivative fair value income     (58,118 )     (92,946 )     (98,229 )     (88,736 )
Net cash receipts on derivative settlements     51,855       62,033       37,849       98,072  
Exploration expense     5,557       7,820       17,365       21,426  
Lawsuit settlements and other     151       11       1,081       101  
Exit costs     6,334       8,085       22,853       25,484  
Deferred compensation plan     (52 )     (765 )     735       2,026  
Stock-based compensation (direct operating, brokered natural gas, NGLs and marketing, exploration and general and administrative)     11,561       10,884       36,042       33,717  
Bad debt expense     –       –       –       –  
Interest – amortization of debt issuance costs     833       1,068       2,490       3,610  
Depletion, depreciation and amortization     102,049       93,793       283,657       275,866  
(Gain) loss on sale of assets     (3 )     6       (32 )     (158 )
Loss (gain) on early extinguishment of debt     –       –       12,344       (3 )
Abandonment and impairment of unproved properties     5,774       4,899       14,232       16,254  
Cash margin, a non-GAAP measure   $ 349,968     $ 278,232     $ 1,236,202     $ 982,779  


Important Information for Investors and Shareholders; Additional Information and Where to Find It

In connection with the proposed transaction, EQT intends to file with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 (the “registration statement”) that will include a joint proxy statement of EQT and Range and that will also constitute a prospectus of EQT (the “joint proxy statement/prospectus”). Range and EQT also intend to file other documents regarding the proposed transaction with the SEC. This communication is not a substitute for the joint proxy statement/prospectus or the registration statement. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND SECURITY HOLDERS OF EQT AND RANGE ARE URGED TO READ THE REGISTRATION STATEMENT, THE JOINT PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT MAY BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT EQT, RANGE, THE PROPOSED TRANSACTION, THE RISKS THERETO AND RELATED MATTERS. After the registration statement has been declared effective, a definitive joint proxy statement/prospectus will be mailed to the shareholders of EQT and the shareholders of Range. Investors and security holders will be able to obtain free copies of the registration statement and joint proxy statement/prospectus and other relevant documents filed or that will be filed with the SEC by EQT or Range through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by Range will be available free of charge on Range’s website at www. ir.rangeresources.com. Copies of the documents filed with the SEC by EQT will be available free of charge on EQT’s website at www.ir.eqt.com/investor-relations. The information included on, or accessible through, Range’s or EQT’s website is not incorporated by reference into this communication.

Participants in the Solicitation

Range, EQT and their respective directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction contemplated by the joint proxy statement/prospectus. Information regarding Range’s directors and executive officers and their ownership of Range’s securities is set forth in Range’s filings with the SEC, including Range’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 that was filed with the SEC on February 24, 2026 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000315852/000119312526067292/rrc-20251231.htm) and its Definitive Proxy Statement on Schedule 14A that was filed with the SEC on March 31, 2026 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000315852/000119312526134699/rrc-20260325.htm). To the extent such person’s ownership of Range’s securities has changed since the filing of such proxy statement, such changes have been or will be reflected on Statements of Changes in Beneficial Ownership on Form 4 filed with the SEC. Information regarding EQT’s directors and executive officers and their ownership of EQT’s securities is set forth in EQT’s filings with the SEC, including EQT’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000033213/000003321326000018/eqt-20251231.htm) and its Definitive Proxy Statement on Schedule 14A that was filed with the SEC on February 26, 2026 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000033213/000110465926020027/tm261383-1_def14a.htm). To the extent such person’s ownership of EQT’s securities has changed since the filing of such proxy statement, such changes have been or will be reflected on Statements of Changes in Beneficial Ownership on Form 4 filed with the SEC. Additional information regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction may be obtained by reading the joint proxy statement/prospectus and other relevant materials that will be filed with the SEC regarding the proposed transaction when such documents become available. You may obtain free copies of these documents as described in the preceding paragraph.

No Offer or Solicitation

This release relates to the proposed transaction. This release is for informational purposes only and is not intended to and shall not constitute an offer to buy, sell or exchange or the solicitation of an offer to buy, sell or exchange any securities, or a solicitation of any vote or approval, in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance, exchange or transfer of the securities referred to in this document in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

FORT WORTH, Texas, Oct. 27, 2026 (GLOBE NEWSWIRE) — RANGE RESOURCES CORPORATION (NYSE: RRC) today announced its third quarter 2026 financial results.

Third Quarter 2026 Highlights –

  • Cash flow from operating activities of $308 million
  • Cash flow from operations, before working capital changes, of $347 million
  • Capital spending was $170 million, approximately 25% of the annual 2026 budget
  • Realized price, including hedges, was $3.43 per mcfe – a $0.48 premium versus NYMEX natural gas
  • Pre-hedge NGL realizations of $27.54 per barrel, a premium of $1.54 over the Mont Belvieu equivalent
  • Production averaged 2.50 Bcfe per day, approximately 68% natural gas
  • Record liquids production of 133,173 barrels per day

Dennis Degner, the Company’s CEO said, “Our third quarter results showed consistent progress on our multi-year development plan, as key infrastructure was commissioned in Range’s liquids-rich area. As a result of strong well performance and expanded infrastructure, Range’s liquids production increased to a Company record of over 130,000 barrels per day. Increased liquids production, paired with strategic access to international markets, drove strong cash margins and free cash flow during the quarter, further bolstering Range’s financial position.

“We have considerable momentum across our business and will be exiting 2026 in the strongest position in Range’s history. We believe our pending transaction with EQT Corporation is a natural next step in our journey that will allow us to scale our business, expand our reach to meet demand and accelerate our mission. With EQT, we will have improved market access, best-in-class inventory, enhanced cash flow generation, and fortified resiliency to drive profitable growth and shareholder value creation through commodity cycles. We look forward to completing the transaction and unlocking its compelling benefits for our team, customers, partners and shareholders.”

Financial Discussion

Except for generally accepted accounting principles (“GAAP”) reported amounts, specific expense categories exclude non-cash impairments, unrealized mark-to-market adjustment on derivatives, non-cash stock compensation and other items shown separately on the attached tables. “Unit costs” as used in this release are composed of direct operating, transportation, gathering, processing and compression, taxes other than income, general and administrative, interest and depletion, depreciation and amortization costs divided by production. See “Non-GAAP Financial Measures” for a definition of non-GAAP financial measures and the accompanying tables that reconcile each non-GAAP measure to its most directly comparable GAAP financial measure.

Third Quarter 2026 Results

GAAP revenues and other income for third quarter 2026 totaled $843 million, GAAP net cash provided from operating activities (including changes in working capital) was $308 million, and GAAP net income was $175 million ($0.75 per diluted share). Third quarter earnings results include a $58 million mark-to-market derivative gain due to decreases in commodity prices.

Cash flow from operations before changes in working capital, a non-GAAP measure, was $347 million. Adjusted net income comparable to analysts’ estimates, a non-GAAP measure, was $191 million ($0.81 per diluted share) in third quarter 2026.

The following table details Range’s third quarter 2026 unit costs per mcfe(a):

Expenses   3Q 2026
(per mcfe)
    3Q 2025
(per mcfe)
    Increase (Decrease)  
                 
Direct operating(a)   $ 0.13     $ 0.11     18 %
Transportation, gathering, processing and compression(a)     1.52       1.47     3 %
Taxes other than income     0.03       0.04     (25 )%
General and administrative(a)     0.16       0.17     (6 )%
Interest expense(a)     0.06       0.11     (45 )%
Total cash unit costs(b)     1.91       1.91     0 %
Depletion, depreciation and amortization (DD&A)     0.44       0.46     (4 )%
Total unit costs plus DD&A(b)   $ 2.35     $ 2.37     (1 )%

(a) Excludes stock-based compensation, one-time settlements, and amortization of debt issuance costs.
(b) Totals may not add due to rounding.

The following table details Range’s average production and realized pricing for third quarter 2026(a):

    3Q26 Production & Realized Pricing  
    Natural Gas
(mcf)
  Oil (bbl)   NGLs
(bbl)
  Natural Gas
Equivalent (mcfe)
 
                   
Net production per day   1,700,068   6,499   126,674   2,499,104  
                   
Average NYMEX price   $ 2.95   $ 85.60   $ 26.00      
Differential, including basis hedging   (0.55)   (10.03)   1.54      
Realized prices before NYMEX hedges   2.40   75.57   27.54   3.23  
Settled NYMEX hedges   0.34   (6.24)   (0.07)   0.21  
Average realized prices after hedges   $ 2.74   $ 69.33   $ 27.47   $ 3.43  

(a) Totals may not add due to rounding.

Third quarter 2026 natural gas, NGLs and oil price realizations (including the impact of cash-settled hedges and derivative settlements) averaged $3.43 per mcfe.

  • The average natural gas price, including the impact of basis hedging, was $2.40 per mcf, or a ($0.55) per mcf differential to NYMEX.
  • Range’s pre-hedge NGL price during the quarter was $27.54 per barrel, approximately $1.54 above the Mont Belvieu weighted equivalent.
  • Crude oil and condensate price realizations, before realized hedges, averaged $75.57 per barrel, or $10.03 below WTI (West Texas Intermediate).

Financial Position and Repurchase Activity

As of September 30, 2026, Range had net debt outstanding of approximately $794 million, consisting of $500 million of senior notes and $294 million on the credit facility.

During the quarter, Range did not repurchase shares. As of September 30, 2026, the Company had $1.4 billion of availability under the share repurchase program previously authorized by the Board of Directors.

Capital Expenditures and Operational Activity

Third quarter 2026 drilling and completion expenditures were $160 million. In addition, during the quarter, approximately $5 million was invested in acreage, and $5 million was invested in infrastructure, pneumatic upgrades, and other investments. Third quarter capital spending represented approximately 25% of Range’s total capital budget in 2026.

During the quarter, Range drilled ~178,000 lateral feet across 10 wells, while turning to sales ~240,000 feet across 17 wells. The table below summarizes expected 2026 activity plans regarding the number of wells to sales in each area.

    2026 YTD Wells TIL   Remaining
2026
  Planned Wells TIL in 2026  
Liquids Rich   43   7   50  
Dry Gas   12   6   18  
Total Appalachia   55   13   68  


Hedging Status

Range hedges portions of its expected future production volumes to increase the predictability of cash flow and maintain a strong, flexible financial position. Please see the detailed hedging schedule posted on the Range website under Investor Relations – Financial Information.

Range has also hedged basis across the Company’s numerous natural gas sales points to limit volatility between benchmark and regional prices. The combined fair value of natural gas basis hedges as of September 30, 2026, was a net loss of $8.4 million.

Conference Call Information

Due to the pending merger with EQT, Range will not host a conference call or webcast to discuss its third quarter 2026 results.

Non-GAAP Financial Measures

To supplement the presentation of its financial results prepared in accordance with generally accepted accounting principles (GAAP), the Company’s earnings press release contains certain financial measures that are not presented in accordance with GAAP. Management believes certain non-GAAP measures may provide financial statement users with meaningful supplemental information for comparisons within the industry. These non-GAAP financial measures may include, but are not limited to Net Income, excluding certain items, Cash flow from operations before changes in working capital, realized prices, Net debt and Cash margin.

Adjusted net income comparable to analysts’ estimates as set forth in this release represents income or loss from operations before income taxes adjusted for certain non-cash items (detailed in the accompanying table) less income taxes. We believe adjusted net income comparable to analysts’ estimates is calculated on the same basis as analysts’ estimates and that many investors use this published research in making investment decisions and evaluating operational trends of the Company and its performance relative to other oil and gas producing companies. Diluted earnings per share (adjusted) as set forth in this release represents adjusted net income comparable to analysts’ estimates on a diluted per share basis. A table is included which reconciles income or loss from operations to adjusted net income comparable to analysts’ estimates and diluted earnings per share (adjusted). On its website, the Company provides additional comparative information on prior periods.

Cash flow from operations before changes in working capital represents net cash provided by operations before changes in working capital and exploration expense adjusted for certain non-cash compensation items. Cash flow from operations before changes in working capital (sometimes referred to as “adjusted cash flow”) is widely accepted by the investment community as a financial indicator of an oil and gas company’s ability to generate cash to internally fund exploration and development activities and to service debt. Cash flow from operations before changes in working capital is also useful because it is widely used by professional research analysts in valuing, comparing, rating and providing investment recommendations of companies in the oil and gas exploration and production industry. In turn, many investors use this published research in making investment decisions. Cash flow from operations before changes in working capital is not a measure of financial performance under GAAP and should not be considered as an alternative to cash flows from operations, investing, or financing activities as an indicator of cash flows, or as a measure of liquidity. A table is included which reconciles net cash provided by operations to cash flow from operations before changes in working capital as used in this release. On its website, the Company provides additional comparative information on prior periods for cash flow, cash margins and non-GAAP earnings as used in this release.

The cash prices realized for oil and natural gas production, including the amounts realized on cash-settled derivatives and net of transportation, gathering, processing and compression expense, is a critical component in the Company’s performance tracked by investors and professional research analysts in valuing, comparing, rating and providing investment recommendations and forecasts of companies in the oil and gas exploration and production industry. In turn, many investors use this published research in making investment decisions. Due to the GAAP disclosures of various derivative transactions and third-party transportation, gathering, processing and compression expense, such information is now reported in various lines of the income statement. The Company believes that it is important to furnish a table reflecting the details of the various components of each income statement line to better inform the reader of the details of each amount and provide a summary of the realized cash-settled amounts and third-party transportation, gathering, processing and compression expense, which were historically reported as natural gas, NGLs and oil sales. This information is intended to bridge the gap between various readers’ understanding and fully disclose the information needed.

Net debt is calculated as total debt less cash and cash equivalents. The Company believes this measure is helpful to investors and industry analysts who utilize Net debt for comparative purposes across the industry.

The Company discloses in this release the detailed components of many of the single line items shown in the GAAP financial statements included in the Company’s Annual or Quarterly Reports on Form 10-K or 10-Q. The Company believes that it is important to furnish this detail of the various components comprising each line of the Statements of Operations to better inform the reader of the details of each amount, the changes between periods and the effect on its financial results.

We believe that the presentation of PV10 value of our proved reserves is a relevant and useful metric for our investors as supplemental disclosure to the standardized measure, or after-tax amount, because it presents the discounted future net cash flows attributable to our proved reserves before taking into account future corporate income taxes and our current tax structure. While the standardized measure is dependent on the unique tax situation of each company, PV10 is based on prices and discount factors that are consistent for all companies. Because of this, PV10 can be used within the industry and by credit and security analysts to evaluate estimated net cash flows from proved reserves on a more comparable basis.

RANGE RESOURCES CORPORATION (NYSE: RRC) is a leading U.S. independent natural gas and NGL producer with operations focused in the Appalachian Basin. The Company is headquartered in Fort Worth, Texas. More information about Range can be found at www.rangeresources.com.

This release contains “forward-looking statements” within the meaning of the federal securities laws. Statements that do not relate strictly to historical or current facts are forward-looking and are usually identified by the use of words such as “anticipates,” “believes,” “cause,” “continue,” “could,” “depend,” “develop,” “estimates,” “expects,” “forecasts,” “goal,” “guidance,” “have,” “impact,” “implement,” “increase,” “intends,” “lead,” “maintain,” “may,” “might,” “plans,” “potential,” “possible,” “projected,” “reduce,” “remain,” “result,” “scheduled,” “seek,” “should,” “will,” “would” and other similar words or expressions. The absence of such words or expressions does not necessarily mean the statements are not forward-looking. Without limiting the generality of the foregoing, forward-looking statements in this release may include statements regarding the proposed transaction (the “proposed transaction”) between EQT Corporation (“EQT”) and Range Resources Corporation (“Range”), the expected closing of the proposed transaction and the timing thereof and the pro forma combined company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, synergies, opportunities and anticipated future performance, expected accretion to earnings and free cash flow and anticipated dividends. Information adjusted for the proposed transaction should not be considered a forecast of future results.

Forward-looking statements contained herein reflect the current views of EQT and Range about future events. Although Range believes its forward-looking statements are based on reasonable expectations and assumptions, statements made regarding future results are not guarantees of future performance and are inherently subject to significant business, economic, competitive, regulatory and other risks and uncertainties, many of which are difficult to predict and beyond EQT’s and Range’s control. Actual outcomes and results may be materially different from the results stated or implied in the forward-looking statements included in this release due to a number of factors, including, but not limited to: the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement related to the proposed transaction (the “Merger Agreement”); the possibility that shareholders of EQT may not approve the issuance of EQT shares required in the proposed transaction; the possibility that the shareholders of Range may not adopt the Merger Agreement; the risk that EQT or Range may be unable to obtain governmental and regulatory approvals required for the proposed transaction, or required governmental and regulatory approvals may delay the proposed transaction or result in the imposition of conditions that could cause the parties to abandon the proposed transaction; the risk that the parties may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all; risks related to disruption of management’s time from ongoing business operations due to the proposed transaction; the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of EQT’s or Range’s common stock; the risk of any unexpected costs or expenses resulting from the proposed transaction; the risk of any litigation relating to the proposed transaction; the risk that the proposed transaction and its announcement could have an adverse effect on the ability of EQT and Range to retain and hire key personnel, on the ability of EQT or Range to attract third-party customers and maintain their relationships with derivatives and joint venture counterparties and on EQT’s and Range’s operating results and businesses generally; the risk that problems may arise in successfully integrating the businesses of EQT and Range, which may result in the combined company not operating as effectively and efficiently as expected; the risk that the combined company may be unable to achieve synergies or other anticipated benefits of the proposed transaction or it may take longer than expected to achieve those synergies or benefits and other important factors that could cause actual results to differ materially from those projected; the volatility in commodity prices for crude oil and natural gas; the effect of future regulatory or legislative actions on EQT and Range or the industry in which they operate, including the risk of new restrictions with respect to oil and natural gas development activities; the risk that the credit ratings of the combined business may be different from what EQT and Range expect; the ability of management to execute its plans to meet its goals and other risks inherent in EQT’s and Range’s businesses; public health crises and any related government policies and actions; the potential disruption or interruption of EQT’s or Range’s operations due to war, accidents, political events, civil unrest, severe weather, cyber threats, terrorist acts, or other natural or human causes beyond EQT’s or Range’s control; the combined company’s ability to identify and mitigate the risks and hazards inherent in operating in the global energy industry; and other factors detailed in EQT’s and Range’s Annual Reports on Form 10-K for the year ended December 31, 2025 and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

All such factors are difficult to predict and are beyond EQT’s and Range’s control. Additional risks or uncertainties that are not currently known to EQT or Range, that EQT or Range currently deem to be immaterial, or that could apply to any company could also cause actual outcomes and results to differ materially from those included in the forward-looking statements in this release.

Any forward-looking statement speaks only as of the date on which such statement is made. EQT and Range undertake no obligation to publicly correct or update the forward-looking statements in this release, in other documents or on their respective websites to reflect new information, future events or otherwise, except as required by applicable law. All such statements are expressly qualified by this cautionary statement. Readers are cautioned not to place undue reliance on these forward-looking statements as a prediction of actual results.

The SEC permits oil and gas companies, in filings made with the SEC, to disclose proved reserves, which are estimates that geological and engineering data demonstrate with reasonable certainty to be recoverable in future years from known reservoirs under existing economic and operating conditions as well as the option to disclose probable and possible reserves. Range has elected not to disclose its probable and possible reserves in its filings with the SEC. Range uses certain broader terms such as “resource potential,” “unrisked resource potential,” “unproved resource potential” or “upside” or other descriptions of volumes of resources potentially recoverable through additional drilling or recovery techniques that may include probable and possible reserves as defined by the SEC’s guidelines. Range has not attempted to distinguish probable and possible reserves from these broader classifications. The SEC’s rules prohibit us from including in filings with the SEC these broader classifications of reserves. These estimates are by their nature more speculative than estimates of proved, probable and possible reserves and accordingly are subject to substantially greater risk of actually being realized. Unproved resource potential refers to Range’s internal estimates of hydrocarbon quantities that may be potentially discovered through exploratory drilling or recovered with additional drilling or recovery techniques and have not been reviewed by independent engineers. Unproved resource potential does not constitute reserves within the meaning of the Society of Petroleum Engineer’s Petroleum Resource Management System and does not include proved reserves. Area wide unproven resource potential has not been fully risked by Range’s management. “EUR”, or estimated ultimate recovery, refers to our management’s estimates of hydrocarbon quantities that may be recovered from a well completed as a producer in the area. These quantities may not necessarily constitute or represent reserves within the meaning of the Society of Petroleum Engineer’s Petroleum Resource Management System or the SEC’s oil and natural gas disclosure rules. Actual quantities that may be recovered from Range’s interests could differ substantially. Factors affecting ultimate recovery include the scope of Range’s drilling program, which will be directly affected by the availability of capital, drilling and production costs, commodity prices, availability of drilling services and equipment, drilling results, lease expirations, transportation constraints, regulatory approvals, field spacing rules, recoveries of gas in place, length of horizontal laterals, actual drilling results, including geological and mechanical factors affecting recovery rates and other factors. Estimates of resource potential may change significantly as development of our resource plays provides additional data.

In addition, our production forecasts and expectations for future periods are dependent upon many assumptions, including estimates of production decline rates from existing wells and the undertaking and outcome of future drilling activity, which may be affected by significant commodity price or drilling cost changes. Investors are urged to consider closely the disclosure in our most recent Annual Report on Form 10-K, available from our website at www.rangeresources.com or by written request to 100 Throckmorton Street, Suite 1200, Fort Worth, Texas 76102. You can also obtain this Form 10-K on the SEC’s website at www.sec.gov or by calling the SEC at 1-800-SEC-0330.

SOURCE:   Range Resources Corporation

Range Investor Contacts:

Laith Sando
817-869-4267

Matt Schmid
817-869-1538

Range Media Contact:

Mark Windle
724-873-3223

RANGE RESOURCES CORPORATION  
                                     
STATEMENTS OF OPERATIONS
 
Based on GAAP reported earnings with additional  
details of items included in each line in Form 10-Q  
(Unaudited, In thousands, except per share data)  
                                     
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     %     2026     2025     %  
Revenues and other income:                                    
Natural gas, NGLs and oil sales (a)   $ 737,919     $ 611,491           $ 2,450,258     $ 2,070,049        
Derivative fair value income     58,118       92,946             98,229       88,736        
Brokered natural gas and marketing     46,523       43,807             161,248       131,224        
ARO settlement gain (b)     –       –             –       1        
Interest income (b)     39       52             121       4,867        
(Gain) loss on sale of assets (b)     3       (6 )           32       158        
Other (b)     224       238             679       322        
Total revenues and other income     842,826       748,528       13 %     2,710,567       2,295,357       18 %
                                     
Costs and expenses:                                    
Direct operating     30,395       23,305             85,796       70,757        
Direct operating – stock-based compensation (c)     537       525             1,601       1,566        
Transportation, gathering, processing and compression     349,934       301,110             990,075       911,933        
Taxes other than income     7,354       8,265             20,103       23,087        
Brokered natural gas, NGLs and marketing     47,530       48,256             163,389       139,800        
Brokered natural gas, NGLs and marketing – stock-based compensation (c)     676       626             2,277       2,268        
Exploration     5,557       7,820             17,365       21,426        
Exploration – stock-based compensation (c)     396       285             1,116       998        
Abandonment and impairment of unproved properties     5,774       4,899             14,232       16,254        
General and administrative     37,588       35,253             108,620       99,563        
General and administrative – stock-based compensation (c)     9,952       9,448             31,048       28,885        
General and administrative – lawsuit settlements and other     151       11             1,081       101        
Exit costs     6,334       8,085             22,853       25,484        
Deferred compensation plan (d)     (52 )     (765 )           735       2,026        
Interest expense     13,791       23,200             45,970       76,615        
Interest expense – amortization of debt issuance costs (e)     833       1,068             2,490       3,610        
Loss (gain) on early extinguishment of debt     –       –             12,344       (3 )      
Depletion, depreciation and amortization     102,049       93,793             283,657       275,866        
Total costs and expenses     618,799       565,184       9 %     1,804,752       1,700,236       6 %
                                     
Income before income taxes     224,027       183,344       22 %     905,815       595,121       52 %
                                     
Income tax expense (benefit)                                    
Current     2,775       (1,022 )           11,205       5,623        
Deferred     45,929       40,059             182,334       110,561        
      48,704       39,037             193,539       116,184        
                                     
Net income   $ 175,323     $ 144,307       21 %   $ 712,276     $ 478,937       49 %
                                     
                                     
Net income Per Common Share                                    
Basic   $ 0.75     $ 0.61           $ 3.04     $ 2.00        
Diluted   $ 0.75     $ 0.60           $ 3.02     $ 1.99        
                                     
Weighted average common shares outstanding, as reported                                    
Basic     233,487       237,378       -2 %     234,419       238,523       -2 %
Diluted     235,035       239,026       -2 %     235,958       240,255       -2 %
                                     
                                     
(a) See separate natural gas, NGLs and oil sales information table.  
(b) Included in Other income in the 10-Q.  
(c) Costs associated with stock compensation and amortization, which have been reflected in the categories associated with the direct personnel costs, are combined with the cash costs in the 10-Q.  
(d) Reflects the change in market value of the vested Company stock held in the deferred compensation plan.  
(e) Included in interest expense in the 10-Q.  

RANGE RESOURCES CORPORATION  
             
BALANCE SHEET            
(Unaudited, In thousands)   September 30,     December 31,  
    2026     2025  
             
Assets            
Current assets   $ 345,035     $ 390,835  
Derivative assets     131,367       69,397  
Natural gas, NGLs and oil properties, net (successful efforts method)     6,941,366       6,708,366  
Other property and equipment, net     17,609       4,935  
Operating lease right-of-use assets     130,583       173,477  
Other     78,466       74,938  
    $ 7,644,426     $ 7,421,948  
             
Liabilities and Stockholders’ Equity            
Current liabilities   $ 625,590     $ 658,783  
Asset retirement obligations     1,173       1,173  
Derivative liabilities     2,547       1,196  
             
Bank debt, net of unamortized debt issuance costs     284,484       106,700  
Senior notes, net of unamortized debt issuance costs     496,434       1,091,634  
Deferred tax liabilities     883,926       701,601  
Derivative liabilities     2,602       2,363  
Deferred compensation liabilities     70,773       68,635  
Operating lease liabilities     77,345       115,515  
Asset retirement obligations and other liabilities     161,376       153,081  
Divestiture contract obligation     166,225       202,586  
      2,772,475       3,103,267  
             
Common stock and retained deficit     5,724,195       5,064,743  
Accumulated other comprehensive income     389       424  
Common stock held in treasury     (852,633 )     (746,486 )
Total stockholders’ equity     4,871,951       4,318,681  
    $ 7,644,426     $ 7,421,948  

RECONCILIATION OF TOTAL DEBT AS REPORTED  
TO NET DEBT, a non-GAAP measure  
(Unaudited, in thousands)  
                   
    September 30,     December 31,        
    2026     2025     %  
                   
Total debt, net of deferred financing costs, as reported   $ 780,918     $ 1,198,334       -35 %
Unamortized debt issuance costs, as reported     13,082       19,666        
Less cash and cash equivalents, as reported     (12 )     (204 )      
Net debt, a non-GAAP measure   $ 793,988     $ 1,217,796       -35 %

RANGE RESOURCES CORPORATION  
                         
CASH FLOWS FROM OPERATING ACTIVITIES  
(Unaudited, in thousands)  
                         
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
                         
Net income   $ 175,323     $ 144,307     $ 712,276     $ 478,937  
Adjustments to reconcile net cash provided from continuing operations:                        
Deferred income tax expense     45,929       40,059       182,334       110,561  
Depletion, depreciation and amortization     102,049       93,793       283,657       275,866  
Abandonment and impairment of unproved properties     5,774       4,899       14,232       16,254  
Derivative fair value income     (58,118 )     (92,946 )     (98,229 )     (88,736 )
Cash settlements on derivative financial instruments     51,855       62,033       37,849       98,072  
Divestiture contract obligation, including accretion     6,334       8,085       22,853       25,484  
Amortization of deferred financing costs and other     1,274       852       3,464       2,996  
Deferred and stock-based compensation     11,612       10,248       37,435       36,378  
(Gain) loss on sale of assets     (3 )     6       (32 )     (158 )
Loss (gain) on early extinguishment of debt     –       –       12,344       (3 )
                         
Changes in working capital:                        
Accounts receivable     (12,265 )     (5,001 )     56,514       63,063  
Other current assets     (10,709 )     3,426       (10,794 )     (5,084 )
Accounts payable     (21,739 )     (1,142 )     (15,418 )     8,016  
Accrued liabilities and other     10,285       (21,074 )     (76,733 )     (107,828 )
Net changes in working capital     (34,428 )     (23,791 )     (46,431 )     (41,833 )
Net cash provided from operating activities   $ 307,601     $ 247,545     $ 1,161,752     $ 913,818  
                         
                         
RECONCILIATION OF NET CASH PROVIDED FROM OPERATING
 
ACTIVITIES, AS REPORTED, TO CASH FLOW FROM OPERATIONS
 
BEFORE CHANGES IN WORKING CAPITAL, a non-GAAP measure
 
(Unaudited, in thousands)  
                         
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
Net cash provided from operating activities, as reported   $ 307,601     $ 247,545     $ 1,161,752     $ 913,818  
Net changes in working capital     34,428       23,791       46,431       41,833  
Exploration expense     5,557       7,820       17,365       21,426  
Lawsuit settlements     (257 )     11       169       101  
Sale of seismic data     –       –       (360 )     –  
Non-cash compensation adjustment and other     (136 )     87       (720 )     (22 )
Cash flow from operations before changes in working capital – non-GAAP measure   $ 347,193     $ 279,254     $ 1,224,637     $ 977,156  
                         
                         
ADJUSTED WEIGHTED AVERAGE SHARES OUTSTANDING
 
(Unaudited, in thousands)  
   
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
Basic:                        
Weighted average shares outstanding     233,686       237,643       234,657       239,063  
Stock held by deferred compensation plan     (199 )     (265 )     (238 )     (540 )
Adjusted basic     233,487       237,378       234,419       238,523  
                         
Dilutive:                        
Weighted average shares outstanding     233,686       237,643       234,657       239,063  
Dilutive stock options under treasury method     1,349       1,383       1,301       1,192  
Adjusted dilutive     235,035       239,026       235,958       240,255  

RANGE RESOURCES CORPORATION  
                                     
RECONCILIATION OF NATURAL GAS, NGLs AND OIL SALES  
AND DERIVATIVE FAIR VALUE INCOME (LOSS) TO  
CALCULATED CASH REALIZED NATURAL GAS, NGLs AND  
OIL PRICES WITH AND WITHOUT THIRD-PARTY  
TRANSPORTATION, GATHERING, PROCESSING AND  
COMPRESSION COSTS, a non-GAAP measure  
(Unaudited, In thousands, except per unit data)  
                         
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     %     2026     2025     %  
Natural gas, NGLs and Oil Sales components:                                    
Natural gas sales   $ 371,772     $ 361,124           $ 1,415,649     $ 1,249,456        
NGLs sales     320,962       224,376             893,016       738,064        
Oil sales     45,185       25,991             141,593       82,529        
Total Natural Gas, NGLs and Oil Sales, as reported   $ 737,919     $ 611,491       21 %   $ 2,450,258     $ 2,070,049       18 %
                                     
Derivative Fair Value Income, as reported   $ 58,118     $ 92,946           $ 98,229     $ 88,736        
Cash settlements on derivative financial instruments – (gain) loss:                                    
Natural gas     (56,384 )     (56,420 )           (63,504 )     (90,263 )      
NGLs     797       (4,000 )           7,986       (5,096 )      
Oil     3,732       (1,613 )           17,669       (2,713 )      
Total change in fair value related to commodity derivatives prior to settlement, a non-GAAP measure   $ 6,263     $ 30,913           $ 60,380     $ (9,336 )      
                                     
Transportation, gathering, processing and compression components:                                    
Natural Gas   $ 170,125     $ 157,193           $ 491,422     $ 469,416        
NGLs     179,054       142,815             496,252       439,862        
Oil     755       1,102             2,401       2,655        
Total transportation, gathering, processing and compression, as reported   $ 349,934     $ 301,110           $ 990,075     $ 911,933        
                                     
Natural gas, NGL and Oil sales, including cash-settled derivatives: (c)                                    
Natural gas sales   $ 428,156     $ 417,544           $ 1,479,153     $ 1,339,719        
NGLs sales     320,165       228,376             885,030       743,160        
Oil Sales     41,453       27,604             123,924       85,242        
Total   $ 789,774     $ 673,524       17 %   $ 2,488,107     $ 2,168,121       15 %
                                     
Production of natural gas, NGLs and oil during the periods (a):                                    
Natural Gas (mcf)     156,406,269       141,133,949       11 %     433,149,336       413,394,538       5 %
NGLs (bbls)     11,653,966       10,158,612       15 %     32,139,618       30,107,652       7 %
Oil (bbls)     597,916       479,142       25 %     1,928,670       1,483,512       30 %
Gas equivalent (mcfe) (b)     229,917,561       204,960,473       12 %     637,559,064       602,941,522       6 %
                                     
Production of natural gas, NGLs and oil – average per day (a):                                    
Natural Gas (mcf)     1,700,068       1,534,065       11 %     1,586,628       1,514,266       5 %
NGLs (bbls)     126,674       110,420       15 %     117,728       110,284       7 %
Oil (bbls)     6,499       5,208       25 %     7,065       5,434       30 %
Gas equivalent (mcfe) (b)     2,499,104       2,227,831       12 %     2,335,381       2,208,577       6 %
                                     
Average prices, excluding derivative settlements and before third-party transportation costs:                                    
Natural Gas (per mcf)   $ 2.38     $ 2.56       -7 %   $ 3.27     $ 3.02       8 %
NGLs (per bbl)   $ 27.54     $ 22.09       25 %   $ 27.79     $ 24.51       13 %
Oil (per bbl)   $ 75.57     $ 54.25       39 %   $ 73.41     $ 55.63       32 %
Gas equivalent (per mcfe) (b)   $ 3.21     $ 2.98       8 %   $ 3.84     $ 3.43       12 %
                                     
Average prices, including derivative settlements before third-party transportation costs: (c)                                    
Natural Gas (per mcf)   $ 2.74     $ 2.96       -7 %   $ 3.41     $ 3.24       5 %
NGLs (per bbl)   $ 27.47     $ 22.48       22 %   $ 27.54     $ 24.68       12 %
Oil (per bbl)   $ 69.33     $ 57.61       20 %   $ 64.25     $ 57.46       12 %
Gas equivalent (per mcfe) (b)   $ 3.43     $ 3.29       4 %   $ 3.90     $ 3.59       9 %
                                     
Average prices, including derivative settlements and after third-party transportation costs: (d)                                    
Natural Gas (per mcf)   $ 1.65     $ 1.84       -10 %   $ 2.28     $ 2.11       8 %
NGLs (per bbl)   $ 12.11     $ 8.42       44 %   $ 12.10     $ 10.07       20 %
Oil (per bbl)   $ 68.07     $ 55.31       23 %   $ 63.01     $ 55.67       13 %
Gas equivalent (per mcfe) (b)   $ 1.91     $ 1.82       5 %   $ 2.35     $ 2.08       13 %
                                     
Transportation, gathering and compression expense per mcfe   $ 1.52     $ 1.47       3 %   $ 1.55     $ 1.51       3 %
(a) Represents volumes sold regardless of when produced.
(b) Oil and NGLs are converted at the rate of one barrel equals six mcfe based upon the approximate relative energy content of oil to natural gas, which is not necessarily indicative of the relationship of oil and natural gas prices.
(c) Excluding third-party transportation, gathering, processing and compression costs.
(d) Net of transportation, gathering, processing and compression costs.
 

RANGE RESOURCES CORPORATION
 
                                   
RECONCILIATION OF INCOME BEFORE INCOME
 
TAXES AS REPORTED TO INCOME BEFORE INCOME TAXES
 
EXCLUDING CERTAIN ITEMS, a non-GAAP measure
 
(Unaudited, In thousands, except per share data)  
                                   
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     %     2026     2025     %  
                                   
Income from operations before income taxes, as reported   $ 224,027     $ 183,344       22 %   $ 905,815     $ 595,121       52 %
Adjustment for certain special items:                                  
(Gain) loss on the sale of assets     (3 )     6             (32 )     (158 )    
ARO settlement gain     –       –             –       (1 )    
Sale of seismic data     –       –             (360 )     –      
Change in fair value related to derivatives prior to settlement     (6,263 )     (30,913 )           (60,380 )     9,336      
Abandonment and impairment of unproved properties     5,774       4,899             14,232       16,254      
Loss (gain) on early extinguishment of debt     –       –             12,344       (3 )    
Lawsuit settlements and other     151       11             1,081       101      
Exit costs     6,334       8,085             22,853       25,484      
Direct operating – stock-based compensation     537       525             1,601       1,566      
Brokered natural gas, NGLs and marketing – stock-based compensation     676       626             2,277       2,268      
Exploration expenses – stock-based compensation     396       285             1,116       998      
General & administrative – stock-based compensation     9,952       9,448             31,048       28,885      
Deferred compensation plan – non-cash adjustment     (52 )     (765 )           735       2,026      
                                   
Income before income taxes, as adjusted     241,529       175,551       38 %     932,330       681,877       37 %
                                   
Income tax expense (benefit), as adjusted                                  
Current     2,775       (1,022 )           11,205       5,623      
Deferred (a)     47,946       41,399             184,584       151,209      
                                   
Net income, excluding certain items, a non-GAAP measure   $ 190,808     $ 135,174       41 %   $ 736,541     $ 525,045       40 %
                                   
Non-GAAP income per common share                                  
Basic   $ 0.82     $ 0.57       44 %   $ 3.14     $ 2.20       43 %
Diluted   $ 0.81     $ 0.57       42 %   $ 3.12     $ 2.19       42 %
                                   
Non-GAAP diluted shares outstanding, if dilutive     235,035       239,026             235,958       240,255      
                                   
(a) Taxes are estimated to be approximately 21% for 2026 and 23% for 2025.  

RANGE RESOURCES CORPORATION  
                         
RECONCILIATION OF NET INCOME, EXCLUDING
 
CERTAIN ITEMS AND ADJUSTED EARNINGS PER
 
SHARE, non-GAAP measures
 
(In thousands, except per share data)  
                         
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
                         
Net income, as reported   $ 175,323     $ 144,307     $ 712,276     $ 478,937  
Adjustments for certain special items:                        
(Gain) loss on the sale of assets     (3 )     6       (32 )     (158 )
ARO settlement gain     –       –       –       (1 )
Sale of seismic data     –       –       (360 )     –  
Loss (gain) on early extinguishment of debt     –       –       12,344       (3 )
Change in fair value related to derivatives prior to settlement     (6,263 )     (30,913 )     (60,380 )     9,336  
Abandonment and impairment of unproved properties     5,774       4,899       14,232       16,254  
Lawsuit settlements and other     151       11       1,081       101  
Exit costs     6,334       8,085       22,853       25,484  
Stock-based compensation     11,561       10,884       36,042       33,717  
Deferred compensation plan     (52 )     (765 )     735       2,026  
Tax impact     (2,017 )     (1,340 )     (2,250 )     (40,648 )
                         
Net income, excluding certain items, a non-GAAP measure   $ 190,808     $ 135,174     $ 736,541     $ 525,045  
                         
Net income per diluted share, as reported   $ 0.75     $ 0.60     $ 3.02     $ 1.99  
Adjustments for certain special items per diluted share:                        
(Gain) loss on the sale of assets     –       –       –       –  
ARO settlement gain     –       –       –       –  
Sale of seismic data     –       –       –       –  
Loss (gain) on early extinguishment of debt     –       –       0.05       –  
Change in fair value related to derivatives prior to settlement     (0.03 )     (0.13 )     (0.26 )     0.04  
Abandonment and impairment of unproved properties     0.02       0.02       0.06       0.07  
Lawsuit settlements and other     –       –       –       –  
Exit costs     0.03       0.03       0.10       0.11  
Stock-based compensation     0.05       0.05       0.15       0.14  
Deferred compensation plan     –       –       –       0.01  
Adjustment for rounding differences     –       0.01       0.01       –  
Tax impact     (0.01 )     (0.01 )     (0.01 )     (0.17 )
Dilutive share impact (rabbi trust and other)     –       –       –       –  
                         
Net income per diluted share, excluding certain items, a non-GAAP measure   $ 0.81     $ 0.57     $ 3.12     $ 2.19  
                         
Adjusted earnings per share, a non-GAAP measure:                        
Basic   $ 0.82     $ 0.57     $ 3.14     $ 2.20  
Diluted   $ 0.81     $ 0.57     $ 3.12     $ 2.19  

RANGE RESOURCES CORPORATION
 
   
RECONCILIATION OF CASH MARGIN PER MCFE, a non-GAAP measure  
(Unaudited, In thousands, except per unit data)  
             
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
                         
Revenues                        
Natural gas, NGLs and oil sales, as reported   $ 737,919     $ 611,491     $ 2,450,258     $ 2,070,049  
Derivative fair value income, as reported     58,118       92,946       98,229       88,736  
Less non-cash fair value (gain) loss     (6,263 )     (30,913 )     (60,380 )     9,336  
Brokered natural gas and marketing, as reported     46,523       43,807       161,248       131,224  
Other income, as reported     266       284       832       5,348  
Less (gain) loss on sale of assets     (3 )     6       (32 )     (158 )
Less ARO settlement     –       –       –       (1 )
Cash revenues and other income     836,560       717,621       2,650,155       2,304,534  
                         
Expenses                        
Direct operating, as reported     30,932       23,830       87,397       72,323  
Less direct operating stock-based compensation     (537 )     (525 )     (1,601 )     (1,566 )
Transportation, gathering and compression, as reported     349,934       301,110       990,075       911,933  
Taxes other than income, as reported     7,354       8,265       20,103       23,087  
Brokered natural gas, NGLs and marketing, as reported     48,206       48,882       165,666       142,068  
Less brokered natural gas, NGLs and marketing stock-based compensation     (676 )     (626 )     (2,277 )     (2,268 )
General and administrative, as reported     47,691       44,712       140,749       128,549  
Less G&A stock-based compensation     (9,952 )     (9,448 )     (31,048 )     (28,885 )
Less lawsuit settlements and other     (151 )     (11 )     (1,081 )     (101 )
Interest expense, as reported     14,624       24,268       48,460       80,225  
Less amortization of debt issuance costs     (833 )     (1,068 )     (2,490 )     (3,610 )
Cash expenses     486,592       439,389       1,413,953       1,321,755  
                         
Cash margin, a non-GAAP measure   $ 349,968     $ 278,232     $ 1,236,202     $ 982,779  
                         
Mmcfe produced during period     229,918       204,961       637,559       602,942  
                         
Cash margin per mcfe   $ 1.52     $ 1.36     $ 1.94     $ 1.63  
                         
                         
RECONCILIATION OF INCOME BEFORE INCOME TAXES TO CASH MARGIN, a non-GAAP measure                        
(Unaudited, in thousands, except per unit data)                        
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2026     2025     2026     2025  
                         
Income before income taxes, as reported   $ 224,027     $ 183,344     $ 905,815     $ 595,121  
Adjustments to reconcile income before income taxes to cash margin:                        
ARO settlements     –       –       –       (1 )
Derivative fair value income     (58,118 )     (92,946 )     (98,229 )     (88,736 )
Net cash receipts on derivative settlements     51,855       62,033       37,849       98,072  
Exploration expense     5,557       7,820       17,365       21,426  
Lawsuit settlements and other     151       11       1,081       101  
Exit costs     6,334       8,085       22,853       25,484  
Deferred compensation plan     (52 )     (765 )     735       2,026  
Stock-based compensation (direct operating, brokered natural gas, NGLs and marketing, exploration and general and administrative)     11,561       10,884       36,042       33,717  
Bad debt expense     –       –       –       –  
Interest – amortization of debt issuance costs     833       1,068       2,490       3,610  
Depletion, depreciation and amortization     102,049       93,793       283,657       275,866  
(Gain) loss on sale of assets     (3 )     6       (32 )     (158 )
Loss (gain) on early extinguishment of debt     –       –       12,344       (3 )
Abandonment and impairment of unproved properties     5,774       4,899       14,232       16,254  
Cash margin, a non-GAAP measure   $ 349,968     $ 278,232     $ 1,236,202     $ 982,779  


Important Information for Investors and Shareholders; Additional Information and Where to Find It

In connection with the proposed transaction, EQT intends to file with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 (the “registration statement”) that will include a joint proxy statement of EQT and Range and that will also constitute a prospectus of EQT (the “joint proxy statement/prospectus”). Range and EQT also intend to file other documents regarding the proposed transaction with the SEC. This communication is not a substitute for the joint proxy statement/prospectus or the registration statement. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND SECURITY HOLDERS OF EQT AND RANGE ARE URGED TO READ THE REGISTRATION STATEMENT, THE JOINT PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT MAY BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT EQT, RANGE, THE PROPOSED TRANSACTION, THE RISKS THERETO AND RELATED MATTERS. After the registration statement has been declared effective, a definitive joint proxy statement/prospectus will be mailed to the shareholders of EQT and the shareholders of Range. Investors and security holders will be able to obtain free copies of the registration statement and joint proxy statement/prospectus and other relevant documents filed or that will be filed with the SEC by EQT or Range through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by Range will be available free of charge on Range’s website at www. ir.rangeresources.com. Copies of the documents filed with the SEC by EQT will be available free of charge on EQT’s website at www.ir.eqt.com/investor-relations. The information included on, or accessible through, Range’s or EQT’s website is not incorporated by reference into this communication.

Participants in the Solicitation

Range, EQT and their respective directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction contemplated by the joint proxy statement/prospectus. Information regarding Range’s directors and executive officers and their ownership of Range’s securities is set forth in Range’s filings with the SEC, including Range’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 that was filed with the SEC on February 24, 2026 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000315852/000119312526067292/rrc-20251231.htm) and its Definitive Proxy Statement on Schedule 14A that was filed with the SEC on March 31, 2026 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000315852/000119312526134699/rrc-20260325.htm). To the extent such person’s ownership of Range’s securities has changed since the filing of such proxy statement, such changes have been or will be reflected on Statements of Changes in Beneficial Ownership on Form 4 filed with the SEC. Information regarding EQT’s directors and executive officers and their ownership of EQT’s securities is set forth in EQT’s filings with the SEC, including EQT’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000033213/000003321326000018/eqt-20251231.htm) and its Definitive Proxy Statement on Schedule 14A that was filed with the SEC on February 26, 2026 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000033213/000110465926020027/tm261383-1_def14a.htm). To the extent such person’s ownership of EQT’s securities has changed since the filing of such proxy statement, such changes have been or will be reflected on Statements of Changes in Beneficial Ownership on Form 4 filed with the SEC. Additional information regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction may be obtained by reading the joint proxy statement/prospectus and other relevant materials that will be filed with the SEC regarding the proposed transaction when such documents become available. You may obtain free copies of these documents as described in the preceding paragraph.

No Offer or Solicitation

This release relates to the proposed transaction. This release is for informational purposes only and is not intended to and shall not constitute an offer to buy, sell or exchange or the solicitation of an offer to buy, sell or exchange any securities, or a solicitation of any vote or approval, in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance, exchange or transfer of the securities referred to in this document in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

PERRYSBURG, Ohio, Oct. 27, 2026 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI), an S&P Smallcap 600 member, today announced financial results for the third quarter ended September 30, 2026. 

Please follow the links below to view our third quarter 2026 earnings documents.

O-I Glass Third Quarter 2026 Earnings Release with Financial Tables
O-I Glass Third Quarter 2026 Earnings Presentation

O-I CEO Gordon Hardie and CFO John Haudrich will conduct a conference call to discuss the company’s latest results on Wednesday, October 28, 2026, at 8:00 a.m. ET. A live webcast of the conference call, including presentation materials, will be available on the O-I website, www.o-i.com/investors, in the Events and Presentations section. A replay of the call will be available on the website for a year following the event.

ABOUT O-I GLASS

At O-I Glass, Inc. (NYSE: OI), we are proud to be one of the leading producers of glass bottles and jars around the globe. Glass is not only beautiful, it is also pure, healthy, and completely recyclable, making it the most sustainable rigid packaging material. Headquartered in Perrysburg, Ohio (USA), O-I is the preferred partner for many of the world’s leading food and beverage brands. We innovate in line with customers’ needs to create iconic packaging that builds brands around the world. Led by our diverse team of approximately 19,000 people across 61 plants in 18 countries, O-I achieved revenues of $6.4 billion in 2025. O-I is an S&P Smallcap 600 member and a component of more than 100 Exchange Traded Funds from iShares, Vanguard, Schwab, Invesco and other firms. Learn more about us: o-i.com /  Instagram / LinkedIn  

CONTACT: 

CHRIS MANUEL        
VP, Investor Relations   
Chris.Manuel@o-i.com
567.336.2600

SASHA SEKPEH
Sr. Finance Coordinator
Alexandra.Sekpeh@o-i.com
567.336.5128

Attachments

PERRYSBURG, Ohio, Oct. 27, 2026 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI), an S&P Smallcap 600 member, today announced financial results for the third quarter ended September 30, 2026. 

Please follow the links below to view our third quarter 2026 earnings documents.

O-I Glass Third Quarter 2026 Earnings Release with Financial Tables
O-I Glass Third Quarter 2026 Earnings Presentation

O-I CEO Gordon Hardie and CFO John Haudrich will conduct a conference call to discuss the company’s latest results on Wednesday, October 28, 2026, at 8:00 a.m. ET. A live webcast of the conference call, including presentation materials, will be available on the O-I website, www.o-i.com/investors, in the Events and Presentations section. A replay of the call will be available on the website for a year following the event.

ABOUT O-I GLASS

At O-I Glass, Inc. (NYSE: OI), we are proud to be one of the leading producers of glass bottles and jars around the globe. Glass is not only beautiful, it is also pure, healthy, and completely recyclable, making it the most sustainable rigid packaging material. Headquartered in Perrysburg, Ohio (USA), O-I is the preferred partner for many of the world’s leading food and beverage brands. We innovate in line with customers’ needs to create iconic packaging that builds brands around the world. Led by our diverse team of approximately 19,000 people across 61 plants in 18 countries, O-I achieved revenues of $6.4 billion in 2025. O-I is an S&P Smallcap 600 member and a component of more than 100 Exchange Traded Funds from iShares, Vanguard, Schwab, Invesco and other firms. Learn more about us: o-i.com /  Instagram / LinkedIn  

CONTACT: 

CHRIS MANUEL        
VP, Investor Relations   
Chris.Manuel@o-i.com
567.336.2600

SASHA SEKPEH
Sr. Finance Coordinator
Alexandra.Sekpeh@o-i.com
567.336.5128

Attachments

MCLEAN, Va., Oct. 27, 2026 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB:FMCC) announced today that it plans to report its Third Quarter 2026 financial results before the U.S. financial markets open on Thursday, October 29, 2026.

The company will hold a webcast at 9 a.m. Eastern Time (ET) on Thursday, October 29, 2026, to publicly share the company’s results with the media. A replay will be available on the company’s website for approximately 30 days. All materials related to the call will be available on the Investor Relations page of the company’s website.

Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability and affordability in the housing market throughout all economic cycles. Since 1970, we have helped tens of millions of families buy, rent or keep their home. Learn More: Website | Consumers | X | LinkedIn | Facebook | Instagram | YouTube

MEDIA CONTACT: Frederick Solomon
703-903-3861
Frederick_Solomon@FreddieMac.com  

INVESTOR CONTACT: Mahesh Lal
571-382-3630

Lima, Oct. 27, 2026 (GLOBE NEWSWIRE) — Lima, Peru, October 27, 2026 – Credicorp Ltd. announces to its shareholders and the market that its 3Q26 Earnings Release will be published on Monday, November 9, 2026, after market close.

Credicorp’s webcast and conference call to discuss these results will be held on Tuesday, November 10, 2026, at 9:30 a.m. Lima, Peru time / 9:30 a.m. Eastern Time.

The call will be hosted by the following Credicorp executives

  • Gianfranco Ferrari, Chief Executive Officer
  • Ignacio Belaunde, Chief Financial Officer
  • Francesca Raffo, Chief Innovation Officer
  • Cesar Rios, Chief Risk Officer
  • Diego Cavero, Head of Universal Banking
  • Alejandro Perez Reyes, Head of Microfinance
  • Eduardo Montero, Head of Insurance and Pensions
  • Investor Relations Team

Participants are encouraged to pre-register for the listen-only webcast at the following link:
https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10212780&linkSecurityString=1051f96b8f4

Callers who pre-register will receive a conference passcode and unique PIN for immediate access to the call, bypassing the live operator. Participants may pre-register at any time, including up to and after the call begins.

Those unable to register may join the call by dialing:
Participant dial-in (USA/Canada toll-free): 1 844 435 0321
Participant international dial in: 1 412 317 5615
Participant Web Phone: Click Here
Conference ID: Credicorp Conference Call

A replay will be available later that day and archived for one year on Credicorp’s Investor Relations website:
https://credicorp.gcs-web.com/events-and-presentations/past-events

Credicorp reminds you that we filed our Annual Report on Form 20-F for the fiscal year ended December 31, 2025 (2025 Form 20-F) with the Securities and Exchange Commission on April 27, 2026. The 2025 Form 20-F includes audited consolidated financial statements of Credicorp and its subsidiaries as of December 31, 2023, 2024 and 2025 under IFRS. Our 2025 Form 20- F can be downloaded from Credicorp’s website: https://credicorp.gcs-web.com/annual-materials Holders of Credicorp’s securities and any other interested parties may request a hard copy of our 2025 Form 20-F, free of charge, by filling out the form located on the link “mail request” on Credicorp’s website.

About Credicorp
Credicorp (NYSE: BAP) is the leading financial services holding company in Peru with presence in Chile, Colombia, Bolivia, and Panama and United States. Credicorp has a diversified business portfolio organized into four lines of business (“LoBs”): Universal Banking, through BCP and Banco de Crédito de Bolivia; Microfinance, through Mibanco in Peru and Colombia; Insurance & Pension Funds, through Grupo Pacifico and Prima AFP; and Investment Management & Advisory, through Credicorp Capital, Wealth Management at BCP and ASB Bank Corp. Additionally, it complements its operations through Krealo, its Corporate Venture Capital am.

For further information, please contact the IR team:
investorrelations@credicorpperu.com

Investor Relations
Credicorp Ltd.

Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended September 30, 2026 and 2025:

KING OF PRUSSIA, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) — Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $308.7 million, or $5.22 per diluted share, during the third quarter of 2026, as compared to $373.0 million, or $5.86 per diluted share, during the third quarter of 2025. Net revenues increased by 5.3% to $4.733 billion during the third quarter of 2026, as compared to $4.495 billion during the third quarter of 2025.

Included in our operating results during the third quarter of 2026, was an aggregate net favorable pre-tax impact of approximately $21 million recorded in connection with the following items which were not included in our 2026 operating results forecast, as previously disclosed on July 27, 2026: (i) a favorable net pre-tax impact of $47 million (net of related provider taxes) recorded in connection with increases in amounts received from Medicaid supplemental payment programs in various states (consisting primarily of Washington, D.C. and California), partially offset by; (ii) an unfavorable pre-tax impact of $26 million resulting from an increase to our reserves for self-insured professional and general liability claims due primarily to the tentative settlement agreement reached during the third quarter of 2026 in the matter discussed below in Legal Proceedings Update.

Included in our operating results during the third quarter of 2025, was an aggregate net favorable pre-tax impact of approximately $55 million recorded in connection with the following: (i) $90 million of pre-tax reimbursements (net of related provider taxes), covering the period of October 1, 2024 through September 30, 2025, in connection with a Medicaid state directed payment program in Washington, D.C., and; (ii) a $35 million pre-tax charge incurred to increase our reserves for self-insured professional and general liabilities resulting from unfavorable claims’ trends.

As reflected on the Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”), there were no adjustments applicable to our operating results during the third quarter of 2026.

As reflected on the Supplemental Schedule, included in our reported results during the third quarter of 2025 were: (i) an unrealized after-tax gain of $10.0 million, or $.16 per diluted share ($13.1 million pre-tax), resulting from an increase in the market value of certain equity securities that were sold during the fourth quarter of 2025 (included in “Other (income) expense, net”), and; (ii) a favorable net after-tax impact of $0.6 million, or $.01 per diluted share, resulting from the net tax benefit recorded in connection with “ASU 2016-09”, Compensation – Stock Compensation: Improvements to Employee Share-Based Payment Accounting, net of the impact of executive compensation limitations pursuant to IRC section 162(m). After giving effect to these items, our adjusted net income during the third quarter of 2025 was $362.3 million, or $5.69 per diluted share.

As calculated on the attached Supplemental Schedule, our earnings before interest, taxes, depreciation & amortization (“EBITDA net of NCI”, NCI is net income attributable to noncontrolling interests), was $640.4 million during the third quarter of 2026, as compared to $684.2 million during the third quarter of 2025. Our adjusted earnings before interest, taxes, depreciation & amortization (“Adjusted EBITDA net of NCI”), which excludes the impact of other (income) expense, net, was $624.6 million during the third quarter of 2026, as compared to $670.6 million during the third quarter of 2025.

Consolidated Results of Operations, As Reported and As Adjusted – Nine-month periods ended September 30, 2026 and 2025:

Reported net income attributable to UHS was $1.016 billion, or $16.86 per diluted share, during the first nine months of 2026, as compared to $1.043 billion, or $16.07 per diluted share, during the comparable period of 2025. Net revenues increased by 7.7% to $13.867 billion during the first nine months of 2026, as compared to $12.879 billion during the comparable period of 2025.

As reflected on the Supplemental Schedule, our adjusted net income during the first nine months of 2026 was $1.014 billion, or $16.83 per diluted share, as compared to $1.030 billion, or $15.87 per diluted share, during the comparable period of 2025.

As reflected on the Supplemental Schedule, included in our reported results during the first nine months of 2026 was a favorable net after-tax impact of $2.2 million, or $.03 per diluted share, resulting from the net tax benefit recorded in connection with ASU 2016-09. Included in our reported results during the first nine months of 2025 were the following: (i) an unrealized after-tax gain of $11.3 million, or $.17 per diluted share ($14.7 million pre-tax), resulting from an increase in the market value of certain equity securities that were sold during the fourth quarter of 2025, and; (ii) a favorable net after-tax impact of $1.9 million, or $.03 per diluted share, resulting from the net tax benefit recorded in connection with ASU 2016-09.

As calculated on the attached Supplemental Schedule, our EBITDA net of NCI, was $1.972 billion during the first nine months of 2026, as compared to $1.939 billion during the comparable period of 2025. Our Adjusted EBITDA net of NCI, which excludes the impact of other (income) expense, net, was $1.951 billion during the first nine months of 2026, as compared to $1.912 billion during the comparable period of 2025.

Acute Care Services – Three and nine-month periods ended September 30, 2026 and 2025:

During the third quarter of 2026, at our acute care hospitals owned during both periods (“same facility basis”), adjusted admissions (adjusted for outpatient activity) and adjusted patient days each increased by 4.9%, as compared to the third quarter of 2025. At these facilities, during the third quarter of 2026, net revenue per adjusted admission and net revenue per adjusted patient day each decreased by 1.7%, as compared to the third quarter of 2025. Net revenues generated from our acute care services, on a same facility basis, increased by 4.7% during the third quarter of 2026, as compared to the third quarter of 2025.

During the first nine months of 2026, on a same facility basis, adjusted admissions increased by 2.6% and adjusted patient days increased by 2.9%, as compared to the comparable period of 2025. At these facilities, during the first nine months of 2026, net revenue per adjusted admission increased by 2.4% while net revenue per adjusted patient day increased by 2.1%, as compared to the comparable period of 2025. Net revenues generated from our acute care services, on a same facility basis, increased by 7.0% during the first nine months of 2026, as compared to the comparable period of 2025.

Behavioral Health Care Services – Three and nine-month periods ended September 30, 2026 and 2025:

During the third quarter of 2026, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 2.5% while adjusted patient days increased by 2.1%, as compared to the third quarter of 2025. At these facilities, during the third quarter of 2026, net revenue per adjusted admission increased by 1.7% and net revenue per adjusted patient day increased by 2.1%, as compared to the third quarter of 2025. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 4.0% during the third quarter of 2026, as compared to the third quarter of 2025.

During the first nine months of 2026, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 1.4% while adjusted patient days increased by 1.7%, as compared to the comparable period of 2025. At these facilities, during the first nine months of 2026, net revenue per adjusted admission increased by 4.9% and net revenue per adjusted patient day increased by 4.7%, as compared to the comparable period of 2025. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 6.2% during the first nine months of 2026, as compared to the comparable period of 2025.

Net Cash Provided by Operating Activities and Capital Resources:

Net Cash Provided by Operating Activities:

During the nine-month period ended September 30, 2026, our net cash provided by operating activities increased by 14.9% to $1.481 billion as compared to $1.290 billion during the first nine months of 2025.

The $192 million net increase in our net cash provided by operating activities consisted of: (i) an unfavorable change of $179 million in other working capital accounts due primarily to the timing of accrued expenses and accounts payable disbursements; (ii) a favorable change of $178 million in accounts receivable; (iii) a favorable change of $90 million in accrued insurance expense, net of payments made in settlement of self-insured claims; (iv) a favorable change of $77 million in accrued and deferred income taxes, and; (v) $26 million of other combined net favorable changes.

Capital Resources:

As of September 30, 2026, pursuant to the terms of our $1.5 billion revolving credit facility, we had $1.187 billion of available borrowing capacity, net of outstanding borrowings ($310 million) and letters of credit ($3 million). 

Stock Repurchase Program:

In connection with our stock repurchase program, shares of our Class B Common Stock may be repurchased, from time to time as conditions allow, on the open market or in negotiated private transactions. 

Pursuant to this program, during the third quarter of 2026, we have repurchased 1.35 million shares at an aggregate cost of approximately $242.1 million (average price of approximately $179 per share). During the first nine months of 2026, we have repurchased 3.915 million shares at an aggregate cost of approximately $689.6 million (average price of approximately $176 per share).

As of September 30, 2026, we had an aggregate available repurchase authorization of approximately $735.4 million pursuant to our stock repurchase program.

Conference call information:

We will hold a conference call for investors and analysts at 8:00 a.m. eastern time on October 28, 2026. A live webcast of the call will be available on our website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. Supplemental financial disclosures related to our financial results are available on our website.

Legal Proceedings Update:

The disclosure below provides an update for recent developments related to the matter referenced which has been previously disclosed in various Forms 10-Q and 10-K, as filed with the Securities and Exchange Commission, most recently our Form 10-Q for the quarterly period ended June 30, 2026.

K.E.E., et al., Plaintiffs v. Cumberland Hospital, LLC d/b/a Cumberland Hospital for Children and Adolescents, et al. (and related lawsuits)

Cumberland Hospital for Children and Adolescents (“Cumberland”), an indirect subsidiary of Universal Health Services, Inc. (the “Company”) and UHS of Delaware, Inc. (“UHS Delaware”), our administrative services company, are defendants in multi-plaintiff lawsuits filed in the Circuit Court for Richmond, Virginia (the “Cumberland Litigation”). The lawsuits relate to allegations of, among other things, inappropriate sexual contact during medical examinations by Dr. Daniel Davidow, an independent contractor and the former medical director for Cumberland. 

The claims asserted by three of the plaintiffs in the Cumberland Litigation were consolidated for trial in September 2024. There are approximately 53 additional claimants making similar allegations with claims pending in the Cumberland Litigation. The Company and UHS Delaware were dismissed from the September 2024 trial on the first three plaintiffs’ claims. In late September 2024, a jury entered a verdict finding Dr. Davidow and Cumberland liable and awarded these three plaintiffs combined compensatory damages of $60 million for all liability theories, an additional combined $180 million in trebled damages for violation of the Virginia Consumer Protection Act, and an additional combined $120 million in punitive damages. Based upon Virginia law, the Court reduced the punitive damage amount to a combined maximum of $1.05 million ($350,000 per plaintiff).

In August 2026, we reached a tentative settlement agreement, which is subject to execution of final release agreements and certain court approvals (as necessary), to resolve all of the outstanding claims related to the current claimants in the Cumberland Litigation. Pursuant to the tentative settlement agreement, the terms of the aggregate settlement are confidential. We believe a substantial portion of the tentative aggregate settlement amount, and related expenses, is covered by our commercial excess insurance and the remainder is covered by our reserves recorded in connection with the Cumberland Litigation.   

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

Headquartered in King of Prussia, PA, UHS is one of the nation’s largest and most respected providers of hospital and healthcare services, with annual revenues of approximately $17.4 billion during 2025. Through its subsidiaries, UHS employs more than 102,000 employees and, as of September 30, 2026, operated 30 inpatient acute care facilities, 388 inpatient behavioral health facilities, 169 outpatient and other facilities, nationwide virtual behavioral health services, an insurance offering, a physician network and various related services with physical locations in 40 states, Washington, D.C., Puerto Rico, Ireland and the United Kingdom. Since our founding in 1979, UHS has grown steadily into a premier Fortune 500® corporation perennially recognized by multiple esteemed national rating entities.  Our strategy includes investing in talented staff, facilities, technology and innovation across broad care continuums to deliver favorable patient outcomes and contribute to the overall health and wellbeing of the patients we are privileged to serve. A wholly-owned subsidiary of UHS also acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE: UHT). For additional information, please visit www.uhs.com.

        This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 2-Forward Looking Statements and Risk Factors in our Form 10-Q for the quarter ended June 30, 2026 and in Item 1A–Risk Factors, and Item 7-Forward-Looking Statements and Risk Factors, in our Form 10-K for the year ended December 31, 2025), may cause the results to differ materially from those anticipated in the forward-looking statements. These statements are subject to risks and uncertainties and therefore actual results may differ materially. Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Many of the factors that could affect our future results are beyond our control or ability to predict, including, but not limited to:

  • A significant portion of our revenues are derived from federal and state government programs including the Medicare and Medicaid programs. Payments from these programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions. Changes to these programs could materially affect program payments which could materially impact our results of operations. In addition, we receive substantial reimbursement from multiple states in connection with various supplemental Medicaid payment programs. Failure to renew these programs beyond their scheduled termination dates, failure of the public hospitals to provide the necessary Inter-Governmental Transfers for the states’ share of the Medicaid disproportionate share hospital programs, and the failure of our hospitals that currently receive supplemental Medicaid revenues to qualify for future funds under these programs could cause our actual results of operations for the year ended December 31, 2026 to differ materially from our 2026 operating results forecast.
  • Legislation adopted on July 4, 2025, attaches work and community service requirements to eligibility for Medicaid benefits that will have the effect of limiting Medicaid enrollment and expenditures. That legislation also places limits on provider fees used to increase federal Medicaid funding to states and eliminated certain exchange premium tax credits beyond 2025. As these provisions become effective over the next several years, they may be expected to reduce our revenues and likely increase the level of uncompensated care provided by our facilities.
  • The increase in interest rates during the past few years has increased our interest expense significantly thereby reducing our free cash flow. As such, the effects of increased borrowing rates have adversely impacted our results of operations, financial condition and cash flows. We cannot predict future changes to interest rates, however, significant increases in our borrowing rates could have a material unfavorable impact on our future results of operations and our ability to access the capital markets on favorable terms.
  • Changes in laws or policies governing the terms of foreign trade, and in particular, increased trade restrictions, tariffs or taxes on imports from where our products or materials are made (either directly or through our suppliers) could have an impact on our competitive position, business operations and financial results.
  • The outcome of known and unknown litigation, liabilities and other claims asserted against us and/or our subsidiaries.
  • The ability to successfully integrate and realize the benefits and synergies from our acquisition of Talkspace, Inc. which was completed in August 2026.

We believe that adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA net of NCI and Adjusted EBITDA net of NCI, which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it may neutralize the effect of material items impacting our net income attributable to UHS, such as, changes in the value of certain non-marketable securities (in connection with our minority ownership in a healthcare generative artificial intelligence company), the impact of ASU 2016-09, and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of goodwill, long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, potential impacts of non-ordinary acquisitions, divestitures, joint ventures or other strategic transactions, and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP, and as presented in the condensed consolidated financial statements and notes thereto in this report or in our filings with the Securities and Exchange Commission including our Report on Form 10-Q for the quarter ended June 30, 2026 and our Report on Form 10-K for the year ended December 31, 2025. Since the items that may be included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

CONTACT: Darren Lehrich
  Vice President-Investor Relations
  610-382-3310
  Darren.Lehrich@uhsinc.com

Universal Health Services, Inc.  
Consolidated Statements of Income  
(in thousands, except per share amounts)  
(unaudited)  
                 
  Three months   Nine months  
  ended September 30,   ended September 30,  
    2026       2025       2026       2025    
                 
Net revenues $ 4,733,352     $ 4,495,245     $ 13,866,546     $ 12,878,781    
                 
Operating charges:                
Salaries, wages and benefits   2,210,461       2,071,898       6,438,999       6,037,953    
Other operating expenses   1,425,781       1,294,721       4,061,667       3,563,039    
Supplies expense   426,500       414,583       1,276,300       1,236,249    
Depreciation and amortization   174,845       155,060       497,609       455,409    
Lease and rental expense   41,316       37,295       117,987       109,348    
    4,278,903       3,973,557       12,392,562       11,401,998    
                 
Income from operations   454,449       521,688       1,473,984       1,476,783    
                 
Interest expense, net   56,277       38,431       133,322       113,851    
Other (income) expense, net   (15,738 )     (13,629 )     (21,490 )     (27,767 )  
                 
Income before income taxes   413,910       496,886       1,362,152       1,390,699    
                 
Provision for income taxes   100,577       117,781       325,551       327,354    
                 
Net income   313,333       379,105       1,036,601       1,063,345    
                 
Less: Net income (loss) attributable to                
noncontrolling interests (“NCI”)   4,649       6,148       20,788       20,490    
                 
Net income attributable to UHS $ 308,684     $ 372,957     $ 1,015,813     $ 1,042,855    
                 
                 
Basic earnings per share attributable to UHS (a) $ 5.25     $ 5.92     $ 16.98     $ 16.27    
                 
Diluted earnings per share attributable to UHS (a) $ 5.22     $ 5.86     $ 16.86     $ 16.07    
                 
Universal Health Services, Inc.
Footnotes to Consolidated Statements of Income
(in thousands, except per share amounts)
(unaudited)
               
  Three months   Nine months
(a) Earnings per share calculation: ended September 30,   ended September 30,
    2026     2025     2026     2025
Basic and diluted:              
Net income attributable to UHS – basic and diluted $ 308,684   $ 372,957   $ 1,015,813   $ 1,042,855
               
Weighted average number of common shares – basic   58,795     62,974     59,841     64,100
               
Basic earnings per share attributable to UHS: $ 5.25   $ 5.92   $ 16.98   $ 16.27
               
Weighted average number of common shares   58,795     62,974     59,841     64,100
Add: Other share equivalents   350     689     400     797
Weighted average number of common shares and equiv. – diluted   59,145     63,663     60,241     64,897
               
Diluted earnings per share attributable to UHS: $ 5.22   $ 5.86   $ 16.86   $ 16.07
               
Universal Health Services, Inc.  
Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)
For the Three Months ended September 30, 2026 and 2025  
(in thousands, except per share amounts)  
(unaudited)  
                 
Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA/Adjusted EBITDA net of NCI”)  
                 
  Three months ended   % Net   Three months ended   % Net  
  September 30, 2026   revenues   September 30, 2025   revenues  
                 
Net income attributable to UHS $ 308,684         $ 372,957        
Depreciation and amortization   174,845           155,060        
Interest expense, net   56,277           38,431        
Provision for income taxes   100,577           117,781        
EBITDA net of NCI $ 640,383       13.5 %   $ 684,229       15.2 %  
                 
Other (income) expense, net   (15,738 )         (13,629 )      
Adjusted EBITDA net of NCI $ 624,645       13.2 %   $ 670,600       14.9 %  
                 
Net revenues $ 4,733,352         $ 4,495,245        
                 
                 
                 
Calculation of Adjusted Net Income Attributable to UHS  
                 
  Three months ended   Three months ended  
  September 30, 2026   September 30, 2025  
      Per       Per  
  Amount   Diluted Share Amount   Diluted Share
                 
Net income attributable to UHS $ 308,684     $ 5.22     $ 372,957     $ 5.86    
Plus/minus after-tax adjustments:                
Unrealized gain on equity securities   –       –       (10,043 )     (0.16 )  
Impact of ASU 2016-09, net   –       –       (623 )     (0.01 )  
Subtotal adjustments   –       –       (10,666 )     (0.17 )  
Adjusted net income attributable to UHS $ 308,684     $ 5.22     $ 362,291     $ 5.69    
                 
Universal Health Services, Inc.  
Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)
For the Nine Months ended September 30, 2026 and 2025  
(in thousands, except per share amounts)  
(unaudited)  
                 
Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA/Adjusted EBITDA net of NCI”)  
                 
  Nine months ended   % Net   Nine months ended   % Net  
  September 30, 2026   revenues   September 30, 2025   revenues  
                 
Net income attributable to UHS $ 1,015,813         $ 1,042,855        
Depreciation and amortization   497,609           455,409        
Interest expense, net   133,322           113,851        
Provision for income taxes   325,551           327,354        
EBITDA net of NCI $ 1,972,295       14.2 %   $ 1,939,469       15.1 %  
                 
Other (income) expense, net   (21,490 )         (27,767 )      
Adjusted EBITDA net of NCI $ 1,950,805       14.1 %   $ 1,911,702       14.8 %  
                 
Net revenues $ 13,866,546         $ 12,878,781        
                 
                 
                 
Calculation of Adjusted Net Income Attributable to UHS  
                 
  Nine months ended   Nine months ended  
  September 30, 2026   September 30, 2025  
      Per       Per  
  Amount   Diluted Share Amount   Diluted Share
                 
Net income attributable to UHS $ 1,015,813     $ 16.86     $ 1,042,855     $ 16.07    
Plus/minus after-tax adjustments:                
Unrealized gain on equity securities   –       –       (11,292 )     (0.17 )  
Impact of ASU 2016-09, net   (2,164 )     (0.03 )     (1,880 )     (0.03 )  
Subtotal adjustments   (2,164 )     (0.03 )     (13,172 )     (0.20 )  
Adjusted net income attributable to UHS $ 1,013,649     $ 16.83     $ 1,029,683     $ 15.87    
                 
Universal Health Services, Inc.  
Condensed Consolidated Balance Sheets  
(in thousands)  
(unaudited)  
               
      September 30,     December 31,  
      2026       2025    
Assets              
Current assets:              
Cash and cash equivalents   $ 168,749     $ 137,797    
Accounts receivable, net     2,813,703       2,602,434    
Supplies     235,557       232,110    
Other current assets     462,155       435,574    
Total current assets     3,680,164       3,407,915    
               
Property and equipment     14,051,199       13,489,811    
Less: accumulated depreciation     (6,833,095 )     (6,481,714 )  
      7,218,104       7,008,097    
               
Other assets:              
Goodwill     4,736,949       3,990,213    
Deferred income taxes     95,986       70,517    
Right of use assets-operating leases     421,597       374,239    
Deferred charges     9,220       9,272    
Other     1,023,746       667,340    
Total Assets   $ 17,185,766     $ 15,527,593    
               
Liabilities and Stockholders’ Equity              
Current liabilities:              
Current maturities of long-term debt   $ 79,813     $ 748,158    
Accounts payable and other liabilities     2,521,448       2,416,276    
Operating lease liabilities     79,824       73,237    
Federal and state taxes     6,271       1,930    
Total current liabilities     2,687,356       3,239,601    
               
Other noncurrent liabilities     736,430       527,827    
Operating lease liabilities noncurrent     389,154       340,715    
Deferred income taxes     3,232       5,649    
Long-term debt     5,627,528       4,004,393    
               
Redeemable noncontrolling interest     74,213       70,620    
               
UHS common stockholders’ equity     7,596,849       7,275,792    
Noncontrolling interest     71,004       62,996    
Total equity     7,667,853       7,338,788    
               
Total Liabilities and Stockholders’ Equity   $ 17,185,766     $ 15,527,593    
               
Universal Health Services, Inc.  
Consolidated Statements of Cash Flows  
(in thousands)  
(unaudited)  
  Nine months  
  ended September 30,  
    2026       2025    
         
Cash Flows from Operating Activities:        
Net income $ 1,036,601     $ 1,063,345    
Adjustments to reconcile net income to net        
cash provided by operating activities:        
Depreciation & amortization   497,609       455,409    
Stock-based compensation expense   71,777       70,586    
(Gain) loss on sales of assets and businesses   (6,315 )     2,833    
Changes in assets & liabilities, net of effects from        
acquisitions and dispositions:        
Accounts receivable   (116,437 )     (294,210 )  
Accrued interest   18,841       7,052    
Accrued and deferred income taxes   37,744       (39,287 )  
Other working capital accounts   (158,676 )     20,415    
Other assets and deferred charges   (11,309 )     (29,629 )  
Other, net   7,792       19,114    
Accrued insurance expense, net of commercial premiums paid   256,664       177,054    
Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements   (152,804 )     (162,978 )  
Net cash provided by operating activities   1,481,487       1,289,704    
         
Cash Flows from Investing Activities:        
Property and equipment additions   (659,732 )     (733,932 )  
Proceeds received from sales of assets and businesses   17,884       2,980    
Acquisition of businesses and property   (1,002,852 )     (47,772 )  
Inflows (outflows) from foreign exchange hedge contracts   16,217       (49,351 )  
Costs incurred for purchase and development of enterprise resource planning application   (15,535 )     (18,676 )  
Decrease in capital reserves of commercial insurance subsidiary   85       100    
Net cash used in investing activities   (1,643,933 )     (846,651 )  
         
Cash Flows from Financing Activities:        
Repayments of long-term debt   (828,487 )     (27,791 )  
Additional borrowings   1,800,040       208,986    
Financing costs   (15,261 )     (382 )  
Repurchase of common shares   (729,863 )     (615,941 )  
Dividends paid   (36,552 )     (38,902 )  
Issuance of common stock   12,936       12,119    
Profit distributions to noncontrolling interests   (13,333 )     (10,409 )  
Purchase of ownership interests by minority members, net   4,865       18,728    
Net cash provided by (used in) financing activities   194,345       (453,592 )  
         
Effect of exchange rate changes on cash and cash equivalents   (639 )     2,390    
Increase (decrease) in cash, cash equivalents and restricted cash   31,260       (8,149 )  
Cash, cash equivalents and restricted cash, beginning of period   271,322       224,752    
Cash, cash equivalents and restricted cash, end of period $ 302,582     $ 216,603    
         
Supplemental Disclosures of Cash Flow Information:        
Interest paid $ 110,379     $ 103,050    
Income taxes paid, net of refunds $ 290,239     $ 355,968    
Noncash purchases of property and equipment $ 78,068     $ 146,650    
         
Universal Health Services, Inc.  
Supplemental Statistical Information  
(unaudited)  
                     
                     
              % Change   % Change  
              3 Months ended   9 Months ended
Same Facility:             9/30/2026   9/30/2026  
                     
Acute Care Hospitals (1)                    
Revenues               4.7 %     7.0 %  
Adjusted Admissions               4.9 %     2.6 %  
Adjusted Patient Days               4.9 %     2.9 %  
Revenue Per Adjusted Admission               -1.7 %     2.4 %  
Revenue Per Adjusted Patient Day             -1.7 %     2.1 %  
                     
Behavioral Health Hospitals (1)                    
Revenues               4.0 %     6.2 %  
Adjusted Admissions               2.5 %     1.4 %  
Adjusted Patient Days               2.1 %     1.7 %  
Revenue Per Adjusted Admission               1.7 %     4.9 %  
Revenue Per Adjusted Patient Day             2.1 %     4.7 %  
                     
UHS Consolidated     Third Quarter Ended   Nine Months Ended  
      9/30/2026   9/30/2025   9/30/2026   9/30/2025  
                     
Revenues     $ 4,733,352     $ 4,495,245     $ 13,866,546     $ 12,878,781    
EBITDA net of NCI     $ 640,383     $ 684,229     $ 1,972,295     $ 1,939,469    
EBITDA Margin net of NCI       13.5 %     15.2 %     14.2 %     15.1 %  
Adjusted EBITDA net of NCI     $ 624,645     $ 670,600     $ 1,950,805     $ 1,911,702    
Adjusted EBITDA Margin net of NCI     13.2 %     14.9 %     14.1 %     14.8 %  
                     
Cash Flow From Operations     $ 636,556     $ 380,678     $ 1,481,487     $ 1,289,704    
Capital Expenditures     $ 214,942     $ 228,892     $ 659,732     $ 733,932    
Days Sales Outstanding               55       55    
                     
                     
Debt             $ 5,707,341     $ 4,691,120    
UHS’ Shareholders Equity             $ 7,596,849     $ 7,169,693    
Debt / Total Capitalization               42.9 %     39.6 %  
Debt / EBITDA net of NCI (2)               2.07       1.83    
Debt / Adjusted EBITDA net of NCI (2)             2.17       1.86    
Debt / Cash From Operations (2)               2.78       2.41    
                     
(1) Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.  
(2) Latest 4 quarters.  
                     
Universal Health Services, Inc.  
Acute Care Hospital Services  
For the Three and Nine Months ended  
September 30, 2026 and 2025  
(in thousands)  
(unaudited)  
                                   
Same Facility Basis – Acute Care Hospital Services
                                   
    Three months ended   Three months ended   Nine months ended   Nine months ended  
    September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025  
    Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues  
Net revenues   $ 2,610,702     100.0 %   $ 2,492,536     100.0 %   $ 7,588,636     100.0 %   $ 7,093,193     100.0 %  
Operating charges:                                  
Salaries, wages and benefits     1,044,653     40.0 %     973,522     39.1 %     2,989,221     39.4 %     2,825,945     39.8 %  
Other operating expenses     776,378     29.7 %     722,724     29.0 %     2,283,559     30.1 %     2,033,495     28.7 %  
Supplies expense     363,780     13.9 %     354,698     14.2 %     1,091,408     14.4 %     1,064,615     15.0 %  
Depreciation and amortization     103,340     4.0 %     97,388     3.9 %     302,133     4.0 %     288,747     4.1 %  
Lease and rental expense     28,533     1.1 %     25,543     1.0 %     81,230     1.1 %     75,127     1.1 %  
Subtotal-operating expenses     2,316,684     88.7 %     2,173,875     87.2 %     6,747,551     88.9 %     6,287,929     88.6 %  
Income from operations     294,018     11.3 %     318,661     12.8 %     841,085     11.1 %     805,264     11.4 %  
Interest expense, net     1,302     0.0 %     528     0.0 %     3,589     0.0 %     1,177     0.0 %  
Other (income) expense, net     (9,338 )   (0.4 )%     (678 )   (0.0 )%     (13,082 )   (0.2 )%     (10,261 )   (0.1 )%  
Income before income taxes   $ 302,054     11.6 %   $ 318,811     12.8 %   $ 850,578     11.2 %   $ 814,348     11.5 %  
                                   
                                   
All Acute Care Hospital Services  
                                   
    Three months ended   Three months ended   Nine months ended   Nine months ended  
    September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025  
    Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues  
Net revenues   $ 2,764,072     100.0 %   $ 2,630,065     100.0 %   $ 7,984,207     100.0 %   $ 7,391,716     100.0 %  
Operating charges:                                  
Salaries, wages and benefits     1,054,866     38.2 %     973,680     37.0 %     3,027,576     37.9 %     2,827,912     38.3 %  
Other operating expenses     930,909     33.7 %     878,746     33.4 %     2,676,638     33.5 %     2,352,957     31.8 %  
Supplies expense     365,597     13.2 %     354,697     13.5 %     1,097,029     13.7 %     1,064,486     14.4 %  
Depreciation and amortization     108,924     3.9 %     97,389     3.7 %     311,865     3.9 %     288,751     3.9 %  
Lease and rental expense     28,675     1.0 %     25,543     1.0 %     81,417     1.0 %     75,127     1.0 %  
Subtotal-operating expenses     2,488,971     90.0 %     2,330,055     88.6 %     7,194,525     90.1 %     6,609,233     89.4 %  
Income from operations     275,101     10.0 %     300,010     11.4 %     789,682     9.9 %     782,483     10.6 %  
Interest expense, net     1,302     0.0 %     528     0.0 %     3,589     0.0 %     1,177     0.0 %  
Other (income) expense, net     (9,329 )   (0.3 )%     (623 )   (0.0 )%     (12,446 )   (0.2 )%     (9,806 )   (0.1 )%  
Income before income taxes   $ 283,128     10.2 %   $ 300,105     11.4 %   $ 798,539     10.0 %   $ 791,112     10.7 %  
                                   
                                   
We believe that providing our results on a “Same Facility” basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Acute Care Hospital Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2025 and our Form 10-Q for the quarter ended June 30, 2026.
                                   
Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.
                                   
The All Acute Care Hospital Services table summarizes the results of operations for all our acute care operations during the periods presented. These amounts include: (i) our acute care results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months.
Universal Health Services, Inc.  
Behavioral Health Care Services  
For the Three and Nine Months ended  
September 30, 2026 and 2025  
(in thousands)  
(unaudited)  
                                   
Same Facility Basis – Behavioral Health Care Services  
                                   
    Three months ended   Three months ended   Nine months ended   Nine months ended  
    September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025  
    Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues  
Net revenues   $1,857,445   100.0%   $1,786,231   100.0%   $5,605,292   100.0%   $5,276,686   100.0%  
Operating charges:                                  
Salaries, wages and benefits   1,032,001   55.6%   975,934   54.6%   3,044,335   54.3%   2,854,754   54.1%  
Other operating expenses   361,742   19.5%   342,491   19.2%   1,051,744   18.8%   987,686   18.7%  
Supplies expense   60,459   3.3%   58,016   3.2%   176,804   3.2%   169,968   3.2%  
Depreciation and amortization   58,984   3.2%   53,787   3.0%   170,904   3.0%   156,539   3.0%  
Lease and rental expense   12,271   0.7%   11,167   0.6%   35,630   0.6%   32,457   0.6%  
Subtotal-operating expenses   1,525,457   82.1%   1,441,395   80.7%   4,479,417   79.9%   4,201,404   79.6%  
Income from operations   331,988   17.9%   344,836   19.3%   1,125,875   20.1%   1,075,282   20.4%  
Interest expense, net   1,009   0.1%   1,244   0.1%   3,369   0.1%   3,423   0.1%  
Other (income) expense, net   (5,909)   (0.3)%   733   0.0%   (7,775)   (0.1)%   (929)   (0.0)%  
Income before income taxes   $336,888   18.1%   $342,859   19.2%   $1,130,281   20.2%   $1,072,788   20.3%  
                                   
                                   
All Behavioral Health Care Services
                                   
    Three months ended   Three months ended   Nine months ended   Nine months ended  
    September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025  
    Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues  
Net revenues   $1,966,427   100.0%   $1,860,259   100.0%   $5,873,644   100.0%   $5,476,596   100.0%  
Operating charges:                                  
Salaries, wages and benefits   1,057,054   53.8%   995,570   53.5%   3,098,752   52.8%   2,894,489   52.9%  
Other operating expenses   460,853   23.4%   390,783   21.0%   1,296,503   22.1%   1,136,457   20.8%  
Supplies expense   61,022   3.1%   59,696   3.2%   178,284   3.0%   173,133   3.2%  
Depreciation and amortization   63,522   3.2%   55,294   3.0%   179,051   3.0%   159,616   2.9%  
Lease and rental expense   12,568   0.6%   11,652   0.6%   36,295   0.6%   33,979   0.6%  
Subtotal-operating expenses   1,655,019   84.2%   1,512,995   81.3%   4,788,885   81.5%   4,397,674   80.3%  
Income from operations   311,408   15.8%   347,264   18.7%   1,084,759   18.5%   1,078,922   19.7%  
Interest expense, net   1,214   0.1%   1,265   0.1%   3,759   0.1%   3,444   0.1%  
Other (income) expense, net   (5,909)   (0.3)%   733   0.0%   (7,775)   (0.1)%   (929)   (0.0)%  
Income before income taxes   $316,103   16.1%   $345,266   18.6%   $1,088,775   18.5%   $1,076,407   19.7%  
                                   
   
We believe that providing our results on a “Same Facility” basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Behavioral Health Care Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2025 and our Form 10-Q for the quarter ended June 30, 2026.
   
Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.
   
The All Behavioral Health Care Services table summarizes the results of operations for all our behavioral health care facilities during the periods presented. These amounts include: (i) our behavioral health results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired/divested or opened/closed or had changes in governmental certifications/licensure status during the last twelve months.
Universal Health Services, Inc.  
Selected Hospital Statistics  
For the Three Months ended  
September 30, 2026 and 2025  
(unaudited)  
                           
AS REPORTED:                          
                           
    ACUTE   BEHAVIORAL HEALTH  
    9/30/26   9/30/25   % change 9/30/26   9/30/25   % change
                           
Hospitals owned and leased     30       29     3.4 %     388       345     12.5 %  
Average licensed beds     7,519       7,161     5.0 %     24,715       24,398     1.3 %  
Average available beds     7,347       6,989     5.1 %     24,615       24,298     1.3 %  
Patient days     429,842       412,353     4.2 %     1,654,546       1,639,882     0.9 %  
Average daily census     4,672.2       4,482.1     4.2 %     17,984.2       17,824.8     0.9 %  
Occupancy-licensed beds     62.1 %     62.6 %   -0.7 %     72.8 %     73.1 %   -0.4 %  
Occupancy-available beds     63.6 %     64.1 %   -0.8 %     73.1 %     73.4 %   -0.4 %  
Admissions     90,722       86,984     4.3 %     121,428       120,655     0.6 %  
Length of stay     4.7       4.7     -0.1 %     13.6       13.6     0.3 %  
                           
Inpatient revenue   $ 15,763,396     $ 13,935,095     13.1 %   $ 3,356,016     $ 3,063,186     9.6 %  
Outpatient revenue     11,370,036       9,827,354     15.7 %     344,838       282,966     21.9 %  
Total patient revenue     27,133,432       23,762,449     14.2 %     3,700,854       3,346,152     10.6 %  
Other revenue     378,328       315,779     19.8 %     105,977       99,370     6.6 %  
Gross revenue     27,511,760       24,078,228     14.3 %     3,806,831       3,445,522     10.5 %  
Total deductions     24,747,688       21,448,163     15.4 %     1,840,404       1,585,263     16.1 %  
Net revenue   $ 2,764,072     $ 2,630,065     5.1 %   $ 1,966,427     $ 1,860,259     5.7 %  
                           
                           
SAME FACILITY:                          
                           
    ACUTE   BEHAVIORAL HEALTH  
    9/30/26   9/30/25   % change 9/30/26   9/30/25   % change
                           
Hospitals owned and leased     29       29     0.0 %     341       341     0.0 %  
Average licensed beds     7,363       7,161     2.8 %     23,706       23,635     0.3 %  
Average available beds     7,191       6,989     2.9 %     23,606       23,535     0.3 %  
Patient days     428,858       412,353     4.0 %     1,623,726       1,589,558     2.1 %  
Average daily census     4,661.5       4,482.1     4.0 %     17,649.2       17,277.8     2.1 %  
Occupancy-licensed beds     63.3 %     62.6 %   1.1 %     74.5 %     73.1 %   1.8 %  
Occupancy-available beds     64.8 %     64.1 %   1.1 %     74.8 %     73.4 %   1.8 %  
Admissions     90,414       86,984     3.9 %     120,168       117,107     2.6 %  
Length of stay     4.7       4.7     0.1 %     13.5       13.6     -0.5 %  
                           
                           
Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.  
                           
Universal Health Services, Inc.  
Selected Hospital Statistics  
For the Nine Months ended  
September 30, 2026 and 2025  
(unaudited)  
                           
AS REPORTED:                          
                           
    ACUTE   BEHAVIORAL HEALTH  
    9/30/26   9/30/25   % change 9/30/26   9/30/25   % change
                           
Hospitals owned and leased     30       29     3.4 %     388       345     12.5 %  
Average licensed beds     7,373       7,105     3.8 %     24,624       24,246     1.6 %  
Average available beds     7,201       6,933     3.9 %     24,524       24,146     1.6 %  
Patient days     1,280,916       1,254,271     2.1 %     4,905,510       4,849,272     1.2 %  
Average daily census     4,692.0       4,594.4     2.1 %     17,968.9       17,762.9     1.2 %  
Occupancy-licensed beds     63.6 %     64.7 %   -1.6 %     73.0 %     73.3 %   -0.4 %  
Occupancy-available beds     65.2 %     66.3 %   -1.7 %     73.3 %     73.6 %   -0.4 %  
Admissions     267,260       262,352     1.9 %     355,776       355,524     0.1 %  
Length of stay     4.8       4.8     0.2 %     13.8       13.6     1.1 %  
                           
Inpatient revenue   $ 47,313,330     $ 42,140,253     12.3 %   $ 9,924,833     $ 8,901,308     11.5 %  
Outpatient revenue     33,377,475       28,793,716     15.9 %     983,819       851,989     15.5 %  
Total patient revenue     80,690,805       70,933,969     13.8 %     10,908,652       9,753,297     11.8 %  
Other revenue     1,069,466       881,912     21.3 %     298,188       281,291     6.0 %  
Gross revenue     81,760,271       71,815,881     13.8 %     11,206,840       10,034,588     11.7 %  
Total deductions     73,776,064       64,424,165     14.5 %     5,333,196       4,557,992     17.0 %  
Net revenue   $ 7,984,207     $ 7,391,716     8.0 %   $ 5,873,644     $ 5,476,596     7.2 %  
                           
                           
SAME FACILITY:                          
                           
    ACUTE   BEHAVIORAL HEALTH  
    9/30/26   9/30/25   % change 9/30/26   9/30/25   % change
                           
Hospitals owned and leased     29       29     0.0 %     341       341     0.0 %  
Average licensed beds     7,239       7,105     1.9 %     23,809       23,714     0.4 %  
Average available beds     7,067       6,933     1.9 %     23,709       23,614     0.4 %  
Patient days     1,274,419       1,254,271     1.6 %     4,814,191       4,736,987     1.6 %  
Average daily census     4,668.2       4,594.4     1.6 %     17,634.4       17,351.6     1.6 %  
Occupancy-licensed beds     64.5 %     64.7 %   -0.3 %     74.1 %     73.2 %   1.2 %  
Occupancy-available beds     66.1 %     66.3 %   -0.3 %     74.4 %     73.5 %   1.2 %  
Admissions     265,756       262,352     1.3 %     351,347       346,589     1.4 %  
Length of stay     4.8       4.8     0.3 %     13.7       13.7     0.3 %  
                           
                           
Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.  
                           

Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended September 30, 2026 and 2025:

KING OF PRUSSIA, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) — Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $308.7 million, or $5.22 per diluted share, during the third quarter of 2026, as compared to $373.0 million, or $5.86 per diluted share, during the third quarter of 2025. Net revenues increased by 5.3% to $4.733 billion during the third quarter of 2026, as compared to $4.495 billion during the third quarter of 2025.

Included in our operating results during the third quarter of 2026, was an aggregate net favorable pre-tax impact of approximately $21 million recorded in connection with the following items which were not included in our 2026 operating results forecast, as previously disclosed on July 27, 2026: (i) a favorable net pre-tax impact of $47 million (net of related provider taxes) recorded in connection with increases in amounts received from Medicaid supplemental payment programs in various states (consisting primarily of Washington, D.C. and California), partially offset by; (ii) an unfavorable pre-tax impact of $26 million resulting from an increase to our reserves for self-insured professional and general liability claims due primarily to the tentative settlement agreement reached during the third quarter of 2026 in the matter discussed below in Legal Proceedings Update.

Included in our operating results during the third quarter of 2025, was an aggregate net favorable pre-tax impact of approximately $55 million recorded in connection with the following: (i) $90 million of pre-tax reimbursements (net of related provider taxes), covering the period of October 1, 2024 through September 30, 2025, in connection with a Medicaid state directed payment program in Washington, D.C., and; (ii) a $35 million pre-tax charge incurred to increase our reserves for self-insured professional and general liabilities resulting from unfavorable claims’ trends.

As reflected on the Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”), there were no adjustments applicable to our operating results during the third quarter of 2026.

As reflected on the Supplemental Schedule, included in our reported results during the third quarter of 2025 were: (i) an unrealized after-tax gain of $10.0 million, or $.16 per diluted share ($13.1 million pre-tax), resulting from an increase in the market value of certain equity securities that were sold during the fourth quarter of 2025 (included in “Other (income) expense, net”), and; (ii) a favorable net after-tax impact of $0.6 million, or $.01 per diluted share, resulting from the net tax benefit recorded in connection with “ASU 2016-09”, Compensation – Stock Compensation: Improvements to Employee Share-Based Payment Accounting, net of the impact of executive compensation limitations pursuant to IRC section 162(m). After giving effect to these items, our adjusted net income during the third quarter of 2025 was $362.3 million, or $5.69 per diluted share.

As calculated on the attached Supplemental Schedule, our earnings before interest, taxes, depreciation & amortization (“EBITDA net of NCI”, NCI is net income attributable to noncontrolling interests), was $640.4 million during the third quarter of 2026, as compared to $684.2 million during the third quarter of 2025. Our adjusted earnings before interest, taxes, depreciation & amortization (“Adjusted EBITDA net of NCI”), which excludes the impact of other (income) expense, net, was $624.6 million during the third quarter of 2026, as compared to $670.6 million during the third quarter of 2025.

Consolidated Results of Operations, As Reported and As Adjusted – Nine-month periods ended September 30, 2026 and 2025:

Reported net income attributable to UHS was $1.016 billion, or $16.86 per diluted share, during the first nine months of 2026, as compared to $1.043 billion, or $16.07 per diluted share, during the comparable period of 2025. Net revenues increased by 7.7% to $13.867 billion during the first nine months of 2026, as compared to $12.879 billion during the comparable period of 2025.

As reflected on the Supplemental Schedule, our adjusted net income during the first nine months of 2026 was $1.014 billion, or $16.83 per diluted share, as compared to $1.030 billion, or $15.87 per diluted share, during the comparable period of 2025.

As reflected on the Supplemental Schedule, included in our reported results during the first nine months of 2026 was a favorable net after-tax impact of $2.2 million, or $.03 per diluted share, resulting from the net tax benefit recorded in connection with ASU 2016-09. Included in our reported results during the first nine months of 2025 were the following: (i) an unrealized after-tax gain of $11.3 million, or $.17 per diluted share ($14.7 million pre-tax), resulting from an increase in the market value of certain equity securities that were sold during the fourth quarter of 2025, and; (ii) a favorable net after-tax impact of $1.9 million, or $.03 per diluted share, resulting from the net tax benefit recorded in connection with ASU 2016-09.

As calculated on the attached Supplemental Schedule, our EBITDA net of NCI, was $1.972 billion during the first nine months of 2026, as compared to $1.939 billion during the comparable period of 2025. Our Adjusted EBITDA net of NCI, which excludes the impact of other (income) expense, net, was $1.951 billion during the first nine months of 2026, as compared to $1.912 billion during the comparable period of 2025.

Acute Care Services – Three and nine-month periods ended September 30, 2026 and 2025:

During the third quarter of 2026, at our acute care hospitals owned during both periods (“same facility basis”), adjusted admissions (adjusted for outpatient activity) and adjusted patient days each increased by 4.9%, as compared to the third quarter of 2025. At these facilities, during the third quarter of 2026, net revenue per adjusted admission and net revenue per adjusted patient day each decreased by 1.7%, as compared to the third quarter of 2025. Net revenues generated from our acute care services, on a same facility basis, increased by 4.7% during the third quarter of 2026, as compared to the third quarter of 2025.

During the first nine months of 2026, on a same facility basis, adjusted admissions increased by 2.6% and adjusted patient days increased by 2.9%, as compared to the comparable period of 2025. At these facilities, during the first nine months of 2026, net revenue per adjusted admission increased by 2.4% while net revenue per adjusted patient day increased by 2.1%, as compared to the comparable period of 2025. Net revenues generated from our acute care services, on a same facility basis, increased by 7.0% during the first nine months of 2026, as compared to the comparable period of 2025.

Behavioral Health Care Services – Three and nine-month periods ended September 30, 2026 and 2025:

During the third quarter of 2026, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 2.5% while adjusted patient days increased by 2.1%, as compared to the third quarter of 2025. At these facilities, during the third quarter of 2026, net revenue per adjusted admission increased by 1.7% and net revenue per adjusted patient day increased by 2.1%, as compared to the third quarter of 2025. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 4.0% during the third quarter of 2026, as compared to the third quarter of 2025.

During the first nine months of 2026, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 1.4% while adjusted patient days increased by 1.7%, as compared to the comparable period of 2025. At these facilities, during the first nine months of 2026, net revenue per adjusted admission increased by 4.9% and net revenue per adjusted patient day increased by 4.7%, as compared to the comparable period of 2025. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 6.2% during the first nine months of 2026, as compared to the comparable period of 2025.

Net Cash Provided by Operating Activities and Capital Resources:

Net Cash Provided by Operating Activities:

During the nine-month period ended September 30, 2026, our net cash provided by operating activities increased by 14.9% to $1.481 billion as compared to $1.290 billion during the first nine months of 2025.

The $192 million net increase in our net cash provided by operating activities consisted of: (i) an unfavorable change of $179 million in other working capital accounts due primarily to the timing of accrued expenses and accounts payable disbursements; (ii) a favorable change of $178 million in accounts receivable; (iii) a favorable change of $90 million in accrued insurance expense, net of payments made in settlement of self-insured claims; (iv) a favorable change of $77 million in accrued and deferred income taxes, and; (v) $26 million of other combined net favorable changes.

Capital Resources:

As of September 30, 2026, pursuant to the terms of our $1.5 billion revolving credit facility, we had $1.187 billion of available borrowing capacity, net of outstanding borrowings ($310 million) and letters of credit ($3 million). 

Stock Repurchase Program:

In connection with our stock repurchase program, shares of our Class B Common Stock may be repurchased, from time to time as conditions allow, on the open market or in negotiated private transactions. 

Pursuant to this program, during the third quarter of 2026, we have repurchased 1.35 million shares at an aggregate cost of approximately $242.1 million (average price of approximately $179 per share). During the first nine months of 2026, we have repurchased 3.915 million shares at an aggregate cost of approximately $689.6 million (average price of approximately $176 per share).

As of September 30, 2026, we had an aggregate available repurchase authorization of approximately $735.4 million pursuant to our stock repurchase program.

Conference call information:

We will hold a conference call for investors and analysts at 8:00 a.m. eastern time on October 28, 2026. A live webcast of the call will be available on our website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. Supplemental financial disclosures related to our financial results are available on our website.

Legal Proceedings Update:

The disclosure below provides an update for recent developments related to the matter referenced which has been previously disclosed in various Forms 10-Q and 10-K, as filed with the Securities and Exchange Commission, most recently our Form 10-Q for the quarterly period ended June 30, 2026.

K.E.E., et al., Plaintiffs v. Cumberland Hospital, LLC d/b/a Cumberland Hospital for Children and Adolescents, et al. (and related lawsuits)

Cumberland Hospital for Children and Adolescents (“Cumberland”), an indirect subsidiary of Universal Health Services, Inc. (the “Company”) and UHS of Delaware, Inc. (“UHS Delaware”), our administrative services company, are defendants in multi-plaintiff lawsuits filed in the Circuit Court for Richmond, Virginia (the “Cumberland Litigation”). The lawsuits relate to allegations of, among other things, inappropriate sexual contact during medical examinations by Dr. Daniel Davidow, an independent contractor and the former medical director for Cumberland. 

The claims asserted by three of the plaintiffs in the Cumberland Litigation were consolidated for trial in September 2024. There are approximately 53 additional claimants making similar allegations with claims pending in the Cumberland Litigation. The Company and UHS Delaware were dismissed from the September 2024 trial on the first three plaintiffs’ claims. In late September 2024, a jury entered a verdict finding Dr. Davidow and Cumberland liable and awarded these three plaintiffs combined compensatory damages of $60 million for all liability theories, an additional combined $180 million in trebled damages for violation of the Virginia Consumer Protection Act, and an additional combined $120 million in punitive damages. Based upon Virginia law, the Court reduced the punitive damage amount to a combined maximum of $1.05 million ($350,000 per plaintiff).

In August 2026, we reached a tentative settlement agreement, which is subject to execution of final release agreements and certain court approvals (as necessary), to resolve all of the outstanding claims related to the current claimants in the Cumberland Litigation. Pursuant to the tentative settlement agreement, the terms of the aggregate settlement are confidential. We believe a substantial portion of the tentative aggregate settlement amount, and related expenses, is covered by our commercial excess insurance and the remainder is covered by our reserves recorded in connection with the Cumberland Litigation.   

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

Headquartered in King of Prussia, PA, UHS is one of the nation’s largest and most respected providers of hospital and healthcare services, with annual revenues of approximately $17.4 billion during 2025. Through its subsidiaries, UHS employs more than 102,000 employees and, as of September 30, 2026, operated 30 inpatient acute care facilities, 388 inpatient behavioral health facilities, 169 outpatient and other facilities, nationwide virtual behavioral health services, an insurance offering, a physician network and various related services with physical locations in 40 states, Washington, D.C., Puerto Rico, Ireland and the United Kingdom. Since our founding in 1979, UHS has grown steadily into a premier Fortune 500® corporation perennially recognized by multiple esteemed national rating entities.  Our strategy includes investing in talented staff, facilities, technology and innovation across broad care continuums to deliver favorable patient outcomes and contribute to the overall health and wellbeing of the patients we are privileged to serve. A wholly-owned subsidiary of UHS also acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE: UHT). For additional information, please visit www.uhs.com.

        This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 2-Forward Looking Statements and Risk Factors in our Form 10-Q for the quarter ended June 30, 2026 and in Item 1A–Risk Factors, and Item 7-Forward-Looking Statements and Risk Factors, in our Form 10-K for the year ended December 31, 2025), may cause the results to differ materially from those anticipated in the forward-looking statements. These statements are subject to risks and uncertainties and therefore actual results may differ materially. Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Many of the factors that could affect our future results are beyond our control or ability to predict, including, but not limited to:

  • A significant portion of our revenues are derived from federal and state government programs including the Medicare and Medicaid programs. Payments from these programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions. Changes to these programs could materially affect program payments which could materially impact our results of operations. In addition, we receive substantial reimbursement from multiple states in connection with various supplemental Medicaid payment programs. Failure to renew these programs beyond their scheduled termination dates, failure of the public hospitals to provide the necessary Inter-Governmental Transfers for the states’ share of the Medicaid disproportionate share hospital programs, and the failure of our hospitals that currently receive supplemental Medicaid revenues to qualify for future funds under these programs could cause our actual results of operations for the year ended December 31, 2026 to differ materially from our 2026 operating results forecast.
  • Legislation adopted on July 4, 2025, attaches work and community service requirements to eligibility for Medicaid benefits that will have the effect of limiting Medicaid enrollment and expenditures. That legislation also places limits on provider fees used to increase federal Medicaid funding to states and eliminated certain exchange premium tax credits beyond 2025. As these provisions become effective over the next several years, they may be expected to reduce our revenues and likely increase the level of uncompensated care provided by our facilities.
  • The increase in interest rates during the past few years has increased our interest expense significantly thereby reducing our free cash flow. As such, the effects of increased borrowing rates have adversely impacted our results of operations, financial condition and cash flows. We cannot predict future changes to interest rates, however, significant increases in our borrowing rates could have a material unfavorable impact on our future results of operations and our ability to access the capital markets on favorable terms.
  • Changes in laws or policies governing the terms of foreign trade, and in particular, increased trade restrictions, tariffs or taxes on imports from where our products or materials are made (either directly or through our suppliers) could have an impact on our competitive position, business operations and financial results.
  • The outcome of known and unknown litigation, liabilities and other claims asserted against us and/or our subsidiaries.
  • The ability to successfully integrate and realize the benefits and synergies from our acquisition of Talkspace, Inc. which was completed in August 2026.

We believe that adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA net of NCI and Adjusted EBITDA net of NCI, which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it may neutralize the effect of material items impacting our net income attributable to UHS, such as, changes in the value of certain non-marketable securities (in connection with our minority ownership in a healthcare generative artificial intelligence company), the impact of ASU 2016-09, and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of goodwill, long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, potential impacts of non-ordinary acquisitions, divestitures, joint ventures or other strategic transactions, and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP, and as presented in the condensed consolidated financial statements and notes thereto in this report or in our filings with the Securities and Exchange Commission including our Report on Form 10-Q for the quarter ended June 30, 2026 and our Report on Form 10-K for the year ended December 31, 2025. Since the items that may be included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

CONTACT: Darren Lehrich
  Vice President-Investor Relations
  610-382-3310
  Darren.Lehrich@uhsinc.com

Universal Health Services, Inc.  
Consolidated Statements of Income  
(in thousands, except per share amounts)  
(unaudited)  
                 
  Three months   Nine months  
  ended September 30,   ended September 30,  
    2026       2025       2026       2025    
                 
Net revenues $ 4,733,352     $ 4,495,245     $ 13,866,546     $ 12,878,781    
                 
Operating charges:                
Salaries, wages and benefits   2,210,461       2,071,898       6,438,999       6,037,953    
Other operating expenses   1,425,781       1,294,721       4,061,667       3,563,039    
Supplies expense   426,500       414,583       1,276,300       1,236,249    
Depreciation and amortization   174,845       155,060       497,609       455,409    
Lease and rental expense   41,316       37,295       117,987       109,348    
    4,278,903       3,973,557       12,392,562       11,401,998    
                 
Income from operations   454,449       521,688       1,473,984       1,476,783    
                 
Interest expense, net   56,277       38,431       133,322       113,851    
Other (income) expense, net   (15,738 )     (13,629 )     (21,490 )     (27,767 )  
                 
Income before income taxes   413,910       496,886       1,362,152       1,390,699    
                 
Provision for income taxes   100,577       117,781       325,551       327,354    
                 
Net income   313,333       379,105       1,036,601       1,063,345    
                 
Less: Net income (loss) attributable to                
noncontrolling interests (“NCI”)   4,649       6,148       20,788       20,490    
                 
Net income attributable to UHS $ 308,684     $ 372,957     $ 1,015,813     $ 1,042,855    
                 
                 
Basic earnings per share attributable to UHS (a) $ 5.25     $ 5.92     $ 16.98     $ 16.27    
                 
Diluted earnings per share attributable to UHS (a) $ 5.22     $ 5.86     $ 16.86     $ 16.07    
                 
Universal Health Services, Inc.
Footnotes to Consolidated Statements of Income
(in thousands, except per share amounts)
(unaudited)
               
  Three months   Nine months
(a) Earnings per share calculation: ended September 30,   ended September 30,
    2026     2025     2026     2025
Basic and diluted:              
Net income attributable to UHS – basic and diluted $ 308,684   $ 372,957   $ 1,015,813   $ 1,042,855
               
Weighted average number of common shares – basic   58,795     62,974     59,841     64,100
               
Basic earnings per share attributable to UHS: $ 5.25   $ 5.92   $ 16.98   $ 16.27
               
Weighted average number of common shares   58,795     62,974     59,841     64,100
Add: Other share equivalents   350     689     400     797
Weighted average number of common shares and equiv. – diluted   59,145     63,663     60,241     64,897
               
Diluted earnings per share attributable to UHS: $ 5.22   $ 5.86   $ 16.86   $ 16.07
               
Universal Health Services, Inc.  
Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)
For the Three Months ended September 30, 2026 and 2025  
(in thousands, except per share amounts)  
(unaudited)  
                 
Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA/Adjusted EBITDA net of NCI”)  
                 
  Three months ended   % Net   Three months ended   % Net  
  September 30, 2026   revenues   September 30, 2025   revenues  
                 
Net income attributable to UHS $ 308,684         $ 372,957        
Depreciation and amortization   174,845           155,060        
Interest expense, net   56,277           38,431        
Provision for income taxes   100,577           117,781        
EBITDA net of NCI $ 640,383       13.5 %   $ 684,229       15.2 %  
                 
Other (income) expense, net   (15,738 )         (13,629 )      
Adjusted EBITDA net of NCI $ 624,645       13.2 %   $ 670,600       14.9 %  
                 
Net revenues $ 4,733,352         $ 4,495,245        
                 
                 
                 
Calculation of Adjusted Net Income Attributable to UHS  
                 
  Three months ended   Three months ended  
  September 30, 2026   September 30, 2025  
      Per       Per  
  Amount   Diluted Share Amount   Diluted Share
                 
Net income attributable to UHS $ 308,684     $ 5.22     $ 372,957     $ 5.86    
Plus/minus after-tax adjustments:                
Unrealized gain on equity securities   –       –       (10,043 )     (0.16 )  
Impact of ASU 2016-09, net   –       –       (623 )     (0.01 )  
Subtotal adjustments   –       –       (10,666 )     (0.17 )  
Adjusted net income attributable to UHS $ 308,684     $ 5.22     $ 362,291     $ 5.69    
                 
Universal Health Services, Inc.  
Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)
For the Nine Months ended September 30, 2026 and 2025  
(in thousands, except per share amounts)  
(unaudited)  
                 
Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA/Adjusted EBITDA net of NCI”)  
                 
  Nine months ended   % Net   Nine months ended   % Net  
  September 30, 2026   revenues   September 30, 2025   revenues  
                 
Net income attributable to UHS $ 1,015,813         $ 1,042,855        
Depreciation and amortization   497,609           455,409        
Interest expense, net   133,322           113,851        
Provision for income taxes   325,551           327,354        
EBITDA net of NCI $ 1,972,295       14.2 %   $ 1,939,469       15.1 %  
                 
Other (income) expense, net   (21,490 )         (27,767 )      
Adjusted EBITDA net of NCI $ 1,950,805       14.1 %   $ 1,911,702       14.8 %  
                 
Net revenues $ 13,866,546         $ 12,878,781        
                 
                 
                 
Calculation of Adjusted Net Income Attributable to UHS  
                 
  Nine months ended   Nine months ended  
  September 30, 2026   September 30, 2025  
      Per       Per  
  Amount   Diluted Share Amount   Diluted Share
                 
Net income attributable to UHS $ 1,015,813     $ 16.86     $ 1,042,855     $ 16.07    
Plus/minus after-tax adjustments:                
Unrealized gain on equity securities   –       –       (11,292 )     (0.17 )  
Impact of ASU 2016-09, net   (2,164 )     (0.03 )     (1,880 )     (0.03 )  
Subtotal adjustments   (2,164 )     (0.03 )     (13,172 )     (0.20 )  
Adjusted net income attributable to UHS $ 1,013,649     $ 16.83     $ 1,029,683     $ 15.87    
                 
Universal Health Services, Inc.  
Condensed Consolidated Balance Sheets  
(in thousands)  
(unaudited)  
               
      September 30,     December 31,  
      2026       2025    
Assets              
Current assets:              
Cash and cash equivalents   $ 168,749     $ 137,797    
Accounts receivable, net     2,813,703       2,602,434    
Supplies     235,557       232,110    
Other current assets     462,155       435,574    
Total current assets     3,680,164       3,407,915    
               
Property and equipment     14,051,199       13,489,811    
Less: accumulated depreciation     (6,833,095 )     (6,481,714 )  
      7,218,104       7,008,097    
               
Other assets:              
Goodwill     4,736,949       3,990,213    
Deferred income taxes     95,986       70,517    
Right of use assets-operating leases     421,597       374,239    
Deferred charges     9,220       9,272    
Other     1,023,746       667,340    
Total Assets   $ 17,185,766     $ 15,527,593    
               
Liabilities and Stockholders’ Equity              
Current liabilities:              
Current maturities of long-term debt   $ 79,813     $ 748,158    
Accounts payable and other liabilities     2,521,448       2,416,276    
Operating lease liabilities     79,824       73,237    
Federal and state taxes     6,271       1,930    
Total current liabilities     2,687,356       3,239,601    
               
Other noncurrent liabilities     736,430       527,827    
Operating lease liabilities noncurrent     389,154       340,715    
Deferred income taxes     3,232       5,649    
Long-term debt     5,627,528       4,004,393    
               
Redeemable noncontrolling interest     74,213       70,620    
               
UHS common stockholders’ equity     7,596,849       7,275,792    
Noncontrolling interest     71,004       62,996    
Total equity     7,667,853       7,338,788    
               
Total Liabilities and Stockholders’ Equity   $ 17,185,766     $ 15,527,593    
               
Universal Health Services, Inc.  
Consolidated Statements of Cash Flows  
(in thousands)  
(unaudited)  
  Nine months  
  ended September 30,  
    2026       2025    
         
Cash Flows from Operating Activities:        
Net income $ 1,036,601     $ 1,063,345    
Adjustments to reconcile net income to net        
cash provided by operating activities:        
Depreciation & amortization   497,609       455,409    
Stock-based compensation expense   71,777       70,586    
(Gain) loss on sales of assets and businesses   (6,315 )     2,833    
Changes in assets & liabilities, net of effects from        
acquisitions and dispositions:        
Accounts receivable   (116,437 )     (294,210 )  
Accrued interest   18,841       7,052    
Accrued and deferred income taxes   37,744       (39,287 )  
Other working capital accounts   (158,676 )     20,415    
Other assets and deferred charges   (11,309 )     (29,629 )  
Other, net   7,792       19,114    
Accrued insurance expense, net of commercial premiums paid   256,664       177,054    
Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements   (152,804 )     (162,978 )  
Net cash provided by operating activities   1,481,487       1,289,704    
         
Cash Flows from Investing Activities:        
Property and equipment additions   (659,732 )     (733,932 )  
Proceeds received from sales of assets and businesses   17,884       2,980    
Acquisition of businesses and property   (1,002,852 )     (47,772 )  
Inflows (outflows) from foreign exchange hedge contracts   16,217       (49,351 )  
Costs incurred for purchase and development of enterprise resource planning application   (15,535 )     (18,676 )  
Decrease in capital reserves of commercial insurance subsidiary   85       100    
Net cash used in investing activities   (1,643,933 )     (846,651 )  
         
Cash Flows from Financing Activities:        
Repayments of long-term debt   (828,487 )     (27,791 )  
Additional borrowings   1,800,040       208,986    
Financing costs   (15,261 )     (382 )  
Repurchase of common shares   (729,863 )     (615,941 )  
Dividends paid   (36,552 )     (38,902 )  
Issuance of common stock   12,936       12,119    
Profit distributions to noncontrolling interests   (13,333 )     (10,409 )  
Purchase of ownership interests by minority members, net   4,865       18,728    
Net cash provided by (used in) financing activities   194,345       (453,592 )  
         
Effect of exchange rate changes on cash and cash equivalents   (639 )     2,390    
Increase (decrease) in cash, cash equivalents and restricted cash   31,260       (8,149 )  
Cash, cash equivalents and restricted cash, beginning of period   271,322       224,752    
Cash, cash equivalents and restricted cash, end of period $ 302,582     $ 216,603    
         
Supplemental Disclosures of Cash Flow Information:        
Interest paid $ 110,379     $ 103,050    
Income taxes paid, net of refunds $ 290,239     $ 355,968    
Noncash purchases of property and equipment $ 78,068     $ 146,650    
         
Universal Health Services, Inc.  
Supplemental Statistical Information  
(unaudited)  
                     
                     
              % Change   % Change  
              3 Months ended   9 Months ended
Same Facility:             9/30/2026   9/30/2026  
                     
Acute Care Hospitals (1)                    
Revenues               4.7 %     7.0 %  
Adjusted Admissions               4.9 %     2.6 %  
Adjusted Patient Days               4.9 %     2.9 %  
Revenue Per Adjusted Admission               -1.7 %     2.4 %  
Revenue Per Adjusted Patient Day             -1.7 %     2.1 %  
                     
Behavioral Health Hospitals (1)                    
Revenues               4.0 %     6.2 %  
Adjusted Admissions               2.5 %     1.4 %  
Adjusted Patient Days               2.1 %     1.7 %  
Revenue Per Adjusted Admission               1.7 %     4.9 %  
Revenue Per Adjusted Patient Day             2.1 %     4.7 %  
                     
UHS Consolidated     Third Quarter Ended   Nine Months Ended  
      9/30/2026   9/30/2025   9/30/2026   9/30/2025  
                     
Revenues     $ 4,733,352     $ 4,495,245     $ 13,866,546     $ 12,878,781    
EBITDA net of NCI     $ 640,383     $ 684,229     $ 1,972,295     $ 1,939,469    
EBITDA Margin net of NCI       13.5 %     15.2 %     14.2 %     15.1 %  
Adjusted EBITDA net of NCI     $ 624,645     $ 670,600     $ 1,950,805     $ 1,911,702    
Adjusted EBITDA Margin net of NCI     13.2 %     14.9 %     14.1 %     14.8 %  
                     
Cash Flow From Operations     $ 636,556     $ 380,678     $ 1,481,487     $ 1,289,704    
Capital Expenditures     $ 214,942     $ 228,892     $ 659,732     $ 733,932    
Days Sales Outstanding               55       55    
                     
                     
Debt             $ 5,707,341     $ 4,691,120    
UHS’ Shareholders Equity             $ 7,596,849     $ 7,169,693    
Debt / Total Capitalization               42.9 %     39.6 %  
Debt / EBITDA net of NCI (2)               2.07       1.83    
Debt / Adjusted EBITDA net of NCI (2)             2.17       1.86    
Debt / Cash From Operations (2)               2.78       2.41    
                     
(1) Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.  
(2) Latest 4 quarters.  
                     
Universal Health Services, Inc.  
Acute Care Hospital Services  
For the Three and Nine Months ended  
September 30, 2026 and 2025  
(in thousands)  
(unaudited)  
                                   
Same Facility Basis – Acute Care Hospital Services
                                   
    Three months ended   Three months ended   Nine months ended   Nine months ended  
    September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025  
    Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues  
Net revenues   $ 2,610,702     100.0 %   $ 2,492,536     100.0 %   $ 7,588,636     100.0 %   $ 7,093,193     100.0 %  
Operating charges:                                  
Salaries, wages and benefits     1,044,653     40.0 %     973,522     39.1 %     2,989,221     39.4 %     2,825,945     39.8 %  
Other operating expenses     776,378     29.7 %     722,724     29.0 %     2,283,559     30.1 %     2,033,495     28.7 %  
Supplies expense     363,780     13.9 %     354,698     14.2 %     1,091,408     14.4 %     1,064,615     15.0 %  
Depreciation and amortization     103,340     4.0 %     97,388     3.9 %     302,133     4.0 %     288,747     4.1 %  
Lease and rental expense     28,533     1.1 %     25,543     1.0 %     81,230     1.1 %     75,127     1.1 %  
Subtotal-operating expenses     2,316,684     88.7 %     2,173,875     87.2 %     6,747,551     88.9 %     6,287,929     88.6 %  
Income from operations     294,018     11.3 %     318,661     12.8 %     841,085     11.1 %     805,264     11.4 %  
Interest expense, net     1,302     0.0 %     528     0.0 %     3,589     0.0 %     1,177     0.0 %  
Other (income) expense, net     (9,338 )   (0.4 )%     (678 )   (0.0 )%     (13,082 )   (0.2 )%     (10,261 )   (0.1 )%  
Income before income taxes   $ 302,054     11.6 %   $ 318,811     12.8 %   $ 850,578     11.2 %   $ 814,348     11.5 %  
                                   
                                   
All Acute Care Hospital Services  
                                   
    Three months ended   Three months ended   Nine months ended   Nine months ended  
    September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025  
    Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues  
Net revenues   $ 2,764,072     100.0 %   $ 2,630,065     100.0 %   $ 7,984,207     100.0 %   $ 7,391,716     100.0 %  
Operating charges:                                  
Salaries, wages and benefits     1,054,866     38.2 %     973,680     37.0 %     3,027,576     37.9 %     2,827,912     38.3 %  
Other operating expenses     930,909     33.7 %     878,746     33.4 %     2,676,638     33.5 %     2,352,957     31.8 %  
Supplies expense     365,597     13.2 %     354,697     13.5 %     1,097,029     13.7 %     1,064,486     14.4 %  
Depreciation and amortization     108,924     3.9 %     97,389     3.7 %     311,865     3.9 %     288,751     3.9 %  
Lease and rental expense     28,675     1.0 %     25,543     1.0 %     81,417     1.0 %     75,127     1.0 %  
Subtotal-operating expenses     2,488,971     90.0 %     2,330,055     88.6 %     7,194,525     90.1 %     6,609,233     89.4 %  
Income from operations     275,101     10.0 %     300,010     11.4 %     789,682     9.9 %     782,483     10.6 %  
Interest expense, net     1,302     0.0 %     528     0.0 %     3,589     0.0 %     1,177     0.0 %  
Other (income) expense, net     (9,329 )   (0.3 )%     (623 )   (0.0 )%     (12,446 )   (0.2 )%     (9,806 )   (0.1 )%  
Income before income taxes   $ 283,128     10.2 %   $ 300,105     11.4 %   $ 798,539     10.0 %   $ 791,112     10.7 %  
                                   
                                   
We believe that providing our results on a “Same Facility” basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Acute Care Hospital Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2025 and our Form 10-Q for the quarter ended June 30, 2026.
                                   
Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.
                                   
The All Acute Care Hospital Services table summarizes the results of operations for all our acute care operations during the periods presented. These amounts include: (i) our acute care results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months.
Universal Health Services, Inc.  
Behavioral Health Care Services  
For the Three and Nine Months ended  
September 30, 2026 and 2025  
(in thousands)  
(unaudited)  
                                   
Same Facility Basis – Behavioral Health Care Services  
                                   
    Three months ended   Three months ended   Nine months ended   Nine months ended  
    September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025  
    Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues  
Net revenues   $1,857,445   100.0%   $1,786,231   100.0%   $5,605,292   100.0%   $5,276,686   100.0%  
Operating charges:                                  
Salaries, wages and benefits   1,032,001   55.6%   975,934   54.6%   3,044,335   54.3%   2,854,754   54.1%  
Other operating expenses   361,742   19.5%   342,491   19.2%   1,051,744   18.8%   987,686   18.7%  
Supplies expense   60,459   3.3%   58,016   3.2%   176,804   3.2%   169,968   3.2%  
Depreciation and amortization   58,984   3.2%   53,787   3.0%   170,904   3.0%   156,539   3.0%  
Lease and rental expense   12,271   0.7%   11,167   0.6%   35,630   0.6%   32,457   0.6%  
Subtotal-operating expenses   1,525,457   82.1%   1,441,395   80.7%   4,479,417   79.9%   4,201,404   79.6%  
Income from operations   331,988   17.9%   344,836   19.3%   1,125,875   20.1%   1,075,282   20.4%  
Interest expense, net   1,009   0.1%   1,244   0.1%   3,369   0.1%   3,423   0.1%  
Other (income) expense, net   (5,909)   (0.3)%   733   0.0%   (7,775)   (0.1)%   (929)   (0.0)%  
Income before income taxes   $336,888   18.1%   $342,859   19.2%   $1,130,281   20.2%   $1,072,788   20.3%  
                                   
                                   
All Behavioral Health Care Services
                                   
    Three months ended   Three months ended   Nine months ended   Nine months ended  
    September 30, 2026   September 30, 2025   September 30, 2026   September 30, 2025  
    Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues   Amount   % of Net Revenues  
Net revenues   $1,966,427   100.0%   $1,860,259   100.0%   $5,873,644   100.0%   $5,476,596   100.0%  
Operating charges:                                  
Salaries, wages and benefits   1,057,054   53.8%   995,570   53.5%   3,098,752   52.8%   2,894,489   52.9%  
Other operating expenses   460,853   23.4%   390,783   21.0%   1,296,503   22.1%   1,136,457   20.8%  
Supplies expense   61,022   3.1%   59,696   3.2%   178,284   3.0%   173,133   3.2%  
Depreciation and amortization   63,522   3.2%   55,294   3.0%   179,051   3.0%   159,616   2.9%  
Lease and rental expense   12,568   0.6%   11,652   0.6%   36,295   0.6%   33,979   0.6%  
Subtotal-operating expenses   1,655,019   84.2%   1,512,995   81.3%   4,788,885   81.5%   4,397,674   80.3%  
Income from operations   311,408   15.8%   347,264   18.7%   1,084,759   18.5%   1,078,922   19.7%  
Interest expense, net   1,214   0.1%   1,265   0.1%   3,759   0.1%   3,444   0.1%  
Other (income) expense, net   (5,909)   (0.3)%   733   0.0%   (7,775)   (0.1)%   (929)   (0.0)%  
Income before income taxes   $316,103   16.1%   $345,266   18.6%   $1,088,775   18.5%   $1,076,407   19.7%  
                                   
   
We believe that providing our results on a “Same Facility” basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Behavioral Health Care Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2025 and our Form 10-Q for the quarter ended June 30, 2026.
   
Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.
   
The All Behavioral Health Care Services table summarizes the results of operations for all our behavioral health care facilities during the periods presented. These amounts include: (i) our behavioral health results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired/divested or opened/closed or had changes in governmental certifications/licensure status during the last twelve months.
Universal Health Services, Inc.  
Selected Hospital Statistics  
For the Three Months ended  
September 30, 2026 and 2025  
(unaudited)  
                           
AS REPORTED:                          
                           
    ACUTE   BEHAVIORAL HEALTH  
    9/30/26   9/30/25   % change 9/30/26   9/30/25   % change
                           
Hospitals owned and leased     30       29     3.4 %     388       345     12.5 %  
Average licensed beds     7,519       7,161     5.0 %     24,715       24,398     1.3 %  
Average available beds     7,347       6,989     5.1 %     24,615       24,298     1.3 %  
Patient days     429,842       412,353     4.2 %     1,654,546       1,639,882     0.9 %  
Average daily census     4,672.2       4,482.1     4.2 %     17,984.2       17,824.8     0.9 %  
Occupancy-licensed beds     62.1 %     62.6 %   -0.7 %     72.8 %     73.1 %   -0.4 %  
Occupancy-available beds     63.6 %     64.1 %   -0.8 %     73.1 %     73.4 %   -0.4 %  
Admissions     90,722       86,984     4.3 %     121,428       120,655     0.6 %  
Length of stay     4.7       4.7     -0.1 %     13.6       13.6     0.3 %  
                           
Inpatient revenue   $ 15,763,396     $ 13,935,095     13.1 %   $ 3,356,016     $ 3,063,186     9.6 %  
Outpatient revenue     11,370,036       9,827,354     15.7 %     344,838       282,966     21.9 %  
Total patient revenue     27,133,432       23,762,449     14.2 %     3,700,854       3,346,152     10.6 %  
Other revenue     378,328       315,779     19.8 %     105,977       99,370     6.6 %  
Gross revenue     27,511,760       24,078,228     14.3 %     3,806,831       3,445,522     10.5 %  
Total deductions     24,747,688       21,448,163     15.4 %     1,840,404       1,585,263     16.1 %  
Net revenue   $ 2,764,072     $ 2,630,065     5.1 %   $ 1,966,427     $ 1,860,259     5.7 %  
                           
                           
SAME FACILITY:                          
                           
    ACUTE   BEHAVIORAL HEALTH  
    9/30/26   9/30/25   % change 9/30/26   9/30/25   % change
                           
Hospitals owned and leased     29       29     0.0 %     341       341     0.0 %  
Average licensed beds     7,363       7,161     2.8 %     23,706       23,635     0.3 %  
Average available beds     7,191       6,989     2.9 %     23,606       23,535     0.3 %  
Patient days     428,858       412,353     4.0 %     1,623,726       1,589,558     2.1 %  
Average daily census     4,661.5       4,482.1     4.0 %     17,649.2       17,277.8     2.1 %  
Occupancy-licensed beds     63.3 %     62.6 %   1.1 %     74.5 %     73.1 %   1.8 %  
Occupancy-available beds     64.8 %     64.1 %   1.1 %     74.8 %     73.4 %   1.8 %  
Admissions     90,414       86,984     3.9 %     120,168       117,107     2.6 %  
Length of stay     4.7       4.7     0.1 %     13.5       13.6     -0.5 %  
                           
                           
Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.  
                           
Universal Health Services, Inc.  
Selected Hospital Statistics  
For the Nine Months ended  
September 30, 2026 and 2025  
(unaudited)  
                           
AS REPORTED:                          
                           
    ACUTE   BEHAVIORAL HEALTH  
    9/30/26   9/30/25   % change 9/30/26   9/30/25   % change
                           
Hospitals owned and leased     30       29     3.4 %     388       345     12.5 %  
Average licensed beds     7,373       7,105     3.8 %     24,624       24,246     1.6 %  
Average available beds     7,201       6,933     3.9 %     24,524       24,146     1.6 %  
Patient days     1,280,916       1,254,271     2.1 %     4,905,510       4,849,272     1.2 %  
Average daily census     4,692.0       4,594.4     2.1 %     17,968.9       17,762.9     1.2 %  
Occupancy-licensed beds     63.6 %     64.7 %   -1.6 %     73.0 %     73.3 %   -0.4 %  
Occupancy-available beds     65.2 %     66.3 %   -1.7 %     73.3 %     73.6 %   -0.4 %  
Admissions     267,260       262,352     1.9 %     355,776       355,524     0.1 %  
Length of stay     4.8       4.8     0.2 %     13.8       13.6     1.1 %  
                           
Inpatient revenue   $ 47,313,330     $ 42,140,253     12.3 %   $ 9,924,833     $ 8,901,308     11.5 %  
Outpatient revenue     33,377,475       28,793,716     15.9 %     983,819       851,989     15.5 %  
Total patient revenue     80,690,805       70,933,969     13.8 %     10,908,652       9,753,297     11.8 %  
Other revenue     1,069,466       881,912     21.3 %     298,188       281,291     6.0 %  
Gross revenue     81,760,271       71,815,881     13.8 %     11,206,840       10,034,588     11.7 %  
Total deductions     73,776,064       64,424,165     14.5 %     5,333,196       4,557,992     17.0 %  
Net revenue   $ 7,984,207     $ 7,391,716     8.0 %   $ 5,873,644     $ 5,476,596     7.2 %  
                           
                           
SAME FACILITY:                          
                           
    ACUTE   BEHAVIORAL HEALTH  
    9/30/26   9/30/25   % change 9/30/26   9/30/25   % change
                           
Hospitals owned and leased     29       29     0.0 %     341       341     0.0 %  
Average licensed beds     7,239       7,105     1.9 %     23,809       23,714     0.4 %  
Average available beds     7,067       6,933     1.9 %     23,709       23,614     0.4 %  
Patient days     1,274,419       1,254,271     1.6 %     4,814,191       4,736,987     1.6 %  
Average daily census     4,668.2       4,594.4     1.6 %     17,634.4       17,351.6     1.6 %  
Occupancy-licensed beds     64.5 %     64.7 %   -0.3 %     74.1 %     73.2 %   1.2 %  
Occupancy-available beds     66.1 %     66.3 %   -0.3 %     74.4 %     73.5 %   1.2 %  
Admissions     265,756       262,352     1.3 %     351,347       346,589     1.4 %  
Length of stay     4.8       4.8     0.3 %     13.7       13.7     0.3 %  
                           
                           
Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services’ results have been reclassified into our Acute Care Hospital Services’ results as of January 1, 2025 to conform with current year presentation.  
                           

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.